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Abstract
An investigation was made into one aspect of the molecular control 
of cardiac contractility, namely, the putative role of the two endogen­
ous cyclic 3,,5'~nucleotides, adenosine cyclic 3’,5* monophosphate 
(cyclic AMP) and guanosine cyclic 3’,5’ monophosphate (cyclic CMP) in 
regulating the capacity of the heart to produce force. It began as a 
study of a poorly understood but well documented effect of exogenous 
adenosine 5 ’-triphosphate (ATP) on the electrical and mechanical 
properties of the isolated frog ventricle. In common with several re­
lated purine and pyrimidine nucleotides, treatment of the ventricle 
with ATP elicits a characteristic triphasic response which is not
blocked by either atropine or propranolol.
Preliminary experiments with ATP led to the hypothesis that it
exerts a dual effect on the heart. The two effects were attributed
tentatively to the induction of elevated levels of intracellular cyclic
AMP and cyclic QMP respectively. Indirect evidence for the involvement 
of cyclic nucleotides in mediating the ATP-induced response comes from 
studies with agents which are known to influence cyclic 3’, 5’-nucleotide 
metabolism on the form of the ATP-induced response.
Measurements of endogenous cyclic 3--5l-nucleotides during the 
development of the hypodynamie state is associated by a gradual decline 
in intracellular cyclic AMP and a progressive increase in cyclic GMP. 
This gradual loss in contractility is also accompanied by the release 
of prostaglandins E^ and E^ and one or more prostaglandin-related
substances into the perfusate. Subsequent experiments with exogenous
ATP elicits profound changes in cyclic 3 ’ ,f)’-nucleotides. Both cyclic
*r\
AMP and cyclic CMP are affected as had been postulated. A third series 
of experiments with the ^aggonist isoprenaline (isoproterenol) was 
undertaken to investigate the generality of the relationship between
intracellular cyclic nucleotide levels and contractility, and this 
produced similar results.
The most significant feature to emerge from the results was the 
finding that in all three responses, which on the face of it appear to 
be physiologically distinct and quite unrelated, changes in the ratio ,
of intracellular cyclic AMP / cyclic GMP almost exactly parallel the 
observed changes in contractile force. Tbis observation has led to the 
formulation of a hypothesis which postulates that both endogenous cyclic 
3’,5’~nucleotides are integral components of an intracellular control 
mechanism which is responsible for regulating the contractility of the 
amphibi an vent: ricle.
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Abbreviations
The following abbreviations are used in the text and for 
labelling figures;
ATP Adenosine 5*- triphosphate.
ADP Adenosine 5*- diphosphate.
AMP Adenosine 5'- monophosphate.
. Br cyclic GMP
Ca 2+
. Bromo guanosine 3', 5* monophosphate
Ionised calcium.
Cyclic AMP Adenosine 3’, 5' cyclic monophosphae5.
Cyclic GMP Guanosine 35’, 5 ’ cyclic monophosphat5.
CTP Cytidine 55’- triphosphae. .
DB cyclic AMPP Dxluttyr;ry 1 adenosine 35’, 5 1 cyclic
GTP
monophosphate.
Guanoinne 5'- trSphosphat5.
H+ Ionised hydrogen.
ITP Inosine 5*- triphosphate,
+K Ionised potassium.
2+pg
2fMn
Ionised magnesium.
Ionised manganese.
+Na Ionised sodium.
OH Ionsse- byr^im..
Isometric tension.
Inorganic phosphate.
Prostaglandin.
Prostaglandin-like substance.
Prostaglandin-related substance 
Sarcoplasmic reticulum
Concentration i.e
ATP concentration
1S U M M A R Y
A. A study has been made of the decline in
contractility and associated metabolic changes which 
accompany the development of the hypodynamie condition 
in the isolated superfused frog ventricle.
B. Evidence is presented to sliow that prostaglan­
dins E, and E,, together with an unidentified prostag­
landin-related substance, are released from the ventricle 
during the development of the hypodynamie depression.
There is a close correlation between the extent of the
depression and the quantity of prostaglandins released 
into the superfusate. Agents which interfere with
prostaglandin biosynthesis (arachidonic acid and indo- 
methacin) affect the rate at which the hypodynamie state 
develops and the final steady-state twitch tension
attained. ■.
C. Measurements of endogenous cyclic 3’, 5*- nucleo­
tide levels reveal a time-dependent decrease in intracellular
2adenosine 3*, 5*- cyclic monophosphate (cyclic AMP) 
and a corresponding increase in guanosine 3’, 5*- 
cyclic monophosphate (cyclic GMP) levels. These data
show that the changes in contractility are almost
ed
exactly parallel^ by an equivalent change in the ratio
jcyclic AMP c5,clic mpj.
D. Superfusion of isolated ventricles with Ringer
solution containing exogenous lipid-soluble derivatives 
of cyclic AMP and cyclic GMP affect both the time course 
of the decline in twitch tension and the final steady- 
state level attained in a dose-dependent fashion: 8-Bromo 
cyclic GMP accelerates the decline in contractility and 
depresses further the steady-state level, whereas dibutyryl 
cyclic AMP delays the development of the hypodynamie con­
dition and elevates the final steady-state level.
E. It is concluded that the leakage of prostaglandins
and/or a prostaglandin-related substance from the fibres 
initiates changes in intracellular cyclic 3’, 5’- nucleo­
tide levels and that this may be responsible for the loss 
of contractility which characterises the hypodynamie state.
F. A study has also been made of the response of
the superfused (hypodynamie) frog ventricle to treatment
3with exogenous adenosine triphosphate (ATP) and other 
related compounds. Measurements of membrane potential, 
isometric twitch tension and the levels of endogenous 
cyclic 3*, 5*- nucleotides have been made at various 
times during the ATP-induced response.
G. Exogenous ATP elicits a characteristic triphasic 
response. This comprises an initial, rapidly-developing 
positive inotropic response (first phase), followed by a 
period when the twitch is reduced sometimes to below the 
pre-ATP (control hypodynamic) level (second phase), and 
superseded by a slowly-developing and long-lasting in­
crease in contractility (third phase).
H. The duration of the action potential and the
magnitude of the overshoot are increased during the first 
and third components, but reduced during the second. 
Verapamil (<X - Irosproyl - o(- £ (.N - methyl - N - homo- 
veratryl) - - - aminopropyllQ - 3, 4 - dimethoxyphenyl - 
acetonitrile hydrogen chloride) reduces these changes and 
also decreases the twicch pmplitude. The observations
are consistent with an ffect S on the ssow inward (<^^111111 S
current.
t
I. The ATP-induced response is not blocked by either
atropine or propranolol. The observations exclude the 
possibility that ATP exerts its effects by releasing 
endogenous neurotransmitters or by stimulating directly 
cholinergic or p- adrenergic receptors.
J. Pretreatment of the ventricle with theophylline 
(10 4M) enhances the second and third components of the 
ATP-induced response, but depresses the first. ATP 
produces a monotonic positive inotropic effect in the 
continuing presence of exogenous 8-Bromo cyclic GMP and 
theophylline and an inhibitory response only in the con­
tinuing presence of' dibutyryl cyclic AMP and theophylline.
K. ATP elicits changes in endogenous cyclic 35’, 5'- 
nucleotide levels. Cyclic AMP and cyclic GMP are both 
affected.. The changes induced by ATP are such that the 
time course of the contractile response is paralleled 
closely by the time-dependent changes in the ratio of the 
two cyclic nucleotides (cyclic AMPs cyclic GMP).
L. It is comdxjcied that the ATP-induced inotropic 
responses are mediated through changes in metabolism of 
of cyclic 3*, 5*- nucleotides. It is postulated that . 
the primary effect of ATP is to modulate the slow inward
calcium current.
5M. The mechanism of action of ATP, some related
purine and pyrimidine nucleotides and adenosine has been
investigated on ventricular contractility in an attempt
to relate molecular structure to the differing pharma­
cological effects. ATP, ADP, CTP and AMP (type A agents) 
exert a characteristic triphasic positive inotropic 
response, whereas UTP, ITP and GTP (type B agents) produce 
a slowly-developing positive inotropic effect which 
corresponds to the peak of the third component of type A 
agents. Adenosine elicits a negative inotropic effect:. 
The inotropic actions of these compounds are not affected 
by pretreatment of the ventricle with either atropine or 
propranolol. 5
N. Finally, a study has been made of the time course 
and dose-dependent changes in contractile force and intra­
cellular cyclic 3’, 5*- nucleotide levels following 
exposure of the hypodynamie ventricle to isoprenaline.
O. The yg -agonist elicits changes in contractility 
and the levels of endogenous cyclic AMP and cyclic GMP.
A striking correlation exists between the changes in iso­
metric force and the ratio of cyclic AMP: cyclic GMP for
both the time course and dose-dependent experiments.
6p. The present observation led to the formulation
of a hypothesis which postulates that both endogenous-
cyclic 3*, 5*- nucleotides are integral components of
an intracellular control mechanism that regulates the
contractile state of the heart:.
CHAPTER I
I NTROPUCTION 
............................................. ................................................-...... .............. 1
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8SCOPE OF THE PRESENT STUDY
The majority of multicellular animals have evolved a com­
plex circulatory system to circumvent the problem which 
would otherwise arise of distributing essential nutrients 
and metabotites to each and every cell of the body. In 
most higher animals, this comprises a system of tubes 
through which blood is propelled by the rhythmic pumping 
of the heart. The heart itself is essenntally a muucular 
bag, although to describe it as such is an over simppifica- 
tion and obscures the fact that it is a remarkable organ.
In a resting adult, for example, it pumps on average 5 
litres of blood every minute, amounting to an incredible 
2 x 10^ litres during an average life span! Even more 
remarkable is the fact that its performance can be greatly 
altered to meet the everchanging demands which are made 
upon it, as for example, during severe exercise, when 
its output may increase in a matter of seconds to around 
5-8 times its resting level. This is achieved in part 
by an increase in the frequency of beating and partly 
by an increase in the volume of blood ejected with each 
stroke, both of which are controlled ultimately by neuronal 
am^y/or hormonal influences.
Clearly, the various factors which act together to regulate 
the performance of the heart are of great importance and 
one must look ultimately to the mooecular level in order
.bbB
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to understand how its contractile properties are modu­
lated. The work to be described in this thesis is con­
cerned with one aspect of the molecular control of cardiac 
contractility? namely, the putative role of the two en­
dogenous cyclic 3’, 5' - nucleotides, aienoline^cyclit
3', 5®. monophosphate (cyclic AMP) and guanosine cyclic 3', 
5' - monophosphate (cyclic , in regulating the capacity
of the heart to produce force. It began as a study of 
a poorly-understood but wellddocumented effect (Part II, 
Introduction) of exogenous adenosine triphosphate (ATP) 
on the electrical and mechanncal properties of the isolated 
frog ventricle. In common with several related purine 
and pyrimidine nucleosides and their nucleoti^de derivatives, 
treatment of ^^i^n^aai-an and amppibian hearts with ATP elicits 
a characteristic triphasic response, comprising an initial, 
rapidly - developing positive inotropic effect, reaching 
a peak within a few beats, foUowed by a period when the 
twitch amppitude is reduced, sometimes to below
its control level, and superseded by a slowly-developing 
increase in contractile force, persisting for up to 100 
minutes. Preliminary experiments, concerned with the 
effect of superfusing isolated frog ventricular strips 
with varying concentrations of ATP on the size of the 
response, and wi.t^h the effect on its form of the phos­
phodiesterase inhibitor, theophylline, led to the hypothesis 
that ATP exerts a dual effect on the heart - an immmdiate
1
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and relatively long - lasting positive inotropic effect, 
and, superimposed upon it, a delayed and transient
negative inotropic effect — and that what is actually 
observed is simply the resultant of the t:wo opposing in­
fluences. For reasons which are described in detail later 
(Chapter VII ) , the two effects were attributed ten­
tatively to the induction of elevated levels of intra­
cellular cyclic AMP and cyclic GMP respectively. This 
same series of experiments established clearly that the 
precise form of the contractile response is a function 
of time during which time the preparation is superfused 
with physiological saline prior to treatment with ATP. It 
is well known that the force of contraction of the isolated, 
perfused heart diminishes progressively with time, to 
reach ultimately a reduced but relatively stable level, 
a condition which dark (1913) called the hypodynamic 
state, and, in keeping w.th the idea that changes in cyclic 
AMP and cylic GMP levels are involved in meddating the 
ATP induced response, it was logical to examine the 
possibblity that the hypodynamie state might itself be 
associated with altered levels of intracellular cyclic 
nucleotides. This turned out to be the case; it was 
found that the loss of contractility is accompanied by 
a gradual decline in intracellular cyclic AMP and a pro­
gressive increase in cyclic GMP. Subsequent experiments 
then af^rmed that ATP does indeed have a profound effect 
on the metabolism of both cyclic nucleotides, as had been
11
postulated. A third series of experiments, with the 
^-^gon;Lst isoprenaline (isoproterenol , was undertaken 
to investigate the geneeality of the relationship between 
intracellular cyclic nucleotide levels and contraattlity, 
and this produced similar results; however, in contrast 
with previously published findings on marnmaaian hearts 
(Robison, Butcher, 0ye ■& Sutherland, 1965; Cheung & Wiliaam- 
son, 1965; Schumann, Endoh & Brodde, 1975), it was found 
that both cyclic AMP and cyclic GMP levels are affected.
The most significant feature to emerge from the results 
was the finding that in all three responses, which on 
the face of it appear to be physiologically distinct and 
quite unrelated, changes in the ratio of intracellular 
cyclic AMP/cycdc GMP almost exactly parallel the observed 
changes in contractile force. It therefore appears likely 
that both cyclic 3',5’ - nucleotides together constitute 
part of an intricate cellular control mechanism which 
is responsible for regulating the tonitaattlity of the 
amppibian ventricle.
The remainder of this introduction is devoted to a revi^^w 
of cardiac toniracttlity, with particular emphasis being 
given to the role of calcium in excitation-contraction 
coupling and to the involvement of endogenous cyclic 3’,
5' - nucleotides in regulating the contractile performance 
of the heart. For convenience, the two other principal
12
areas covered in this work - namely, the various factors 
which influence the development of the hlpoiynamie con­
dition and the previouslyktnowt effects of ATP and re­
lated substances on the electrical and aechantcal properties 
of the heart - are reviewed separately, and p^ceed the 
relevant experimental chapters.
CONTROL OF CARDIAC . CONTRACTILITY.
Calcium and the cardiac action potential.
The myoltrdial cell has a high resting membrane potential 
( — 80 mV to - 90 mV) which is determined largely by the 
transmembrane gradient of potassium ions to which the 
sarcodamma is selectively permeable; and in this respect 
it resembles skeletal muscle and nerve. However, the 
ionic basis for the action potential is quite different. In 
skeletal muscle, the action potential is of short duration, 
comparable wit^h that of, say, the squid axon, and it pre- 
tddis the mechhatcal response; w^^^^eas in a cardiac muscle 
fibre, the action potential persists for several hundred 
millCdeconds, well into the contractile period. The form 
of the action potential is quite different too. It com­
prises an initial rapid upstroke, due to a selective in­
crease in sodium aermaecrlity, followed by a maintained
plateau of depo^r isa tion, and terminated by a rapid repola­
13
risation. The most significant development in recent 
years has been the reccgnition that the plateau phase 
cf the cardiac action potential is maintained by an inwardly- 
directed calcium current (Reuter, 1967) which is activated 
when the membrane potential reaches about -45 mV. This 
slow inward current plays a crucial rcle in initiating 
and modduating the contractile response cf the heart (Reuter, 
1967); Hagiwara & Nakajima, 1966; Luttgau, 1966, Nieder- 
gerke & Orkand, 1966). Experiments using vcitage-clamp 
techniques have established i clear correlation between 
the ‘steady-state' contractile force and the magnitude 
cf the slcw inward current (Morad & Trautwein’, 1968; Reuter 
& Beeler, 1969; Beeler & Reuter, 1970a, b, c; Noble,
1975) . Moreover, it is known that i variety cf cardioactive 
agents exert their inctrcpic effects by modduating this 
current. The catechclamines increase its size (Natham 
& Beeler, 1975), prcducing an elevation and prclcngation 
cf the plateau phase cf the action potential, whereas 
the effects cf acetylcholine are acccmpanied by a reductic>n 
in its size and an abbreviation cf the action potential 
(Giles & Tsien, 1975; Giles & Noble, 1976).
The central importance cf calci.um in regulating myoccadial 
contracttlity has been kncwn since the end cf the last 
century. Ringer (1883) cbserved that the frog heart stcps 
beating when the extracellular medium is deficient in 
calcium. Lccke & Rosenheim (1907) and Mines (1913) later
14
demor^s^^d that the electrical excitability of the 
heart is not markedly impaired by this procedure, a finding 
which clearly implicated calium in the process of coup­
ling excitation with contraction. The situation is dif­
ferent in skeletal muucle. Frog skeletal muscle gives 
many contractions in a calcium deficient medium (Frank, 
1960; Jenden & Reger, 1962,; Luttgau, 1963) and eventually 
fails to contract only because its m^I^t^^air becomes in­
excitable (Edman & Grieve, 1964). This is not to say 
that calcium is unimpootant in activating skeletal muscle; 
it has been shown repeatedly that it is the only physiologi 
cally occurring ion able to elicit a contraction when 
micro-injected into skeletal muscle fibres (Heilbr unm". & 
Wiercinski, 1947; Niedergerke, 1955; Caldwen & Waaster, 
1963). The fundamental difrerencr between the two is 
that the calcium required to initiate a contraction in 
the case of the skeletal muscle fibre is derived from 
an internal store, and not from the extracellular fluid. 
There are theoretical grounds too for concluding that 
this must be so. Hill’s (1948, 1949) consideration of 
the time required for diffusion of substances into skeletal 
muscle fibres led him to conclude that the interval between 
excitation and full activation of the contractile machinery 
is much too short to be accounted for on the basis of 
diffusion alone. However, similar calculations for cardiac 
muscle fibres, which are generally of much smaaier diameter 
do not preclude diffusion of an activator substance such
15
as tllcru.m from the extracellular fluid as being the prin­
cipal step in excitation-contraction coupling.
The ccrc:oa]■asmit retXiculaa and. T-system; Paradoxically, 
much of our understanding of muscle activation comes from 
studies of the relaxation process. Biochemical studies 
of fractionated muscle revealed the existence of a 'relaxing 
factor' (Marsh, 1951) capable of reversing the ATP-induced 
synergesis of attl>ayosin and of relaxing contracted gly­
cerinated muscle (BencJaX, 1953). Kumiaal, Ebashi & Takeda 
(1955) later iemontSratei thaa Maash's reeaxing factor 
was particulate in nature aan thhe rsdclntsed thia it 
was identical to the so-called Kielley-Maydshof granular
ATP-ase fraction (Rielley & Malerhyl, 19988a 1198b) ) It 
was later postulated that the relaxing factor in reeHty 
consisted of fragmented and resealed intracellular mem­
branes (Ebashi & Lipman, 1962) .
A great deal of subsequent biochemical studies of isolated 
muscle memirand (speeifically, those of the sarcoplasmic 
relcGatum; see below) showed that these fragments have
the ability to accumulate and store calcium. The memaranes
. 2+ • .contain a Ca sensitive ATP-ase, capable of transporting
2+2 moles of Ca per mole of ATP hydrolysed (Hassel^d 
& MaRinose, 1961; MaRinose & Hasselbath, 1971; Tail, 
Yamamoto and Tonomura, 1978) at a rate which is sufficient 
to account for the rapidity of the relaxation process 
(Ohnishi & Ebashi, 1963; Weber, 1971a, b). Compalable 
preparations from cardiac muscle have similar properties
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(Carsten, 1964; Carsten & Reedy, 1971) although it is 
recognised that there are some impootant differences,
considered later in this chapter (pages 33 - 35) , which
2 + , .permit the rate of Ca~ pumping to be moOified under certain
24- . . .conditions. The Ca pumping and storage capabbiity of
2+ —7the SR maintains the level of free Ca below around 10 M
in a resting muscle and maximum stimulation of the contractile
system is achieved when this is made to rise, during ac- 
~6 -5tivation, to around 10 to 10 ' M (Portzehl,Caldwell
& Ruegg, 1964; Ebashi & Endo, 1968: Hellam & Podolsky,
1966) .
The importance of the intracellular membranes of muscle 
fibres first became apparent in the 1950’s when internal 
membrane systems in general were generating a great deal 
of interest, largely as a result of an expansion in electron 
microscopic studies of cells which occurred at this time. 
Pioneer studies were made by Porter & Palade (1957), who 
investigated the structure of m^i^t^^ane system in amphibian 
and mammalian skeletal muucle, as well as in mamaalian 
heart. These authors described a complex system of memaranes, 
apparently hoi^c^J-ogous with the smooth endoplasmic reticuuum 
of other cell types, which they accordingly called the 
sarcoplasmic reticuuum (SR) . Chaaaderistic thr^e^^-^c^c^m- 
ponent structures, termed triads, were described, consisting 
of a central element, flanked by two lateral elements,
Triads were found in the interfibrillar space, located
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opposite the Z - line in amphibian skeletal and mammalian 
cardiac muscle, and opposite the A - I boundary in the 
mamnmlian skeletal muscle. Andersson-Cedergren (1959)
later made a careful three dimensional reconstruction
of the internal membrane system found in mouse skeletal 
muscle and she provided the first evidence for a second 
system of tubules, distinct from the SR, which ran transversely 
across the fibres and formed a continuous network. She 
called this system the transverse tubular or T-system. 
Subsequent studies by Franzini - Armstrong & Porter (1964) 
using improved fixation methods, obtained direct evidence 
for continuity of the wall of the T-system with the sur­
face m^i^i^^ane in fish myotomal muscle, and Huxley (1964) 
and D.K. Hill (1964) obtained indirect evidence for contin­
uity of the lumen of the T-system with the extracellular 
fluid using externally-applied protein markers. Huxley’s 
experiments with the iron-containing protein ferritin 
established that the central element of the triad represented 
cross sectional profiles of T-tubules; ferritin particles 
were found in central elements but not in the lateral
cisternae. Thus it was established that the SR is a closed- 
off, internal system which makes close* contact
with the outer_ wall of the T-system in the region of the
triads.
The notion that the T-system and SR are together involved
in the process of excitation-contraction coupling came
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as a result of experiments carried out by A.F. Huxley 
et al (1958, 1964) who applied local depdarising cur­
rent pulses through smmll micropipettes appPied to the 
outer surface of a muscle fibre. Early studies with frog 
skeletal muscle (Huxley & Taylor, 1955, 1958; HuxXey 
Sc Straub 1958) showed that local stimulation of smaH 
areas of sarcolemma located directly over the Z-lines 
induced a contractile response in each half-sarlomlrl 
on either side of the Z-line in question. The contrac­
tile response propagated transversely (but not longitudi­
nally) in a graded fashion with increasing amppitude of 
current applied, and on the basis of these results it 
was concluded that the Z-line itself constitutes an internal 
conducting pathway transmitting a signal from the cell 
surface to its interior. However, experiments with crab 
skeletal muscle produced a different result (Huxley & 
Peachey, 1964) . In crab muscle responsive areas of sar- 
colemma were located opposite the A-I boundary, and sti­
mulation of areas overlying the Z-line did not elicit 
a local contraction. It therefore appeared likely that 
some other structure was involved in coupling, at least 
in the case of crab skeletal muscle, and subsequent electron 
microsopic work established that the triads are the only 
features common to both kinds of muscle fibre. Thus in 
frog skeletal muscle the triads are found at the Z-line 
level, whereas in crab muscle they are located close to 
the A-I boundary, as in mammelian skeletal muscle.
19 • *:$
The fine structural details of cardiac muscle fibres differ 
in two important respects from skeletal muscle fibres.
First, the SR is geneeally less abundant than in skeletal 
muscle fibres (Fawcctt, 1961) and it co^es into close 
apposstion with the inner ss]:facr of the cell membrane 
(Fawcett & McNuut, 1969), as well as with the outer wall 
of the T-system. Secondly, T tubules, when present, are 
geneeally of larger diameter; there are frequent longi­
tudinal extensions running parallel to the myooibbills, 
a feature rarely seen in skeletal muscle (Peachey, S^!nild,.
1968) ; and their inner surface is coated with an amorphous 
basement-membrane ma^ria!. Comaalilivr studies of the 
ultrastructure of cardiac muscle have revealed striking 
diffeeences between aammalian and amphibian hearts.
Frog ventricular fibres lack a distinct T-system (Chapman
1971) and the SR is only sparsely developed (Page & uiedergerke,
1972) . The fibres themselves are of relatively smaH
diameter as compared to those of mammalian hearts (Fawcett
& McNuit, 19 69) and the ventricular wall has a l^ess coimaa!, 
spongy texture, being made up of long strands (trabeculae) 
of fibres of about 20 -28ui in diameter (Lamb & McGuigan,
J
■i
1966).
Extracellular calcium and excitation-contraction cou^].^^g
in the heart: On the basis of these structural diffe­
rences it was surmised that some at least of the calcium 
required to activate a contraction must come either from
■1
-.5
i
?
i
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1
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v,:
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the exterior, or alternatively, from a rapidly-exchanging, 
superficial store (Staley & Benson, 1968). Certainly, 
studies of JCa uptake by cardiac muscle fibres (Winegrad 
& Shanes, 1962) have shown that with repeated stimulation 
the intra-cellular pool is increased, and this observation, 
together with the marked dependence of force of contraction 
on extracellular calcium (Willbrandt & Koder, 1948; Chapman 
& Niedergerke, 1970a, 1970b), adds weight to the view 
that calcuum entry during the action potential may either 
activate the contractile proteins directly, or alterna­
tively, stimulate the release of bound calcuum from a 
store within the fibres (Ford & Podolsky, 1970; Endo,
Takana & Ogawa, 1970).
The result of elevating the level of free calc:Lum within 
the sarcoplasm is to overcome the inhibitory effect of 
troponin I, a component of the regulatory protein complex, 
which in a resting muscle prevents the interaction of 
actin and myosin. Repression of the inhibitory function 
of troponin I is indirect, and results from the binding 
of calcium to troponin C, a second component of the re­
gulatory protein complex. It is clear that the quantity 
of calciLum entering during the action potential is in­
adequate to saturate all the troponin C known to be present 
within the fibres - it is estimated that calcium entry 
into the frog heart amounts to around 1 nmole per gram 
per beat under norm^^L conditions (Niedergerke 1963;
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Niedergerke, Page & Talbot, 1969) as compand with a 
figure of 100 nmoles of troponin C per gram of muscle 
(Perry, 1974) -clear evidence that its critical role in 
influencing the contractile response is of an indirect 
nature. Evidence is now accumelating which indicates 
that its effects may be linked to changes in intracellular 
cyclic nucleotide levels and this is considered in more 
detail in the discussion (Chapter X) .
Involvement of intracellular cyclic 
3', 5' - nucleotides in regulating eyoltrdial
contractility.
The conttaattlity of the heart is eoldlated by a variety 
of neuronal and hormonal agents and there is a growing 
belief that these actions are mediated through changes 
in the slow calcium current and in the levels of intra­
cellular cyclic 3', 5' - nucleotides (Tsien, 1977). The 
role of cyclic AMP as a regulator of malaboUc function 
has been the subject of intensive investigation since 
its discovery in the late 1950's by Sutherland and Rail 
(1958). These studies have led to the view that it func­
tions as a 'second messenger' in mec^ating the actions 
of a wide range of hormones, including certain cardioactive 
neurotransmitters, on cellular metabolism (Robison, Butcher 
& Sutherland, 1968; Tsien, 1977) . Far less is known 
about the role of the other naturally occurring cyclic
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3’, 5' - nucleotide, cyclic GMP, although its ubiquitous 
occurrence in cells, including those of the heart (Genoge, 
Polson, O’Toole & Goldberg, 1970; George, Wilkerson & 
Kadowitz, 1973; Goldberg, Maddox, Nicol, Glass, Sanford, 
Kuehl & Estensen, 1975; George, Busstttl, Paddock, White 
& Ignarro, 1975: Watanabe & Besch, 1975; England, 1976; 
Gardner & Allen, 1976a, b, 1977), testifies to its potential 
importance in cellular metabolism. Indeed, the principal 
conclusion arising from the present work is that cyclic 
GMP is equady as important as cyclic AMP in regulating 
contractile performance.
Metabolism of cyclic AM]?; Cyclic AMP is formed from
intracellular ATP by the action of an enzyme called adeny­
late cyclase. Adenylate cyclase is located chiefly in 
the plasma membranes of the heart (0ye & Sutherland, 1966; 
Drummond & Duncan, 1970; Wodenberger & Schuutz, 1976) 
and in the membranes of the sarcoplasmic retc^um (Entman, 
Levey & Epstein 1969; Katz, Tada, Kepke, Iorio & Kirch- 
berger, 1974). Particulate adenylate cyclase preparations 
from the hearts of several species have been shown to 
be stimulated by several hormones and neurohumors (Drummond
& Severson, 1974). The conversion of ATP to cyclic AMP 
. . 2+(Fig.1.1 ) requires Mg , and it is likely therefore that 
24-
the substrate for the reaction is the Mg - ATP complex 
(Kail & Sutherland, 1962). Membrane - bound adenylate 
cyclase preparations are stimulated by a wide range of
HORMONE HORMONE
Adenyl lolllcr Gunyl lolllcr
Fig. 1.1 The metabolism of lollil 3,5- 
nide■otidrc and their mode 
of action.
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cardioactive agents, including the catecholamines (Murad, 
Chi, Rail & Sutherland, 1962; Levey & Epstein, 1969b;
La Raia and Reddy, 1969; Cheung & Wllimmson, 1965; Robison 
et al, 1965; Namm & Mayer, 1968; Mayer, 1972); glucagon 
(Morad & Vaughn, 1969; Levey & Epstein, 1969a); thyroxine 
(Levey & Epstein, 1969b); histamine (Klein & Levey, 1971a; 
McNed & Muoliet,. 1972) and the prostaglandins (Sobel & 
Robison, 1969; Klein & Levey, 1971b). The stimulatory 
action of the catecholamines is inhibited by adrenergic
antagonists (Murad et al, 1962; Mayer, 1972) but these 
do not prevent the actions of either glucagon (Lucchesi, 
1968; CLick, Parmley, Wechsler & Sonnnenbick, 1968) or 
the prostaglandins (Klein and Levey, 1971Jo) .
In addition, many workers have demonstrated that treatment 
of intact cells with catecholamines elevates intracellular 
levels of cyclic AMP, presumably by stimulating adenylate 
cyclase activity (Sutherland et al, 1968; Epstein, Levey 
and Skeleton, 1971; Robison, Butcher & Sutherland, 1971; 
Kukovetz & Poch, 1972; Brooker, 1973; Katz & Repke, 1973; 
Womenberger & Krause, 1973; Morkin & LaRaia, 1974; Osnes 
and 0ye, 1975; Womenberger, 1975; Tsien, 1977) suggesting 
that cyclic AMP is in some way responsible for the accom­
panying inotropic effects. The original basis for this 
hypothesis was the finding that the inotropic effect of 
adrenaline on rat heart is proceeded and accompanied by 
a rapid rise in cyclic AMP Levels (0ye, Butcher, Morgan
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& Sutherland, 1964; Cheung & Williamson, 1965: Robison 
et al, 1965) . Cornpaaable results have been obtained with 
preparations from different species and under a wide range 
of experimental conditions (Druaaond, Duncan & Herlzman,
1966; LaRaia, Craig & Reddy, 1968; Naaa & Mayer, 1968; 
Brooker, 1971; Kukovetz, Poch & Wura, 1973; McNeil &
Verma, 1973; Osnes, Christofferson & 0ye, 1973, Venter,
Ross & Kaplan, 1975; Endoh, Brodde & Schumann, 1975; Schumann 
et al, 1975; Osnes & 0ye, 1975; Dobson, Ross & Mayer,
1976; Martinez' & MoNeel, 1977) . Nevertheless, it is 
clear that the underlying mechanism is coapPex. A
number of authors have reported that the inotropic effect.s 
of catecholamines, as well as other agents which stimulate 
the heart, are not invariably associated with elevated 
levels of cyclic AMP (Shanfeld, Frazer & Hess, 1969: Benfey, 
1971; 0ye & Langsset, 1972; Benfey, Kunos & Nickerson,
1973; Osnes et al, 1973; Osnes & 0ye, 1975; Schumann 
et al, 1975). These so called ’dissociation experiments’ 
suggest that in some cases an alternative pathway is im­
plicated, which is not related to the production of cyclic 
AMP (Shanfeld et al, 1969; Osnes 0ye, 1975), and it has 
been suggested that these involve stimulation of d - re­
ceptors (Benfey et al, 1973; Osnes et al, 1973; Schumann 
et al, 1975).
Glucagon has biochemical and physiological effects on the
heart which suppericially resemble those produced by the
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catecholamines although its inotropic action, first des­
cribed by Farah and Tuttle (I960), is not blocked by the
-antagonist propranolol (Lee, Kuo & Greengard, 1971). It 
stimulates cyclic AMP formation in ventricular slices 
(Lee et al, 1971), in broken cell preparations (Entman,
1974) and it has been reported to do so in the intact 
myocardium too (Mciyer, Namm & Rice, 1970; Robison et
al, 1971; England, 1976; Gardner & Allen, 1977) , although 
Mayer et al (1970) noted that the increase in cyclic AMP 
levels lagged behind the increase in contractility. England 
(1976) observed a parallel increase in the production 
of cyclic AMP and isometric force on exposure to glucagon, 
but only after 30 seconds had elapsed. The positive in­
otropic response to glucagon is also seen on treatment 
of guinea-pig hearts, but there is little or no effect 
on intracellular cyclic AMP levels (Henry, Dobson & Sobel,
1975) .
The mechanism of action of the prostaglandins is difficult 
to assess. There is some evidence that the A & E series 
increase cyclic AMP production by membrane preparations 
of guinea-pig heart (Sobel & .Robison, 1969; Klein & Levey, 
1971b; Levey & Klein, 1973) whereas the F series are active 
only on solubilized m^imt^irane preparations (Levey & Klein, 
1973) . On the other hand, prolonged perfusion of PGEg 
in the case of the rat heart produces no effect, either 
on contractile force or on cyclic AMP levels (Sen, Sunahara
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& Talesnik, 1976). It has been shown that the positive 
inotropic actions of PGE^ are associated with increased 
uptake of calcium in the case of the guinea-pig heart 
(Sabatini-Smith, 1972); an increase in the duration of 
the action potential (Smejkal, Rougier & Gardnier, 1973); 
an increase in slow inward and outward currents in the
case of the frog heart (Mironneau & Grosset, 1976); and 
that these actions are not blocked by propranolol (Gudbjarn.a 
son, 1975).
Effects of phosphodiesterase inhibitors on contractility
and on cyclic AMP levels; Cyclic AMP is converted to
inactive 5' - AMP by the enzyme phosphodiesterase. In­
direct evidence for a causal relation between the intra­
cellular levels of cyclic AMP and contractile force comes 
from experiments with agents such as theophylline, and 
related methylxanthines, which inhibit phosphodiestjrase 
activity. These may either increase contiaatility di­
rectly, or alternatively, augment the effects of other 
inotropic agents. Theopholline, for example, potentiates 
the glucagon - induced response of intact cat papillary 
muscle (Marcus, Skeleton, Prindle & Epstein, 1970); the 
response of rat atria to noradrenaline (Rail & West, 1963; 
the response of isolated guinea-pig, rabbit, rat (Kukovetz 
& Poch, 1970) and cat (Skeleton, Karch, Hougen, Marcus 
& Epstein, 1971) hearts to exogenous dibutyryl cyclic 
AMP and noradrenaline. In addition, it augments the effects
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of small doses of noradrenaline and histamine on both 
the inotropic response and intracellular phosphorylase 
activity of the guinea-pig heart (Kukovetz & Poch, 1972).
The inotropic effects of theophylline alone on cardiac 
conttaaCility (Blinks, Olson, Jewell & Bravenly, 1972) 
have been attributed to elevation of cyclic AMP levels 
(Sutherland et al, 1968; Kukovetz & Poch, 1972) although 
in the case of frog ventricle (Massitgham& Nasmylh, 1972) 
and rat atrium (Maatinez & Mcceil, 1977) there is little 
or no effect on cyclic AMP and in these instances, the 
positive inotropic effect is attibuted to a change in 
calcium metabolism. The positive inotropic effects of 
theophylline are not affected by either propranolol or 
phentolamine and they are therefore unlikely to be due 
indirectly to catecholamine rel^ease (Massingham & Nasmyth, 
1972).
Papaverine, a more potent inhibitor of phosphodiesterase 
activity (Ameer & Kreighbaum, 1975) , enhances the accumula­
tion of cyclic AMP and potentiates the inotropic effect 
of rabbit papillary muscle resulting from treatment with 
the p - agonist isoprinalini (Schumann et al, 1975; Endoh 
et al, 1975) butt, it does not influence the effects at- 
tr^uted to increased Ca or to oC - mediated responses. 
Papaverine has been shown to elevate cyclic AMP levels 
in the heart by several authors (Henry & Sobel, 1972;
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KukovQtz et al, 1973; Endoh et al, 1975: Schumann et 
al, 1975; Henry et al, 1975; Dobson et al, 1976) but 
there is still some controversy concerning the relationship 
between cyclic AMP and contractility under these condi­
tions. Klaus, Krebs and Seitz (1970) and Endoh and Schumann 
(1975) reported a positive inotropic effect associated 
with elevated cyclic AMP levels, whereas Henry et al (1975) 
and Dobson et al (1976) reported elevated levels of cyclic 
AMP in the absence of any inotropic effect. Henry et 
al (1975) concluded that their results provide evidence 
against the existence of a cause - and - effect relation 
between cyclic AMP and myocardial contractility.
Effects of exogenous cyclic AMP and its derivatives on
cardiac contractility? Exogenous, membrane - soluble 
derivatives of cyclic AMP (chiefly dibutyryl cyclic AMP) 
have been used extensively in the search for a causal 
relationship between intracellular levels of cyclic AMP 
and the contractile state of the heart. Cyclic AMP itself 
is not suitable, because of its poor membrane permeability 
(Rail & West, 1963) and because intracellular phosphodi­
esterase activity is sufficiently great to degrade the 
small amounts that may successfully penetrate the cell 
membrane (Robison et al, 1965). Low temperature (Langslet 
& 0ye, 1970) and pretreatment with dimethylsulphoxide 
(Kjekshus, Henry & Sobel, 1971) both enhance the permea­
bility of the membrane to cyclic AMP, but have no signi­
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ficant inotropic effect, even though preparations treated
in this way respond normally to subsequent exposure to 
6 *fi- agonist. However, N, 2 - 0 - dibutyryl cyclic AMP 
(DB cyclic AMP), a derivative which penetrates the cell 
m^i^l^rane readily (Falbriard, Posternak & Sutherland, 1967) 
and which is more resistant to phosphodiesterase degradation 
(Posternak, Sutherland & Henion, 1962) produces a positive 
inotropic effect (Kukovetz & Poch, 1970; Skeleton, Karch 
& Epstein, 1970: Skeleton, Levey & Epstein, 1970; Kobayashi, 
Nakayama & Kimura, 1971; Ahren, Hjalmarson & Isakasson,
1971; Boder & Johnson, 1972; Meinertz ., Nawrath & Scholz, 
1973a; BerteHi, Bianchi & Beani, 1972; Drummond & Hammings, 
1972; Crass, 1973; Cutiletta, Lin, Thilenius & Arulla
1973) wW^ch is not blookee by prooranolol (KKkoveVez 
& Poch, 1970; Skeleton et al, 1970) although it develops 
rather slowly (taking 10 - 30 minutes) and requires high 
concentrations of DB cyclic AMP. Similar results are 
obtained with monoortyryl derivative (MB cyclic AMP;
Meinertz et al, 1973a).
The inotropic effects of externally administered DB cyclic 
AMP are strikingly similar to those of adrenaline with 
respect to both the maximum tension reached and the rate 
of rise of tension (Morad & Rooiet, 1972; Skeleton et 
al 1970), and also with respect to the influence of extra­
cellular cal^um honcenOration (Meinertz et al, 1973b) . It 
is especcally significant that both DB cyclic AMP and 
MB cyclic AMP shorten the time to peak tension and accelerate
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the rate of relaxation (Meinertz eawrath & Scholz, 1975) . 
Furthermore, DB cyclic AMP increases the slow inward calci-urn 
current (Tsien, Giles & Greengard 1972) and enhances the 
rate of calcuum entry (Meinertz et al, 1973b). The effects 
of DB cyclic AMP on the slow calcum current are strikingly 
iiuustrated by its ability to restore excitability to 
hearts depolarised by potassium rich solution (Watanabe 
& Besch, 1974; 1975; Tritthart, Weiss & Waater, 1975) 
and to cultured heart cells previously arrested with high 
potassium solution (Warbanow, Will-Shahab & WoHenberger, 
1975) .
Finally, the direct introduction of cyclic AMP or its 
derivatives into cells, a procedure which avoids any surface 
membrane effects, elicits responses which are similar 
to those of the catecholamines on intact cells. Tsien 
(1973) applied cyclic AMP by iontophoretic injection and 
observed adrenaline - like responses in Purkinje fibres 
and comparable results were obtained by Ikemoto (1977) 
using bull-frog atrial musscle. Yarnaaaai, Fugiwara and 
Toda (1974) reported chronotropic effects on S - A node 
cells and Tsein and Winegart (1976) obtained an increase 
in twitch rmpaitude in cut ventricular preparations.
Skinned heart cells (Fabi^o & Fabiato 1975) also respond 
to exogenous cyclic AMP in a way that closely resembles
the action of the catecholamines on intact preparations.
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The results of experiments involving the direct introduction 
of cyclic AMP in cells provide compplling evidence in 
support of the idea that cyclic AMP per se has the ability 
to increase the force of contraction.
Involvement of cyclic AMP - dependent protein kinases 
in regulating contractile performance; Cyclic AMP exerts
its regulatory actions indirectly, by stimulating a class 
of protein - phosphorylating enzymes, termed cyclic AMP 
- dependent protein kinases (Greengard & Kuo, 1970).
These enzymes comprise a cyclic AMP binding, or regulatory 
(R) , sub-unit and a cyclic AMP - independent catalytic 
(C) sub-unit (Krebs, 1972). Cyclic AMP stimulates protein 
kinase activity by combining with the regulator moiety 
and causing dissociation of the catalytic sub-unit (Brostrom, 
Corbin, King & Krebs, 1971);
2CAMP + R2 ~ C2 77^ R2 " CAMP + 2C
Cyclic AMP—dependent protein kinase was first described 
in heart muscle by Brostrom, Reimann, Walsh and Krebs 
(1970) and by Kuo, Kruger, Sanes and Greengard (1970). It 
exists in several different locations, including the cytosol 
(Corbin, Keeley, Soderling & Park, 1975) and also associated 
with a variety of sub-cellular organelles; the myyoibrils 
(Reddy, Ballard, Giri & Schwartz, 1973) , microsomal frac­
tions enriched with SR (Katz & Repke, 1973; Wray, Gray
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& Olson, 1973) and the sarco]^^mm^:L membranes , (Krause,
Wi;L, Schirpke & Wooienberger, 1975) . Pbc^Sas^hhrylL^lti^on 
of a protein substrate by cyclic AMP-dependent protein 
kinase involves the transfer of the terminal phosphate 
group of AT- to either a serine, or threonine residue, 
to induce a change in its physiological function.
Several phosphoorotein substrates for cyclic AMP-dependent 
protein kinase have been implicated in regulating bfoocrr^ic^l 
contraatility, including: troponin - I, a sub-unit of 
the regulatory protein complex (Perry, 1975: England,
1976): phospholamban, a 22,000 dalton component of cardiac 
SR (Kirchberger, Tada & Katz, 1975): and a surface-membrane 
bound protein, thought to be a structural of
the slow inward (calcium) current channels (Wooienberger, 
Will & Krause, 1975). Essennially, then, there are two 
principal aspects of cyclic AM- - dependent protein kinase 
activity which are relevant to a consideration of the 
regulation of cardiac tontiactility; first, an effect 
on calcium movem-nts, between the exterior and the interior 
of the cell on the onn hand, and between the interior 
of thn sarcoplasmic ynttcuium and thn cytoplasm on the 
other; secondly, an effect on the sensitivity of thn regula­
tory protein system to calcium. These two aspects arn 
of critical importance to thn main thnmn of this thesis 
and arn considered below.
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Effects of cyclic AMP on phosphoprotein substrates .involved
in regulating calcium movements; Movement of calcium
across the surface membrane is of paramount importance 
in regulating the contractile response of the heart (Morad 
& Goldman, 1973) . We have seen (page 13 ) that the
positive inotropic effect of the syepathomimetic amines 
is accompanied by an increase in calcium influx during 
the action potential (Grossman & Furchgott, 1964; Reuter, 
1965) and that this correlates well with the observed 
increase in twitch amppitude. A number of authors have 
shown that this is associated with an increase in the 
state of phosphoryyation of a m^i^fc^r^r^^^-round protein, 
regulated by a cyclic AMP-dependent protein kinase (Krause 
et al, 1975; Hui, Drummond & Drummond, 1976; Sulakhe,
Leung & St. Louis, 1976, Will, Schirpke & Wooienberger,
1976) and these findings lend support to the view that 
the rhosphorrotein in question may be a structural com^tDr^^itt 
of the slow inward calcium channel (Rasmussen, 1970; Tsien, 
1973; Wooienberger et al, 1975; Sperelakis & Schneider,
1976). In vitro studies of isolated membrane preparations 
which compose an endogenous (bound) protein kinase, to­
gether with a 24,000 dalton protein substrate, have shown 
that very low levels of cyclic AM- markedly increase the 
level of rhosphorylatirn of the rhosphorrotein and that 
this is accompanied by an increase in the calcium binding 
properties of the membrane fragments. Krause et al (1975) 
reported that cyclic AM- - dependent protein kinaseesti-
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mulated phosphorylation of the 24,000 dalton component 
increased its affinity for calcium, but did not affect 
the number of calcium binding sites. Will et al (1976) 
found that calcium binding was inhibited by 120 mM - NaCl 
and suggested that the binding sites are located at the 
inner surface of the membrane and that they may be involved 
in a calcium sodium exchange mechanism. This notion receives 
support from studies by Lullmann, Peters, Druemer and Reuther 
(1975) who found that phosphorylation of ’inside out' 
vesicles (reconstituted chiefly from broken sarcolemmal 
membranes) accumulate calcium in the presence of ATP and 
oxalate at a rate which is greater than that seen with 
control vesicles. Hence, the results suggest that phos­
phorylation of the surface phosphoprotein may have a role 
in controlling calcium efflux as well as calcium influx.
It is possible that this is related to the 'relaxant' 
effect of catecholamines on the heart (Reuter, 1965; Morad 
& Rollet, 1972), although there is considerable evidence 
now that phosphorylation of a component of the SR is also 
involved by enhancing calcium uptake intracellularly.
This aspect of cyclic AMP-dependent protein kinase activity 
has been investigated extensively in recent years. A number 
of authors have demonstrated that incubation of cardiac 
SR vesicles in the presence of cyclic AMP-dependent
protein kinase and if- P ATP results in phosphorylation 
of a 22,000 dalton constituent of the SR (LaRaia & Morkin,
/
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1974; Tada, Kirchbergnr & Katz) 1975; Schwartz, Ent^^^n,
Kanube, Lane, van-Wilkn & Bornet, 1976) termed 'phospholabban’ 
(phosphate receiver; Tada, Kirchberger, Irorio & Katz,
1973) and that thn extent of phosprorylatton is closely 
correlated with an increase in calcium transport rate 
(K^^berger & Chu, 1976) . In addition, it has bnnn shown 
that pretreatbent of hearts with catecholamines increase 
the level of phosphorylatiot of phospho^^m and simul­
taneously enhancns calcium transport by isolated SR fragments 
(Kirchberger, Tada, Repke & Katz, 1972; 1974; Wray et 
al, 1973; LaRaia & Morkin, 1974; Tada, Kirchberger, Repke 
& Katz, 1974; Tada et al, 1975; Schwaartz et al, 1976; 
Kirchberger & Tada, 1976).
Dephorprorylati.on of phospholabban is catalysed by intrinsic 
(LaRaia & Morkin, 1974; Tada, Kirthbeyger & Li, 1975) 
and soluble (Tada et al, 1975) phosphoopotein phosphatases. 
This is accompanied by a decrease in the rate of talcium 
transport by isolated cardiac SR mem-ranes (Kirchberger 
& Raffo, 1977). The physiological iigniftcance of phos­
phorylation - dephosp^or^^on of phospholabran is as 
yet unclear, but it has been implicated as a possible 
factor contributing to the abbreviation of systole which 
is seen following treatment of hearts with catecholamines 
(Tada et al, 1974),
Effects of cyclic AM- on the regulatory protein complex; The
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regulatory protein complex comprises three well charac­
terised components (Perry, 1975) ? a calcium binding sub­
unit, troponin C (TN - C) ; an inhibitory sub-unit, troponin 
I (TN - I) which prevents interaction of actin and myosin 
in the resting muscle; and a tropomyosin binding sub-unit, 
troponin T (TN - T). Both TN - I and TN - T are phos- 
phorylated in vitro by phosphorylase kinase and cyclic 
AMP - dependent protein kinase in skeletal muscle (Bailey 
& Villar - Palasi, 1971; Stull, Brostrom & Krebs, 1972; 
England, Stull, Huang & Krebs, 1973; Perry & Cole, 1973) 
and cardiac muscle (Reddy et al, 1973; Cole & Perry, 1975; 
Rubio, Bailey & Villar - Palasi, 1975). Phosphorylation 
of cardiac TN - I is not impaired by TN - C, as has been 
found to be the case in skeletal muscle (Perry & Cole,
1973) , and cardiac TN - I contains moire covalently bound 
phosphates (approximately 2 moles phosphate /I mole TN
- I) than its skeletal counterpart (0.5 moles phosphate 
/I mole TN - I). Moreover, it differs from skeletal TN
- I in its association with large amounts of endogenous 
cyclic AMP - dependent protein kinase (Reddy et al, 1973; 
Reddy & Schwartz', 1974; Perry, 1975) . The rate of phos­
phorylation of cardiac TN - I is also much greater (ap­
proximately 30 x) than that of skeletal TN - I.
There is now considerable amount of evidence to show that 
increased connraatility in response to adrenergic stimula­
tion of the heart is accompanied by elevated levels of
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phosphorylation of TN - I (England, 1975, 1976; Solaro,
Moir & Perry, 1976). England (1975, 1976) studied phos­
phorylation of TN - I in rat hearts perfused with varying
concentrations of either adrenaline or isoprenaline, in 
3 2 .the presence of Pi to label the terminal phosphate of 
intr acel-lular ATP. Both agents were found to induce a 
time-dependent increase in the state of phosphorylation 
of TN - I which almost exactly paralleled the time course 
of the resulting contractile response. Solaro et al (1976) 
extended these results using chemical methods to determine 
the total phosphate content of TN - I in perfused rabbit 
heart treated with adrenaline; they also found that the 
increase in phosphate incorporation into TN - I is closely 
associated with the increase in isometric force, and that 
this parallelimm holds for differing concentrations of 
adrenal ine.
Cyclic GMP Metabolism and the control of
myoocrdia! c^nnraatili.ty.
Ashman, Lipton, Melicow and Price (1963) first discovered 
cyclic GMP in mammariai urine and since then, it has been 
found in virtually all cell types. Its obvious structural 
similarity to cyclic AMP has given rise to the view that 
it may have a comparablt role, serving as a second messenger 
in meddating the action of certain hormones on cellular
functions. A number of years elapsed before a relation­
ship between myooardial cyclic GMP levels and hormonal- 
induced changes in cardiac performance was established.
George et al, (1970) first demoonsrated an acetylcholine-
induced rise in myoocadial cyclic GMP levels in rat heart, 
a finding which has since been confirmed by a number of 
authors (George et al, 1973; Goldberg, Haddox, Hartle 
& Hadden, 1973; Goldberg et al, 1975; George et al, 1975).
The effects of acetylcholine on the contractile performance 
of the heart and on cyclic GMP levels are blocked by atro­
pine (Lee, Kuo & Greengard, 1972; Goldberg et al, 1973;
George et al, 1975; Gardner & Allen, 1977). Signi.fi.cant 
increases in tissue cyclic GMP are also observed in quiescent 
ventricular slices following treatment with acetylcholine 
(Lee et al, 1972; Kuo, Lee, Reyes, Walton, DonneHy & 
Gmngard, 1972) . In guinea-pig, acetylcholine increases 
cyclic GMP levels but has a negligible effect on the con­
tractile performance of the heart (Watanabe & Besch,1975).
A num^^r of authors have established that exogenous cyclic 
GMP, or one of its more lipid - soluble derivatives, mimics 
the chronotropic and inotropic effects of acetylcholine. 
Cyclic GMP itself has little effect on mammanan ventricular 
or atrial preparations (Nawrath, 1976) but cellular fragments 
respond with a decrease in force and frequency of beating 
(TrautweLn & Trube, 1977). Dibutyryl cyclic GMP (DB cyclic 
GMP) mimics the chronotropic effects of carbachol on spon­
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taneously beating cultured cells (K^rause, Hale & Wooienberger, 
1972) and induces a concentration - dependent antagonism 
of the positive inotropic response to isoprenaline on 
the guinea-pig heart (Watanabe & Bosch, 1975). In addition, 
eQnorriylyl cyclic GMP (MB cyclic GMP) antagonises the 
positive . inotropic effect due to exogeno^sy-administered 
DB cyclic AMP in cat papillary muscle (Wilkerson, Paddock 
& George, 1973). Mom recently, the 8 - Bromo derivative 
of cyclic GMP (8 - Br cyclic GMP) has been employed. This 
exerts a negative inotropic action on cat papillary muscle 
and rat atria (Nawrath, 1976; 1977) and negative inotropic 
and chronotropic actions on spontaneously beating cultured 
cells (Trautwein & Trube, 1977). These actions are not 
affected by atropine (Nawmth, 1976). Apart from dimin­
ishing contractile force, 8 - Br cyclic GMP induces a 
shortening of the action potential and an accompanying 
decrease in cal-cuum uptake, with little or no effect on 
either sodium influx or potassium efflux (Nawwath, 1977) .
These results taken together suggest that cyclic GMP exerts 
effects both on force production and on transmembrane 
cal-cuum movemenns.
Metabolism of cyclic GMP; The formation of cyclic GMP
from GTP is catalysed by the enzyme guanylate cyclase. In 
contrast to the ^^r^t^rc^i^^-bound nature of adenylate cyclase, 
guanylate cyclase is present in both particulate and soluble 
forms, each of which has its own distinct properties (Kimura 
& Murad, 1974). Myocardial guanylate cyclase has an ab-
40
2+solute requirement for Mn and there may be a dependence 
on Mn2+/Ca2+ ratio (Krause & Wooienberger, 1977).
The reported effects of neurohumoral agents on guanylate 
cyclase activity are contradictory. Acetylcholine has 
been found to stimulate its activity in broken cell pre­
parations (White, Ignarro & George, 1973; Sulakhe, Sulakhe 
& Leung, 1975), whereas others (Kimura & Murad, 1974;
Limbird & Lefkowitz, 1975) were unable to confirm these 
findings. Whhte et al (1973) found that elevated calcium 
concentration increased guanylate cyclase activity and 
that the stimulation induced by acetylcholine could be 
abolished by atropine.
Cyclic GMP - dependent protein kinases and cardiac contrac­
tility; Kuo (1974) demonnsrated the existence of a 
cyclic GMP - dependent protein kinase in guinea-pig heart 
alhhough to date there have been no reports of any naturally 
occurring substrates for this enzyme in the myocardium. 
However, recent investigations have demoonsrated the pre­
sence of endogenous substrates for cyclic GMP - dependent 
protein kinases in smooth muscle (Casnneiie & Greengard,
1974) , intestinal brush border epit^heL-uum (De Jonge, 1976) 
and the rabbit cerebellum (Schhichter, Casnneiie & Greengard, 
1978). By anology with cyclic AMP - dependent protein 
kinase, it is assumed that the enzyme functions by altering
the state of phosphonylation of phosphoorotein substrates
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within the fibres (Kuo, 1975) . The question of the precise 
role of cyclic GMP in regulating myolcldial contraatility 
is a major consideration in the light of the results to 
be presented, and it will be useful to mention briefly 
at this time that these results are consistent with the 
idea that cyclic GMP acts indirectly, through cyclic GMP- 
dependent protein kinase, to stimulate phosphoprotein 
phosphatase activity in such a way that it opposes the 
action of cyclic protein kinases.
Itter-relatitnships between cyclic 31, 5*
nucleotide levels, calcium entry and
tontraltility.
It has been suggested (Goldberg et al, 1975) that cyclic 
AMP and cyclic GMP have opposing roles in regulating a 
number of biological systems, a hypothesis which receives 
support from this study and from previously published 
work by Nawrath (1976). It has been known for several 
years that synchronised oscillatOons in the levels of 
both cyclic AMP and cyclic GMP occur throughout a single 
heart beat (Brooker, 1973; Wollenberger, Babski, Krause,
Genz, Blohm & Bogdonova, 1973). These have been attributed
„ , i
to pulse synchronised discharges of cardiac sympathetic 
and parasympathetic transmitters and/or to oscillations 
in talciua entry to which both adenylate and guanylate 
cyclases are sensitive. Cyclic AMP fluctuations are absent
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in animals previously treated with 6-hydroxydopamine,
which causes depletion of adrenaline stores, and after
pretreatment with sotalol, ay?- adrenergic blocker. Simi­
larly the transient changes in cyclic GMP levels are di­
minished in the presence of atropine (Krause, Janiszewski, 
Bartel, Karczewski & Wollenberger, (1976).
There is also evidence that the intracellular changes
in the two cyclic nucleotides are interactive. Thus,
addition of acetylcholine results in a significant rise
in cyclic GMP which preceeds a small reduction in cyclic
AMP levels (George et al, 1970, 1973, 1975; Lee et al,
1971; Goldberg et al, 1973; Gardner & Allen, 1976a, b).
Moreover, acetylcholine produces a decline in cyclic AMP
levels which have previously been raised by treatment
with either isoprenaline (Kuo et al, 1972) or adrenaline
(Gardner & Allen, 1976b) and this is accompanied by a
significant rise in tissue cyclic GMP. Conveesely, isoprenaline
(George et al, 1975) and isoprenaline in the presence
of theophylline (George et al, 1970; Goldberg et al, 1973)
elevate cyclic AMP levels and produce a slight decrease
in cyclic GMP Le^^^l.s. These effects are blocked by propranolol
(George et al, 1975). Finally, the acetylcholine induced
rise in cyclic GMP is decreased by isoprenaline (Kuo et
al, 1972) and this too is associated with a rise in cyclic 
be
AMP level. However, it shouldAemphasised that other
workers have questioned this relationship and the situation
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is by no means clear. Several authors observed acetyl­
choline-induced increases in cyclic GMP levels without 1
any change in cyclic AMP levels (Watanabe & Besch, 1975; |
England, 1976; Gardner & Allen, 1977) and it has been
reported (Gardner & Allen, 1976b) that adrenaline elevates 4
1
cyclic AMP without simultaneously affecting cyclic GMP
levels. f
The calcium sensitive moduuator protein; The present
work focuses attention on the significance of the ratio of 
cyclic AMP; cyclic GMP concennrations, rather than on 
the level of each cyclic nucleotide separately. It is 
thought likely that the recently discovered calcium sen­
sitive m^c^uu^^or protein (Wang, 1977) is of importance 
in controlling the levels of both cyclic AMP and cyclic 
GMP. This protein has stimulatory effects on cyclic GMP 
phosphodiesterase activity and on the activity of adenylate
cyclase. Thus, increased activity of the modduator protein,
of calcium
caused by an enhanced influx and/or releaseAfoom the SR, 
would act to lower cyclic GMP levels and simdtaneously 
elevate cyclic AMP levels, leading to an increase in the 
ratio of cyclic AMP; cyclic GMP. Conversely, a reduced 
calcium entry would tend to lower this ratio. Evidence 
is presented later to show that the time course of the 
action potential is markedly affected by treatment with 
exogenous ATP. It is prolonged during the initial and 
secondary phases of the response, and reduced during the
z
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intervening period when the contractile response is seen 
to be depressed. These observations afford the basis 
for the view that one important role for the entry into 
the fibres of extracellular calcium during the action 
potential is to provide a link between the effects of 
cardioactive agents at the cell surface and altered levels 
of cyclic 3’, 5* - nucleotides within the fibres, and 
that the calcium sensitive moduiator protein is involved 
in this process.
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CHAPTER II
GENERAL METHODS AND MATERIALS,
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C HA P T E JR ° II
METHOD S,
All experiments were made with isolated ventricular pre­
parations from the frog. In general, adult male and 
female from the species Rana temporaria were used, but 
in a few cases when these were not available, specimens of 
R. pipiens or R. escuelenta were employed instead. 
Animals were stored at 4°C prior to use. They were killed
with a blow to the head and then pithed. Experiments were
conducted at room temperature (18 - 19°C).
Dissection and mounting procedure; Hearts were rapidly 
excised and the auricles, containing pacemaker tissue, 
were removed with a single incision. The remaining single
ventricle was then cut into posterior and anterior halves, 
providing two cup-shaped pieces of tissue. The prepara­
tion was washed free of blood in physiological salt 
solution (below) and mounted on a wax block, as shown in 
Fig. 2.1. The apex of the ventricle was attached to a 
stainless steel wire (diameter 0.2mm) connected to a strain 
guage. The base of the half ventricle was secured to the
wax block using two entomological pins.
Figure 2.1.
(A) Perfusion and recording apparatus. Flow of
perfusion fluid is from one of two storage Mariotte
bottles via a two-way tap and perfusion tube through 
ventricle tissue, and thence by ’spilling over* and
suction from the wax block to which the half ventricle
is pinned down, to either waste or a peristaltic pump 
which recirculates the fluid. Tension recording is 
by means of an isometric (force) transducer (T) 
connected to the tip of the ventricle. The output of
the transducer is fed, via a bridge (B), to the inputs 
of the cathode ray oscilloscope (C.R.O.) and pen
recorder-.
(B) Suggested route of perfusion fluid through
ventricular tissue. Note the reflected waves on the
perfusing fluid.
Oxygen A
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Electrical and mechanical experiments.
Superfusion procedure: The upturned, inner surface of
the ventricle was superfused with Ringer solution (com­
position (mM) : NaCl, 115; KC1, 2.5; CaC^, 1.0; Na2HP0^, 
2.15; Nal^PO^, 0.85; glucose, 5.55; pH, 7.2) through a 
vertical glass tube (internal diameter 2mm) positioned
1.5 - 2cm above its centre. A flow rate of 100ml min
was used in the majority of experiments. The rational 
for selecting this particular value is discussed later 
(page 71 ). It was found to be sufficiently great to keep 
the ventricle ’inflated’ (Lamb & McGuigan, 1966) thereby 
ensuring that the trabeculae are in an ’opened’ condition, 
providing rapid equilibration of solutions with the fibres. 
The superfusing fluid spilled over the edge of the prepar­
ation and was returned to a reservoir (capacity: generally 
1 litre; see later, page 71), with a Watson-Marlowe peri­
staltic pump. The superfusing solutions were kept 
oxygenated throughout the experiments. Changes of sol­
ution were achieved by means of a two-way tap. The dead 
space clearance time was in the order of 100 - 150 msec. 
Solutions were stored in Mariotte bottles positioned 
approximately 60cm above the preparation. At the end of 
each experiment, the ventricles were gently blotted on 
tissue paper and weighed. Weights of the order 20 - 30mg 
were typical.
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Stimulation: The principal interest was in the inotropic
effects of various agents studied, and to minimise compli­
cations arising from any accompanying chronotropic effects, 
the preparations were paced by stimulating through two
silver wire electrodes located on either side of the ventricle.
Square pulses of 5 msec duration and amplitude of 10 volts 
-1were employed at frequency of 30 min , unless stated other­
wise .
Tension recording;: A device strain guage (Type 4151 - 100 gm)
was used to record the contractile response. The force trans­
ducer was mounted on a micro-manipulator and at the start of 
each experiment the optimal length giving the maximum con­
tractile response was established. The compliance of the 
transducer and that of the connecting stainless steel wire is 
very low, but considerable local shortening of the preparation 
could be seen and so conditions were only nominally isometric. 
The transducer was calibrated at the end of each experiment 
using a series of known weights. Tension responses were 
recorded on either a devices chart recorder (Type DC. 2C 
No,M2 R2) or on a D13 dual beam, storage oscilloscope
(Tektronix, Type 5103N).
Action potential recordings: The experimental conditions
were modified somewhat for making membrane potential recordings 
Smaller ventricular strips were used (approximate dimensions
Figure 2.2.
Schematic diagram of experimental arrangement for
measuring membrane potentials. Flow of perfusion
fluid (as shown by arrows) is from, one of two Mariotte 
bottles via a two-way tap and perfusion tube over the 
muscle through a perfusing channel of a perspex chamber 
and then to waste (suction). One end of the muscle
is pinned down to a wax block embedded into the base 
of the perfusing channel and the other end to an 
isometric (force) transducer (T). The output of the
transducer is fed, via a bridge (B) to the inputs of 
a pen recorder and a Tektronix Storage Oscilloscope (C.R.O.) 
Stimulation is produced by an isolated stimulator(s) 
via two silver wire electrodes set into the sides of 
the perfusing channel. Membrane potentials are 
measured with conventional glass microelectrode filled 
with 3MKC1 and coupled via • an Ag - AgCl wire to the 
high impedience inputs of a preamplifier (P.A.). The 
output of the preamplifier is fed, via a bridge.(B) 
to a Tektronix Storage Oscilloscope (G.R.O.).
OXYGEN
SPEAKER
PEN
RECOR.
PERSPEX- SUCTION
49
1.5mm wide, 1mm thick and 4mm long). The apparatus is 
shown in Fig. 2.2. The perfusion rate was reduced to 
around 20ml min 1 in order to avoid dislodging the micro­
electrodes. Stimulation was by means of two silver strips 
located on either side of the preparation. Square pulses
(5msec duration, 25 volts amplitude) were used at a rate 
-1of 30 beats min . Resting and action potentials were 
recorded by means of conventional intracellular micro­
electrodes filled with 3 M-KCl. Microelectrodes were
pulled from glass capillary tubes using a Narishige elec­
trode puller:. They were coupled to a preamplifier with
high input impedience through silver - silver chloride 
wires. Electrode tip resistances were typically of the 
order of 5 - 15 MJX. Electrical and mechanical responses
were displayed simultaneously on a dual beam oscilloscope 
and recorded photographically. Twitch and action poten­
tial parameters were measured subsequently from photographic 
enlargements.
General procedure;_ In the majority of cases the frog 
ventricle was superfused with frog Ringer until it had
become fully hypodynamic prior to the addition of the test
-1agents. At a flow rate of 100ml min , stimulation frequency 
-1of 30 min and with a circulatory volume of 1 litre, the
steady-state twitch tension reached was around 25-35% of the
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initial response, attained within a period of between
60 to 80 minutes. This condition served as a control
and twitch tensions obtained on subsequent treatment were
expressed as a multiple of this value. In those experi­
ments involving cyclic nucleotide assays (see below), 
the observed levels of cyclic AMP and cyclic GMF in the
fully hypodynamie ventricle were used as controls and test
values were also expressed as multiples of these control
levels.
Experiments involving the measurements
of intracellular cyclic nucleotide
levels,
Procedure; . Two kinds of experiments are described; in the 
first the time course of the changes in cyclic AMP and 
cyclic GMP were followed during three different responses 
(development of the hypodynamie state and during treatment 
with either isoprenaline or ATP); in the second, dose- ,
dependent changes in cyclic nucleotide levels were measured 
at a specific time, usually at the peak of the response.
In all experiments two half-ventricles taken from the same 
heart were used for test and control preparations.
Freezing procedure; At a predetermined time, the ventricles 
were ’crush-frozen* by compression between flattened forceps
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previously cooled by immersion for 15 minutes in liquid 
nitrogen. This was done with the preparation in situ 
to avoid unnecessary delays. The frozen, crushed cells 
were then quickly transferred to liquid nitrogen and 
stored prior to extracting for cyclic nucleotides.
Extraction procedure; The frozen, crushed ventricle was 
pulverized with a stainless steel mortar and pestle and 
then extracted with 2ml acidic ethanol (1ml 1NHC1: 100ml 
ethanol). It was vortex-mixed for 10 seconds, allowed to
stand for a further 5 minutes in an ice-cold water-bath 
and then centrifuged at 3000 rpm (5 minutes; 0°C). The 
supernatant was removed, the pellet resuspended in Iml of 
ice-cold acidic ethanol and the extraction/centrifugation 
procedure repeated. The combined supernatants from the 
two extractions were evaporated to dryness at room temper­
ature using a stream of nitrogen gas. The residue from 
the extraction procedure was dissolved in 1ml of distilled 
water and the total protein content estimated using the 
Biuret method (details given in appendix TX A). The dried, 
extract was dissolved in Tris-EDTA buffer (0.05M Tris, pH, 
7.5, containing 4 mM EDTA). The resulting solution was
used for cyclic nucleotide assays.
Cyclic nucleotide assays; , Cyclic AMP and cyclic GMP were
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estimated using the Radiochemical Centre Kits (TRK 420;
TRK 500). The cyclic AMP assay is based on a competi­
tive protein binding method. Tissue cyclic AMP in a 
sample of the extract displaces previously bound tritiated 
cyclic AMP from, the protein and the radioactivity remain­
ing associated with the protein is estimated by scin­
tillation counting. Cyclic GMP was assayed using a 
specific radioimmunoassay method; again tissue cyclic 
GMP displaces previously bound tritium labelled cyclic 
GMP from the antibody and the radioactivity remaining 
associated with the protein is measured (details of both 
methods are given in appendix II B,C).
The specificity of the assays is high. Cyclic AMP does
not interfere with cyclic GMP assay but there is some
interference of cyclic GMP in the assay for cyclic AMP.
This is not appreciable until the concentration of cyclic
GMP exceeds that of cyclic AMP by a factor of about 1000
(see Radiochemical Centre Booklets Nos.TRK 420; TRK 500).
Generally, tissue levels of cyclic AMP and cyclic GMP 
f — 1were in the region of 8.623 - 0,410 pmoles mg protein 
+ -1and 1.193 - 0.088 pmoles mg protein respectively, in
control (hypodynamic) ventricles. In fresh ventricles,
+ -1the levels were in the region of 15.770 - 0.309 pmoles mg 
+ -1protein and 0.552 - 0.038 pmoles mg protein respectively.
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The lower limits of detection of each method were:
0.05 pmoles of cyclic AMP and 0.04 pmoles of cyclic GMP. 
Linear calibration curves were obtained in the ranges of 
1 to 16 pmoles of cyclic AMP and 0.5 to 8 pmoles of cyclic
GMP.
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RESULTS
P A R T I
THE HYPODYNAMIC STATE.
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INTRODUCTION
It has been known for many years that the force of contrac­
tion of an isolated, perfused heart declines with time. 
dark (1913) referred to this enfeebled condition as the 
hypodynamie state. It has been dei^onssirated that a wide 
variety of factors can influence both the rate of develop­
ment of the hypodynamie condition and the final steady- 
state attained. It is the purpose of this Introduction 
to review briefly some of the more important conclusions 
which have been drawn.
Whole blood and serum components; A number of authors
have demonsSrated that the hypodynamie condition can be 
reversed, at least temppoarily, by the addition of either 
whole blood or serum to the perfusing solution (Kronecker, 1897 
) Ringer, 1885; Schnecking, 1901? Lussana, 1908; dark,
1913; Szent-Gyorgyi, 1953). Walden (1899) attributed 
this benedcial action to the presence of serum protein, 
since the effect was abolished by prolonged boiling. 
Schnecking's (1901) studies showed that perfusion per 
se is important; an isolated, not perfused, heart survives 
for prolonged periods (up to 5 days) but when perfused, 
survival is limited to around 24 hours. dark (1913) 
made extensive studies of the mechanism of the hypodynamie 
effect. He showed that the volume of the perfusing solution 
was important; survival was ^c^^l^ec^ly improved when smaU 
volumes of solution were circulated through the heart
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as compared to large volumes. Moreover, he confirmed 
that the addition of small ammounts (1%) of whole blood 
or serum greatly stimulated the hypodynamic (but not fresh) 
heart and concluded that the beneficial effects were due 
to an alcohol-soluble constituent, rather than to serum 
protein.
Inorganic ions; Clark (1913) also demonstrated that
the hypodynamic heart is more sensitive than the fresh
heart to changes in extracellular inorganic ions. He
found that elevating the ratio of Ca2^: Na+ or Ca2+: K+
increased the force of contraction, whereas changes in 
, + —the ratio of H : OH had little or no effect. He concluded
that the hypodynamic state is characterised by a decrease
• . • 2+ m the sensitivity of the fibres to extracellular Ca
2+Loss of Ca from the heart during the development of 
the hypodynamic state was observed by Boehm (1914) and 
Lieb and Loewi (1918). More recently, Chapman & Niedergerke 
(1970a, b) showed that the hypodynamic condition is accom­
panied by a decrease in calcium influx and they concluded 
that this was due to the loss of a hypothetical calcium 
binding site, normally located in the surface membrane.
2+Ca and membrane bound lipids; Another potentially 
important observation of Clark’s (1913) was his finding 
that the addition of "lipoids" (soaps of aromatic fatty 
acids) to the perfusate had a marked restorative effect. 
Moreover, addition of a small volume of solution which
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had previously been used to perfuse a heart reversed the 
hypodynamic effect. His studies led him to conclude that 
the contractile state of the heart depends upon the semi- 
permeeaility of its fibres to electrolytes, and that this
is regulated by the presence of membiane lipids and bound
2+ . «Ca . The development of the hypodynamie state, in his 
view, is due to the loss of membrane lipids and a conse­
quent increase in permbcbility to electrolytes. He believed 
that the function of calcium was to m^diiEy the ’colloidal' 
nature of associated lipids. Similar conclusions
were reached later by Szent-Gyorgyi (1953) . The more 
modern studies of Chapman & Niedergerke (1970a, b) broadly 
reaffirm darks’s hypothesis. In their view the lipid 
factor lost from the heart during perfusion is in some 
way involved in the entry of calcium during the action 
potential. Its loss results in a reduced cal^um influx 
with the resulting decline in contractile force.
Metabolic changes; A number of metabooites have been 
reported which either delay or, alternatively, accelerate 
the rate of development of the hypodynamie state. Anc^j^zia 
has been shown to accelerate it (Lindner & Rigler, 1931; 
Lundin & Strom, 1948). In other studies, the time course 
of the effect has been shown to be closely paralleled 
by a fall in high - energy metabboites, including endogenous 
ATP (Greiner, 1952) and creatine phosphate (Vassort & 
Ventura-Clapier, 1977). Conversely, perfusion with solu­
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tions containing metabolites, including glycogen(Clark,
1913), ATP (Lichtneckert & Straub, 1949; Marshall & Andrus, 
1953), digitalis (Lundin & Strom, 1948; Sciarini, Ackerman 
& Slater, 1948; Greiner, 1952), creatine phosphate (Saks, 
Rosenshtraukh, Undrovinas, Smirnov & Chazov, 1976) and 
creatine, oxygen or pyruvate in the presence of polyvinyl 
pyrolidone (Vassort & Ventura-Clapier, 1977) all delay 
the onset and/or reverse the hypodynamie condition. The 
last mentioned authors have suggested that the hypodynamie 
state is due primarily to an energetic deficiency.
Prostaglandins; A number of authors have demo^ssjra^ed
that prostaglandins are released from the heart at rest 
and during stimulation (Block & Vane, 1973; Minkes, Douglas 
& Needleham, 1973; Junstad & Wennmalm, 1974; Block, Feinberg, 
Herbaczynska-Cedro & Vane, 1975). These observations 
are of great significance, since precursor fatty acids 
involved in prostaglandin biosynthesis are now known to 
be located in the cell (GudiOarnason, 1975) .
Moreover, prostaglandins E^, E2 and 2, 3 (trans) dehydro 
E, exert a positive inotropic effect on the hypodynamie 
frog heart (Vergroesen & De Boer, 1971). Others have 
iemonsSrated a marked positive inotropic effect of pros­
taglandins E^, E2 and F^^ (Beeti, Lentati & Usardi, 1965; 
Bergstrom, Carlson & Weekes, 1968; Sabatini-Smith, 1970; 
Nakano, 1971; Smeekal, Rougier & Gardnier, 1973; Mironneau 
& Grosset, 1976) on intact hearts. In addition, the con­
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tractile responses of both rat and frog hearts which have
been deliberately depressed either by elevating the K :
2 + . . .Ca ratio or treating with the beta-blocker propranolol,
. . 2+with barbituates or with excess Mg (De Boer, Houtsmuller
& Vergroessen, 1973) , can be restored to noru^^l by pros­
taglandin E1.
The mechanism of action of the prostaglandins is not fully 
understood. Their interest in the context of the present 
work arises from the fact that some prostaglandins (for 
example the E series) have been shown to stimulate cyclic 
AMP production in several tissues, including the heart 
(Robison, Butcher & Sutherland, 1971; Klein & Levey,
1971b).
Present Study; The work reported here was undertaken
to investigate some of the physical factors (rate of per­
fusion, volume of perfusates, stimulation frequency) which 
affect the rate of development of the hypodynamic state, 
and to examine the possibility that dark's lipid factor 
(and Chapman & Niedergerke's postulated caldum binding 
lipid) might in reality be a prostaglandin or a prostag­
landin precursor which is lost from the heart during per­
fusion. These aspects are dealt with in Chapter III. 
Chapter IV is concerned with changes in the levels of 
cyclic AMP and cyclic GMP during the development of the 
hypodynamie condition.
"A1
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A preliminary account of some aspects of this work was 
presented to the physiological Society (Flitney, Lamb 
& Singh, 1978; Flitney & Singh, 1978).
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CHAP T E 1, . . III
FACTORS AFFECTING THE . DEVELOPMENT OF
THE HYPODYNAMIC STATE. EVIDENCE . FOR
THE INVOLVEMENT OF ....A PROSTAGLANDIN
AND/OR A PROSTAGLANDIN-RELATED
SUBSTANCE.
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INTRODUCTION
This series of experiments was undertaken with two aims; 
first, to characterise more precisely the physical condi­
tions which affect the rate of development and extent 
of the hypodynamie depression; and secondly, to investi­
gate the mechanism of the effect.
Physical factors influencing the rate
and extent of the hypodynamie depression.
dark’s (1913) contention that the leakage of a lipid 
soluble factor from the heart leads to the observed loss 
in c^ntrcictil.ity forms the starting point for these experi­
ments. Three parameters have been studied; perfusion rate, 
volume of circulating perfusate and stimulation frequency.
All three variables have been found to affect the rate 
at which the ventricle becomes hypodynamie and/or the 
degree to which contractile force is reduced.
Perfusion rate; In these experiments both stimulation 
frequency and total vol^ime of circulating perfusates were 
held constant (30 ml min 1 and 1 litre, respeccively). Fig. 
3.1A shows the time course of the decline in contractile 
force at perfusion rates of 50, 100 and 200 ml min .
Each point represents mean values + S.E.’s for 6 preparations
It can be seen that both the rate and extent of the depres
Figure 3.1.
(A) Time course of the decline in contractile force
at perfusion rates of 50, 100 and 200 ml. min \ The 
steady-state tension after 100 minutes is markedly
depressed with increasing flow rates. Abscissa;
Time (min). Ordinate; Relative tension.
(B) Relationship between the time taken for iso­
metric tension to decline to 50% of the initial value 
and varying perfusion rates. The rate of development
of the hypodynamie condition increases with increasing 
-1flow rates. Abscissa; Perfusion rates (ml. min ) 
Ordinate; Time to 50% fall in tension (min).
(C) The effects of the 3 different flow rates on 
the final steady-state tension reached after 5 hours of 
perfusion. Even after several hours perfusion, the 
ventricle is becoming more hypodynamie.
-f.Each point is the mean - S.E. taken from 6 preparations. 
Tension values are expressed as multiples of the initial 
(control) levels. Stimulation frequency and perfusate 
volume were kept constant at 30 min and 1 litre 
respectively.
Stimulation parameters: Pulse width: 5 msec; amplitude, 
lOV. Temp, 18.5°C.
Time-min
50 100 175 200
Perfusion Rate |ml min-^J
“'-i£
J
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sion increase with increasing rates of perfusion. After 
100 minutes, the ’steady-state’ twitch tension, expressed 
as a fraction of the initial force developed, amounted 
to 0.57, 0.29 and 0.16, and the times taken for the con­
tractile force to fall to 50% (Fig.3.IB) of its initial 
value were 125, 43 and 24 minutes, at perfusion rates 
of 50, 100 and 200 ml min , respectively. The marked 
differences between the apparent steady-state tension 
reached at the different perfusion rates after 100 min 
perfusion are considerably reduced when preparations are 
superfused for longer periods of time (Fig.3.1C), indicating 
a further, more gradual decrease in contractility.
These results are broadly consistent with the idea that 
an essential factor is lost from the heart during the 
superfusion procedure, the argument being that the rate 
at which it is lost would be expected to increase with 
the increasing rates of perfusion, leading to a more rapid 
onset of the hypodynamic state, as is observed experi­
mentally. However, the differences remaining between 
the steady-state levels attained, even after several hours 
perfusion, are not entirely consistent with the hypothesis, 
since this would not be expected to show any dependence 
on flow rate. The only explanation which can be advanced 
at this time to account for this result is the possibility 
that even after 5 hours the ventricle is still not fully 
hypodynamic.
Figure 3.2.
(A) Time course of decline in isometrie force
following superfusion with 250, 500 and 1000 ml. of 
circulating perfusates. Abscissa; Time (min).
Ordinate; Relative tension.
(B) Rate of development of the hypodynamie
condition at the three perfusate volumes. Abscissa; 
Volume of perfusates. Ordinate; Time to 70% fall
in isometric tension (min).
(C) The extent ff the hypodynamie depression after.
5 hours of perfusion. The data show a linear relation­
ship between the steady-state tension and the volume of 
perfusates. The curve (dashed line) is extrapolated 
intercepting the ordinate at a value approximately 75% 
of the control level. Abscissa; Volume of perfusates. 
Ordinate; Relative tension after 5 hours.
Each point is the mean - S.E. taken from 6 preparations. 
Tension is expressed as a multiple of the initial
(control) level. Stimulation frequency and flow rate
“1 -1 were kept constant at 30 min and 100 ml. min , 
respectively.
Stimulation parameters: Pulse width, 5 msec; amplitude,
lOV; Temp, 18.5°C. R. pipiens.
Relative tension after 5 hours
Time to 70% tension [min]
Relative tension
Volum
e of perfusates 
[m
Q
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Volume of circulating perfusates: In these experiments,
stimulation frequency and perfusion rates were kept constant
~1 -1 .(30 beats min and 100 ml mm , respectively) and the
time course of the decline in contractile force was measured
using circulating volumes of 250 ml, 500 ml and 1000 ml.
The results for 6 experiments (means + S.E.’s) are shown 
in Fig.3.2A. In these experiments, both the rate of develop 
ment of the hypodynamie condition (Fig.3.2B) and the extent 
(Fig. 3.2C) of the depression (after 5 hours of perfusion) 
increase with increasing volumes of perfusates. The data 
in Fig.3.2C show a linear relationship between the steady- 
state tension and the volume of the perfusates, the extra­
polated portion of the curve (dashed line) intercepting 
the ordinate at a value ca. 75% of the control level.
These results too lend weight to dark’s hypothesis. In 
this case, the argument is that the factor lost from the 
heart becomes more diluted when larger volumes of perfusates 
are used. The relatwnship between steady-state contractile 
force and perfusate vo^i^me shown in fig. 3.2C is particularly 
interesting: the relatively high values indicated by the 
broken line suggest that the condition of the heart may 
be subssantially improved by perfusing the preparation 
with very small circulating volumes of fluid, but that 
even under these conditions some reduction ca. 25% in
contractile force remains.
Figure 3.3,
(A) Time course of the development of the hypo­
dynamic state at varying rates of stimulation (from 
effectively *0’ (10 beats at 10 min interval) through
15, 30 and 60 beats min ^). Abscissa; Time (min). 
Ordinate; Relative tension.
(B) Rate of development of the hypodynamic de­
pression at 4 different rates of stimulation. Abscissa; 
Rate of stimulation (beats min ^). Ordinate; Time to 
80% of the initial tension value (min).
(C) Relation between the steady-state tension reached 
after 5 hours of perfusion at the 4 different rates of 
stimulation. Contractility reduced to about 55 - 60%
of the control level at very low frequency (approximately 
to zero). Abscissa; Rate of: stimulation (beats min ^). 
Ordinate; Relative tension after 5 hours.
Each point is the mean - S.E. taken from 6 preparations. 
Tension is expressed as . a multiple of the initial (control) 
level. Flow rates and circulating perfusates were kept 
constant at 100 ml. min '' and 1 litre respectively.
Stimulation parameters; Pulse width.. 5 msec ; amplitude. 
lOV. Temp, 18.5°C. R. pipiens.
Time-min
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Stimulation,frequency; The effects of varying the fre­
quency of stimulation (from effectively 'O’ through • 15,
30 and 60 min,-1) have been studied at a perfusion rate 
100 ml min 1 and with total circulating volume of 1 litre.
The results in Fig. 3.3A clearly show that increasing the 
stimulation frequency leads to a more rapid onset of the 
hypodynamic coned tion, and that it also depresses the 
steady-state amplitude finally attained. These data also 
reveal stimulation frequency - dependent and independent 
components in the mechanism of the hypodynamie effect.
Fig. 3.3C shows that the contraatility of the superfused 
ventricle is subsSantially reduced (down to 55 - 60% 
of the control level) even in the absence of any stimulation 
(i.e. stimulation at a frequency of 10 beats delivered 
every 10 minutes in order to assess the potential for 
force developmect) . Since considerable shortening of 
the preparation could be discerned by eye (i.e. the tension 
recordings were only nominally isomeeric) this result 
may indicate work - dependent and work - independent com­
ponents in the development of the hypodynamie state. . This 
is an area of considerable interest which deserves further 
study.
Is dark’s lipid factor a prostaglandin
or prostaglandin - related substance?
The results presented above support dark's hypothesis
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that the hypodynamie depression results from the loss 
of an essential factor/s from the heart. His conclusion 
that this is a l:Lp>i^^ substance raises the interesting 
possibility that a prostaglandin (PG) or prostaglandin 
~ like substance (PLS) may be involved. The experiments 
described below were made in order to test this hypothesis.
Indirect evidence for the release of a PG or PLS from
the ventricles; Effects of agents which interfere with
PG biosynthesis; The most prevalent precursor in PG
biosynthesis is arachidonic acid, giving rise to PGEg 
and PGFg (Samuelson, 1972). Prostaglandins A, B and 
C arise from PGE by dehydration and isomeeization. The 
synthesis is achieved by a complex of microsomal enzymes 
which are collectively termed ’prostaglandin synthetases'. 
The conversion of arachidonic acid to PGE2 or PGF2is 
inhibited by certain anti-nfflammatory agents, such as 
aspirin and indomethacin (Vane, 1971). In these experi­
ments, the effects of indomethacin and arachidonic acid 
on the rate of development and the extent of the hypodynamie 
depression were investigated.
Fig. 3.4A shows the time course of the decline in contrac­
tility for 7 preparations (control, solid squares). The 
effects of varying concentrations of arachidonic acid 
(open circles) and indomethacin (solid circles) are shown 
for comparison. Indomethacin produces a dose - dependent 
increase in the rate at which the perfused ventricle becomes
Figure 3.4.
(A) Influence of varying concentrations (range
10 ti 10 ^M) i0 arachtdintc acid (open circles) and 
-A ”6(range 10 - 10 M) indomethacin (solid circles) in
the time course i0 the development i0 the hypodynamie 
state. The control response (means - S.E*s 0or 
7 preparations) is illustrated by the broken line 
(solid squares) Oor comparison. Arachidonic acid
elevates the Oinal steady-state tension reached while 
indomethacin depresses it. Abscissa; Time (min). 
Ordinate, Relative tension (expressed as a multiple o0 
the control level),
(B) The effects 0f varying concentrations (10 -
* 5 . / . ——10 M) o0 arachidonic acid (open circles) and (10 -
—6 ■10 M) indomethacin (solid circles) on the rate o0 
development o0 the hypodynamie condition. The control 
is shown by the solid square where the two axes intersect 
Indomethacin accelerates the rate at which the per0used 
ventricle becomes hypodynamie whereas exogenous arachi- 
donic acid delays it.
The data 0or each curve, 0ollowing stimulation with 
either arachidonic acid or indomethacin, were obtained 
0rom one preparation.
Stimulation parameters; Pulse width, 5 msec; amplitude, 
lOV. Frequency, 30 min 1. Flow rate, 100 ml. min 1, 
Temp, 18.5°C.
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hypodynamic, and also it depresses the steady-state levels 
finally attained, whereas increasing concentrations of 
exogenous arachidonic acid have the reverse effects.
The data in Fig. 3.4B emphasise the effects of these 
agents on the time course of the reponses.
The results clearly show that inhibition of prostaglandin 
biosynthesis with indomethacin greatly accelerates the 
rate at Which the ventricle becomes hypodynamic, while 
the converse effect is seen when a supply of exogenous 
PG precursor, in the form of arachidonic acid is provided.
Effects of authentic PGjS-^ and PLS extracted from perfusates 
on the development of the hypodynamie state: Two kinds
of experiments are described. In the first, 6 preparations 
were superfused with frog Ringer solution (50 ml) while 
the contractile force fellto a steady level (around 80 
minutes) . The perfusates were then pooled and treated 
with ethyl acetate to extract lipid soluble substances, 
including prostaglandins. The quantity of PLS in the 
perfusate was then bioassayed using the rat stomach strip 
(see appendix IIDfor detail). The effect of the extract 
on the development of the hypodynamie state was then assessed 
on a fresh half ventricle, using the other half as a control. 
In a second series of experiments, 6 ventricles w^ire similarly 
superfused for period in excess of 80 minutes, but this
, , . _5
time in frog Ringer solution containing 10 M indomeehacin.
Figure 3.5.
Effects of 25 ng.ml (estimated by bioassay) PG ethyl 
acetate extract (open circles), 25 ng.ml authentic
PGE^f(solid circles) and 3 ng.ml (estimated by bio­
assay) ’indomethacin treated* PG ethyl acetate extract 
(solid triangles) on the time course of the decline in 
isometric force. The control response (means - S.E’s 
for 3 preparations) is depicted by the broken line 
(solid squares). PG ethyl acetate was obtained from 
circulating perfusates of 6 preparations that were made 
hypodynamic. The ’indomethacin treated’ PG ethyl 
acetate extract was obtained from perfusates of 6 pre­
parations made hypodynamie following treatment with
-510 M indomethacin (see appendix II D for PG extraction 
and bioassay procedures). Abscissa; Time (min). 
Ordinate; Relative tension (expressed as multiple of
the initial level).
The data for each curve were taken from one experiment 
following stimulation with either authentic PGE,, or 
the unknowns.
Stimulation parameters: Pulse width, 5msec; frequency,
-1 -1 30 min ; amplitude, lOV. Flow rate, 100 ml.min . 
Temp, 18.5°C.
12
Control
40 60
Time-min
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The pooled perfusates were extracted with ethyl acetate, 
bioassayed for PLS using the rat stomach strip, and the 
effect of the extract on the development of the hypodynamie
state tested in a fresh preparation. For comparison,
the effects of perfusing ventricles with authentic PGE^
-1
(25 ng ml ) were tested.
Fig. 3.5 shows the results of these experiments. The
pooled extracts from the perfusate of normally - superfused
preparations were made up to a prostaglandin concentration 
-1(calculated from the bioassay) of 25ng ml . The effect 
of this on a fresh ventricle is shown by the open circles. 
The PG extract significantly delayed the development of 
the hypodynamie condition and, after 80 minutes, elevated 
the final steady-state tension attained as compared to 
the contral response (solid squares) . The same concen­
tration of authentic PG^1 had a similar . effect. In con­
trast, the indomethacin - treated ventricles yielded an 
ethyl acetate extract with a greatly reduced PG content, 
estimated after dilution to be only 3 ng ml .
Its effects on the rate of development of the hypodynamie 
condition and the final steady-state level reached w^ire 
accordingly much less (soZLid triangles) .
Relationship between the of PLS released and the
extent of the hypodynamie depression; In 8 experiments
the ventricles permitted to become partially or fully
Figure 3.6.
(A) The time course of the decline in contractile 
force (broken line, open circles) and the amounts of 
PG*s and/or PLS (solid circles) released into the 
circulating perfusates for 8 preparations at various 
times during the development of the hypodynamie state. 
PC’s and/or PLS in the perfusates were extracted with 
ethyl acetate and estimated by assaying on rat fundus 
strip using authentic PGEE> as the bioassay control
(see appendix II D for details). Abscissa; Time (min). 
Ordinate; Relative tension (expressed as a multiple of 
the initial control level); PG output (expressed as 
ng.mg wet ventricle).
(B) Relationship between the quantity of PG*s
and/or PLS released and the extent of the hypodynamie 
depression. PG’s and/or PLS increase as the preparation
becomes correspondingly more hypodynamic. Abscissa;
PG release (ng.ml wet weight of ventricle). Ordinate; 
Relative tension.
Each point was•taken from one preparation.
Stimulation parameters: Pulse width, 5 msec; amplitude, 
lOV; frequency, 30 min . Flow rate, 100 ml.min 1.
Temp, 18.5°C.
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hypodynamia by superfusing with 200 ml of normal frog 
Ringer for varying lengths of time. The quantity of PLS 
obtained from the perfusates by ethyl acetate extraction 
(expressed as ng mg 1 wet ventricle) was subsequently 
bioassayed and the extent of the hypodynamie depression
measured from the force records.
Fig. 3.6A depicts the quantity of PLS extracted (s<^li^d 
circles) and the hypodynamie depression (open circles) 
as a function of time; the levels of PLS in the extracts 
are seen to increase with increasing superfusing time, 
as the ventricle becomes correspondingly more hypodynamic. 
Fig. 3.6B shows the relationship between these two para­
meters. Co^taa!tlity is plotted on the ordinate, force, 
given as a fraction of the initial (fresh) value, and 
the levels of PLS (ng mg 1 wet ventricle) on the abscissa.
Identification of PG by thin-layer chromatography (TLC);
The results of the preceding experiments provide indirect 
evidence for the loss of a PG or PLS from the ventricle 
during the development of the hypodynamie state. An attempt 
was made to identify which, if any, of the prostaglandins 
is present in the perfusate using TLC. Authentic samples 
of prostaglandins E^, E2, !-]_<< ' F2oC' A1 an<^ A2 were run 
concurrently with samples of the extracted perfusates.
The AI solvent system of Green and Samuulsson (1964) was 
used in one series of TLC's. In this system PG in the
Figure 3.7.
Chromatogram of authentic prostaglandins Eg, EQ, Fg
and F2^ and the unknown sample using the All solvent
system (Green & Samuelsson, 1964). Glass plates 
(0.40 x 20 X 20 cm) were coated with silica gel 
G(Merk) containing) 10% silver nitrate (see appendix 
II D for detail). Authentic prostaglandins E1? E~, 
Fg^and F£ and the extracted prostaglandin-like
material were applied on plates as single spots using 
micropipettes. Prostaglandins in the unknown sample 
have Rf values of 0.52 and 0.72 which correspond to 
PGEg (bright spot) and PGEg (faint spot), respectively. ' 
Also present on the chromatogram is a conspicuous 
spot (?) with Rg value 0.28 which does not correspond 
with authentic prostaglandins E, F or A series.
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extract has an Rf value which corresponds closely with 
that of the E series of the authentic prostaglandins.
In Green and Samuulsson (19 64) Ml solvent system, it 
was found to correspond with PG^1 and PGEg (Fig. 3.7).
In the latter, there was also present a conspicuous spot 
with an value of around 0.28, which did not correspond
with any of the known samples. It is possible that this 
unidentified substance is a PG precursor or metabblite. 
Further work is required to identify this component of 
the extract.
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DISCUSSION
These experiments have demonstrated clearly that both 
the rate of development of the hypodynamie condition and 
the degree to which the steady-state contractile response 
is depressed are markedly influenced by experimental con- 
ditoons; increasing the flow rate, the volume of circilating 
perfisate and stimulation frequency were all found to 
accelerate the rate of decline in connraatility and, in 
addition, to result in progressively smaller steady-state 
responses. The results were found to be highly repeatable 
and this has made it possible to standardise the ^perfusion 
procedure in such a way as to provide a stable preparation 
which serves as a control for assessing the effects, des­
cribed later, of treating test preparations with the various 
inotropic agents studied. This is an important point, 
particularly with the experiments which are concerned 
with the effects of exogenous ATP and isoprenaline on 
.intracellular cyclic nucleotide levels. In the maaority
of experiments, the following conditions were used: sti-
, — 1 — 1 mulatlns frequency, 30 min : flow rate, 100 ml min : 
volume of circulatory perfusate, 1 litre.
The results are consistent with dark's (1913) contention 
that an essennial factor is lost from the fibres during 
^perfusion and this is in some way responsible for the
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observed deterioration in the condition of the heart.
In this context, the results obtained by varying the rates 
of perfusion deserve special mention, since it is found 
that this has a marked effect on the final steady-state 
contractile force, as well as on the rate of development 
of the hypodynamic condition. This was an unexpected 
finding. If it is assumed that a fixed pool of dark’s 
factor exists within the fibres, then varying perfusion 
rate will only influence the rate at which the preparation 
becomes hypodynamic, and not the final condition of the 
ventricle. It therefore seems probable that this is an 
incorrect assumppion, and that the essennial factor is 
being continually resynthesised. Thus, a balance is struck 
between its loss from the fibres and the rate at which 
it is replenished, so that low flow rates favour its reten­
tion in the fibres, whereas higher flow rates result in 
a greater loss.
The experiments with indomethacin and arachidonic acid 
provide circumt^r^t:i.al evidence that the agent which is 
being lost, which dark concluded was a lipid, is in reality 
a prostaglandin (PG) and/or a prostaglandin - like substance 
(PLS). Indomethacin, a potent inhibitor of prostaglandin
synthetase activity (Vane, 1971; Flower & Vane, 1974), 
potentiates the hypodynamie depression, whereas arachidonic 
acid, the chief fatty acid precursor in prostaglandin 
biosynthesis (Samuulsson, 1972) , delayed its onset and
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elevated the final steady-state tension attained. Indo- 
methacin has been shown to depress m^y^oardic^^L prostaglandin 
levels and to reduce the amounts released from the heart
by sev^ira^l authors (Chanh, Junstad & Wennmalm, 1974; Bloak 
et al, 1975) and arnason and Hallgrimsson (1974)
have reported a beneficial effect of araahidonia aaid 
in the response of the heart to overstimulation. These 
latter authors also reported that molifiantion of the 
fatty aaid aommpsition of the cardiac membrane phospholipids 
greatly infuuences the development of myolardial necrosis 
resulting from overstimulation with isoprenaline.
More direat evidenae for the involvement of PG or PLS 
was obtained by bioassaying the perfusates using the rat 
stomaaO strip. These experiments reveal a alear relation 
between PG or PLS aoncentrations in the perfusates and 
the degree of hypodynamic depression; long perfusion times 
produae higher levels of PG or PLS in the perfusates and 
the aontraatility of the ventriale beaomes more depressed 
as aompared with shorter - time's. Bloak et al (1975) also 
demoltirarei that the perfused rabbit heart releases PLS 
into the perfusates and that the levels inarease as the 
pe^a^t^n deteriorates. Moreover, Piper and Vane (1971) 
have suggested that dis^^anae of the aell is
the m^jor faatlr whiah induaes PG release. Traunmtic 
stimuli, suah as mechanncal stimulation and the formation
of gaseous embed have also been shown to stimulate PG
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release from rabbit heart (Block, Poole & Vane, 1974).
Thin-layer chromatography of extracts of the perfusates 
provides evidence that the development of the hypodynamie 
state is accompanied by the release of significant amounts 
of PGI^, and PGEg together with a PLS of unknown identity 
(Fig. 3.7). The findings that PGE^ and PGEg are released 
are particularly interesting, since the E series of pros­
taglandins is known to exert positive inotropic effects 
on the heart. In this study, superfusion of fresh ven­
tricles with frog Ringer solution containing PGE1 (and 
PGEg but data not presented) delayed the development of 
the hypodynamie condition. Moreover, in other experiments, 
also not presented here, both PGE-^ and PGEg were found 
to cause temporary reversal of the hypodynamie depression.
In summary, the results of the experiments described in 
this chapter implicate the loss of PG^1 and PGEg and a 
related PLS from the heart as possible factors contributing 
to the observed deterioration in its contraatility. Estab­
lishing a causal relation is of course difficult; however, 
the work described in the next chapter shows clearly that 
the development of the hypodynamie depression is also 
accompanied by ma irked changes in the levels of intr acellular 
cyclic 3', 5’ - nucleotides, and it is well known that 
the E series of prostaglandins (Sobel & Robison,. 1969;
Klein & Levey, 1971b) is involved in the biosynthesis 
of cyclic AMP in the myocardium.
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C H A P T E R IV
INTRACELLULAR CYCLIC 3'?5t-, NUCLEOTIDE
LEVELS AND VENTRICULAR CONTRACTILITY
DURING THE . DEVELOPMENT OF THE
HYPODYNAMIC CONDITION.
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INTRODUCTION
Evidence was presented in the proceeding chapiter which 
implicated leakage of PGE^ and PGEg and/or a PLS as a 
possible factor contributing to the time - dependent de­
pression of contraccility seen during superfusion of the 
isolated half ventricle. The experiments described in 
this chapter have revealed that changes in levels of in­
tracellular cyclic 3’, 5’ - nucleotides also occur during 
the development of the hypodynamic state; the decline 
in isomeeric twitch tension is accompanied by a progessive 
decrease in the levels of cyclic AMP and a concommitant 
increase in the levels of cyclic GMP. Assays of cyclic 
3’, 5’ - nucleotide levels in the circulating perfusate 
have shown that some of the changes can be accounted for 
by leakage of small amounts of cyclic AMP and cyclic GMP 
from the ventricle, but that the maior changes must occur 
as a result of alterations in the metabolism of cyclic 
AMP and cyclic GMP. Evidence for a causal relatoonship 
between the altered levels of cyclic AMP and cyclic GMP 
and the observed depression of the contractile response 
was obtained from experiments in which the time course 
of the development of the hypodynamie state was studied 
in the presence of exogenous derivatives of cyclic AMP 
and cyclic GMP.
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The most striking finding is that there is a highly signi­
ficant correlation between the extent of the hypodynamic 
depression and changes in the ratio of cyclic AMP/cyclic 
GMP; thus, for example, a 50% reduction in the force of 
contraction is invariably associated with a 50% reduction 
in the cyclic nucleotide ratio. This is a recurrent finding, 
as will be seen in subsequent chapters, concerned with 
the effects of two inotropic agents on the contractile 
performance of the heart (exogenous ATP and isoprenaline), 
and it is the main theme of this thesis.
Measurements of intracellular cyclic
3', 51 - nucleotide levels during the 
development of the hypodynamic state.
In these experiments the levels of intracellular cyclic 
AMP and cyclic GMP were measured at different times during 
the development of the hypodynamic state. Isolated ventricles 
were divided into two halves, one of which was ’crush - 
frozen' immediately (see Methods) and then assayed for 
cyclic AMP and cyclic GMP and for total protein. The 
values obtained from these freshly frozen half ventricles 
provided control levels. The second half of the ventricle 
was rendered partially or wholly hypodynamic by superfusion
with frog Ringer using the standard conditions (stimula-
, -1 - . -1tion frequency 30 mm ; perfusion rate 100 ml min ;
volume of circulating perfusate 1 litre), after which
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it was ’crush - frozen’ and cyclic nucleotide levels and
total protein estimated. The observed changes in cyclic 
3’, 5’ - nucleotide levels in the test half ventricle 
was expressed as a multiple of the level obtained in the 
control half ventricle.
In the second series of experiments, the superfusates 
were assayed for cyclic AMP and cyclic GMP in order to 
investigate the possibility of leakage of either or both 
cyclic nucleotides from the preparation.
Fig. 4.1 shows the decline in contractile force (solid 
triangles) and the measured levels of cyclic AMP (solid 
circles) and cyclic GMP (open circles) for 10 half ventricles 
frozen at different times during the superfusion procedure. 
Each point represents data from one ventricle, and all 
values are plotted as muutiples of those observed in the 
freshly frozen (control) half ventricle.
The data show, a progressive decline in the level of cyclic 
AMP and an increase in the level of cyclic GMP accompanying 
the time dependent depression of isomeeric twitch tension. 
After 90 minutes of superfusion the level of cyclic AMP 
has fallen to around 0.3 times the value obtained in control 
ventricles, and that of cyclic GMP has increased to around 
1.9 times the control level. Mean values for the levels
of cyclic AMP and cyclic GMP in freshly frozen ventricles
Figure 4.1.
Time course of the decline in isometric twitch tension 
(solid triangles) together with observed changes in
intracellular cyclic AMP (solid circles) and cyclic 
GMP (open circles) levels during the development of 
the hypodynamic state. The control (initial) tension 
is denoted by the horizontal broken line. Each point 
represents data from one ventricle. Tension and 
cyclic nucleotide levels are expressed as multiples 
of the initial (control) values. The decline in twitch 
tension is accompanied by a progressive reduction in 
cyclic AMP and a rise in cyclic GMP. Abscissa; Time 
(min). Ordinate, Relative tension and cyclic AMP or 
cyclic GMP levels (fraction of initial values).
Mean values (— S.E's) for levels of cyclic AMP and cyclic 
GMP in freshly frozen ventricles (10 preparations) were 
found to be 15.80 + 0.31 pmol mg 1 protein and 0.55
+ 0.04 pmol mg 1 protein respectively. Recovery of 
known amounts of cyclic AMP and cyclic GMP were 90.80% 
and 89.72% respectively.
Stimulation parameters: Pulse width, 5 msec; frequency,
30 min °; amplitude, lOV. Flow rate, 100 ml.min °.
Temp. 18.5°C.
[cyclic-AMP or cyclic-GMP
and TENSION
(Fractions of initial values)
TIM
E 
M
IN
79
+
(10 preparations) were found to be 15.80 ~ 0.31 pmoles 
mg~1 protein and 0.55 - 0.04 pmole mg protein, respec­
tively. In real terms then, these figures represent sub­
stantial changes, call pmoles cyclic AMP mg 1 protein
, -1 , ‘
and 0.5 pm^].e cyclic GMP mg protein.
Cyclic nucleotide levels in the superfusates; Levels
of cyclic AMP and cyclic GMP in the superfusate were sampled
at different times during the development of the hypodynamie
state. Small but significant levels c£ both were detected.
A total of 3.0 pmoles of cyclic AMP mgheart protein
appeared after 70 minutes of perfusion, and 0.10 pmole 
, -1
of cyclic GMP mg heart protein. Control levels of cyclic
AMP and cyclic GMP w^ire 20.55 and 0.12 pmoles mg""1 protein
respectively, and intracellular levels at the end of the
70 minute superfusion period were 7.99 and 0.25 pmoles 
-1 . .mg protein, respectively. Thus, not more than 15% of
the observed reduction in intracellular cyclic AMP can 
be accounted for by leakage from the fibres. It is probable 
that this leakage occurs from fibres which are damaged 
during the dissection procedure.
Relationship between changes in cyclic 3*, 5* - nucleotides
and contractile force; Fig. 4.2 shows the relation­
ship between the reduction in contractile force and the 
decrease in cyclic AMP on one hand (A) and the increase
in cyclic GMP (B) on the other. Both sets of data yield
Figure 4.2.
Data taken from Fig.4.1.
(A) Relationship between the decline in isometric
force and the reduction in intracellular cyclic AMP 
+levels. Correlation coefficient - S.E. of estimate: 
0.93 ° 0.14, n = 10, P °c0.C01. Abscissa; Relative
tension (fraction of initial tension). Ordinate;
Cyclic AMP (fraction of initial value).
(B) Relation between the decrease in contractile
force and elevated intracellular cyclic GMP levels.
+ + Correlation coefficient ° S.E. of estimate: -0.84 ° 
0.11, n = 10, P 0.001. Abscissa; Relative 
tension (fraction of initial tension). Ordinate;
Cyclic GMP (fraction of initial value).
Note that the correlation coefficient is positive 
in (A) and negative in (B).
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statistically significant correlation. There is a positive 
correlation between contractile force and intracellular 
cyclic AMP (correlation coefficient - S.E. of estimate 
; 0.933 ~ 0.138, n = 10, P<0.001) and a negative correla­
tion between contraatility and intracellular cyclic GMP
+ •levels (correlation coeffici^t - S.E. of estimate : - 
0.859 - 0.11, n = 10, P<0.001).
These results raise the interesting possibility that the 
contractile capacity is regulated by a balance between 
the two nucleotides : cyclic AMP exerting a force - pro­
moting action, and cyclic GMP opposing it. If this is 
the case, a graphical plot of the relationship between 
cor^tj^c^c^ti.le force and the ratio of cyclic AIPP/cyctit GMP 
might be expected to yield a more precise correlation.
Fig. 4.3 shows such a plot. Here the ratio of cyclic 
APPPcyctit GMP for the whooiy or partially hypodynamic 
ventricles is expressed as a fraction of cyclic AMP/cyccic 
GMP of corresponding control half ventricle, thus:
c yclic AMP/cyctic GMP (hypodynamie)
cyclic AMPPeyecic GMP (control)
and plotted against contractile force, again expressed 
as a fraction of the twitch tension generated by the con­
trol preparation:
Figure 4.3.
Data from Fig.4.1.
Relation between isometric force and intracellular
cyclic 3*, 5* - nucleotide ratio. Both parameters
are expressed as multiples of the control values.
+ + Correlation coefficient - S.E. of estimate: 0.98 - 
0.10, n ~ 10, P ^0°-001^. The solid line is drawn
by eye to emphasise a direct 1:1 proportionality 
between contractile force and the cyclic nucleotide 
ratio. The resulting decrease in the ratio jcyclic 
AMp|Q / ^cyclic GMP^ • parallels closely the decrease 
in the contractility. Abscissa; Tension ratio,
P (hypo) . I 
P (control) Ordinate: Nucleotide ratio.
cyclic AMP/cyclic GMP (hypo)
cyclic AMP/cyclic GMP (control)
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P (hypodynamie)
P (control)
This shows clearly that the decrease in ventricular con­
tractility almost exactly parallels the decrease in the 
cyclic nucleotide ratio. Statistically, the data are 
highly significant (correlation coefficient - S.E. of 
estimate : 0.983 - 0.102, n = 10, P,<ib.001).
Is there a causal relation between intracellular cyclic
3*, 5* - nucleotide levels and contractile force? The
results of the preceding section strongly suggest that 
a cause and effect relatwnship exists between the instan­
taneous levels of the two cyclic nucleotides and the capacity 
of the ventricle to produce force, and that the observed 
changes in the ratio of cyclic AMPPcydic GMP are not 
simply a byproduct resulting from the diminished con­
tractility.
In.order to investigate this question further, experiments 
were made in which isolated ventricles were superfused 
with Ringer solution containing either exogenous dibutyryl . 
cyclic AMP (DB cyclic AMP) or exogenous 8 - Bromo cyclic 
GMP (8-Br cyclic GMP) and the effect on the time course 
of the development of the hypodynamie condition and the 
extent of the hypodynamie depression were assessed. The 
aim of making these experiments was to artificially manipu-
Figure 4.4.
Time course responses of the decline in isometric
"3twitch tension during exposure to exogenous (10
10 M) dibutyryl cyclic AMP (open circles) and
-3 -7(10 - 10 M) 8 - Bromo cyclic GMP (solid circles).
The control tension response (solid squares) is 
depicted by the broken line for comparison. Cyclic 
AMP delays the development of the hypodynamic state,
whereas 8 - Bromo cyclic GMP accelerates it.
-3Dibutyryl cyclic AMP (^» 10 M) prevents the decline 
in twitch tension (up to 8 hours). Abscissa; Time 
(min). Ordinate; Relative tension (expressed as
a multiple of the initial (control) value).
The data for each curve, following exposure to either
dibutyryl cyclic AMP or 8 - Bromo cyclic GMP, were
obtained from 1 preparation.
Stimulation parameters: Pulse width, 5 msec;
“1 .frequency, 30 min ; amplitude, lOV. Flow rate:
100 ml.min \ Temp, 18.5°C.
-o
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late the levels of cyclic AMP and cyclic GMP within the
fibres in order to alter the cyclic nucleotide ratio.
The results are summarized in Fig. 4.4. The dashed curve 
shows the time course of the decline in twitch tension 
for control superfused ventricles. The upper and lower 
families of curves show the effects of superfusing with 
DB cyclic AMP and 8-Br cyclic GMP, respectively. It can 
be seen that superfusion with exogenous DB cyclic AMP 
produces a dose - dependent reduction in the rate of de­
cline in twitch tension and also leads to elevated steady- 
state (after 100 minutes) levels, whereas superfusion 
with 8-Br cyclic GMP has converse effects, causing accele­
ration of the rate at which the twitch declines and a 
further reduction in the steady-state level ultimately 
attained. Dose - response curves for the effects of DB 
cyclic AMP and 8-Br cyclic GMP on the steady-state depres­
sion and on the time course of the responses are shown 
in Fig. 4.5A & B respectively.
The effects of treating fully hypodynamia preparations 
with DB cyclic AMP or 8-Br cyclic GMP are presented in 
a subsequent chapter (VI) . Briefly, these show that DB 
cyclic AMP produces a long - lasting potentiation of the 
twitch, whereas 8-Br cyclic GMP has the reverse effect, 
producing an even greater depression.
Figure 4.5.
Data taken from Fig.4.4.
_ O _ O(a) Effects of exogenous (10 - 10 M)
-7dibutyryl cyclic AMP (Solid circles) and (10 - 10 M)
8 - Bromo cyclic GMP (solid circles) on the final steady- 
state tension reached after 100 minutes. The upper 
broken horizontal line shows the control (initial) 
tension. The lower horizontal' solid line depicts the
normal (hypodynamie) tension attained after 100 minutes 
perfusion with normal frog Ringer solution. Dibutyryl 
cyclic AMP elevates the final steady-state level, whereas 
8 - Bromo cyclic GMP depresses it in a dose-dependent 
fashion. Abscissa; Concentration (M) dibutyryl cyclic
AMP and 8 - Bromo cyclic GMP. Ordinate; Relative 
tension (fraction of control value).
-4 "8(B). Influence of exogenous (10 - 10 M) dibutyryl
-3 -7cyclic AMP (open circles) and (10 - 10 M) 8 - Bromo
cyclic GMP (solid circles) on the rate of development 
of the hypodynamie state. The control is depicted 
by the (solid triangle) where the two axes intersect.
Abscissa; Concentration (M) dibutyryl cyclic GMP and 
8 - Bromo cyclic GMP. Ordinate; Time taken for 
tension to decay to 80% of the control (initial) level 
(min).
Relative tension
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These results taken together provide support for the view ?
that a causal relationship exists between the levels of |
cyclic AMP and cyclic GMP and ventricular connraaCility,
$
a conclusion which is strengthened by results presented
later, concerning the effects of exogenous ATP and isopre- |
naline on the ventricle. i
I
I
3
1
I
a
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DISCUSSION
Several factors have been identified as possible causal 
agents in the mechanism of the hypodynamie depression, 
including loss of a lipid substance (Clark, 1913; Szent- 
Gyorgy.i, 1953), lowered intracellular ATP levels (Greiner, 
1952) , reduced calcum influx resulting from the loss 
of a hypothetical calcium binding site (Chapman & Niedergerke, 
1970a, b) and an energetic deficiency which can be compen­
sated by provision of pyruvate (Vassort & Ventura-Clapier, 
1977). The present work identifies yet another change 
in the metabolic status of the ventricle which may well 
prove to be of significance; namely a reduction in intra­
cellular cyclic AMP levels and the accompanying abnormally- 
elevated levels of intracellular cyclic GMP.
The close correlation between changes in the contractile 
state of the superfused preparation and alterations in 
the ratio of cyclic AiPPcyycic GMP is thought to be especcally 
significant. It suggests that the two agents exert opposing 
influences on the mechanism of force production, a con­
clusion which finds considerable support in the literature. 
Nawrath (1976; 1977) found dose - dependent negative inotropic 
effects of exogenous 8 - Br cyclic GMP on rat atria and 
on cat papillary muscle, and increases in the levels of 
endogenous cyclic GMP are known to accompanying the negative
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inotropic effects of acetylcholine (see also George et 
al, 1970, 1973, 1975; Watanabe & Besch, 1975; England, 
1976). Conversely, treatment with exogenous DB cyclic 
AMP has been shown to produce positive inotropic effects 
(^i^l^ovetz & PBch, 1970; Skeleton et al, 1970; Ahren 
et al, 1971; Drummond & Hemming, 1972; Meinertz et al, 
1973; Nawrath, 1976; Tsien, 1977) and many authors (see 
review by Tsien, 1977 and Introduction) have reported 
elevated cyclic AMP levels following stimulation of the 
heart with p- agonists such as adrenaline and isoprenaline
The probability that the observed relation between altered 
cyclic nucleotide levels and contractility is a causal 
one is increased by the results reported in subsequent 
chapters, which show that this correspondence holds in 
other, physiologically - different situations. This makes 
it seem less likely that the observed changes in the 
levels of intracellular cyclic AMP and cyclic GMP during 
the development of the hypodynamie state are merely a 
consequence of impaired contractile performance. Time 
course experiments, showing potentiation of the hypodynamie 
condition following superfusion with 8 - Br cyclic GMP 
and, in contrast, improved contractility following super­
fusion with DB. cyclic AMP, reinforce this view.
It is less clear what initiates the change in cyclic AMP
and cyclic GMP levels. Evidence was presented earlier to
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show that PGE, and PGE9, together with a PLS, are released 
into the superfusates, and since PGE^, and PGEg 
to stimulate adenylate cyclase activity (Klein 
1971b; Levey & Klein, 1973), their loss might
in a lower conversion of ATP to cyclic AMP within the 
fibres. Certainly, it is clear that relatively little 
cyclic AMP is actually lost into the perfusates and so 
the depressed levels must be due either to low adenylate 
cyclase activity or alternatively to increase cyclic AMP 
phosphodiesterase activity.
A literature search has failed to yield any information 
relating to the actions of prostaglandins on phosphodiesterase 
activity (see Hittelman & Butcher, 1973) , nor it seems 
is there any information concerning the actions of pros­
taglandins on guanylate cyclase activity. It is difficult, 
therefore, to see why the levels of cyclic GMP should
increase unless the level of cyclic AMP acts in some way 
to regulate the levels of cyclic GMP. It was pointed 
out earlier (main Introduction) that several situatoons 
have been documented in which the primary effect of a 
cardioactive substance (such as, for example, acetylcholine 
and isoprenaline) appears to be on one of the two cyclic 
3*, 5 * - nucleotides, but in which changes in the levels 
of the other are detectable. Examples of ’phase-shifted* 
changes in cyclic AMP and cyclic GMP following treatment 
of hypodynamie ventricles with exogenous ATP and isoprena- 
line will be referred to later.
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In conclusion, the results presented in Chapters III and
IV suggest that the loss of PGE, and PGEg and/or a PLS -I 2
from the ventricle may be responsible for initiating changes 
in levels of cyclic AMP and cyclic GMP, which in turn 
have an effect on force generating mechanism. Further 
discussion of the nature of this effect is deferred until
later.
88
PART II
EFFECTS OF EXOGENOUS ATP AND
RELATED COMPOUNDS ON VENTRICULAR
CONTRACTILITY AND ON CYCLIC 3, 5-
NUCLEOTIDE METABOLISM
89
A HISTORICAL REVIEW OF THE
LITERATURE PERTAINING TO THE
EFFECTS OF ATP AND RELATED
COMPOUNDS ON THE HEART
90
INTRODUCTION
In 1929 Drury and Szent-Gyorgyi found that crude extracts 
of bullock heart exhibited strong pharmacological effects
on the heart and coronary vessels, producing marked changes 
in cardiac function. Since this time, the action on the 
heart of a wide range of purine and pyrimidine based
nucleosides and their nucleotide derivatives have been
investigated. These substances have profound chronotropic
and inotropic effects on isolated atria, ventricles and 
whole hearts, as well as on the cardiovascular performance 
of intact animals, including Man.
The purpose of this Introduction is to review the literature 
concerning their effects, which although extensive, has 
yielded comparatively little information concerning the 
mode of action of these agents. This is due in part to 
the fact that different regions of the heart respond in 
different ways (Drury, 1936). In intact hearts the chron­
otropic effects exert dominant action, presumably by affect­
ing ; pacemaker activity, and these to some extent obscure, 
the equally important inotropic actions. The situation is 
even more confusing when one compares the reported effects 
of injection into whole animals. Moreover, it is clear •
that the hearts of different species respond in different
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ways and that the nature of the response is dependent 
upon the physiological condition of the preparation.
Actions . of ATP and related compounds on amphibian hearts.;
Lindner and Rigler (1931) demonstrated that the anoxic
-7heart responds to ATP in low concentrations (10 M), show­
ing an immediate but transient increase in the force of 
contraction, followed by a sLower and longer lasting rise. 
Parnas and Ostern (1932) confirmed that ATP produces an 
immediate positive inotropic effect in perfused hypodynamie 
hearts, but reported that this was followed by heart block. 
Gillespie (1934) demonstrated only the blocking action of 
ATP. Later studies confirmed that ATP produces a charac­
teristic triphasic inotropic effect on hearts depressed 
with quinine (Lichtneckert & Straub, 1949), potassium 
(Loewi, 1949) or calcium deficiency (Marshall & Andrus,1953) 
and on perfused hypodynamie hearts (Pettko & Straub), 1948; 
Kanda, Sekiya & Inoue, 1954). Kanda et all (1954) were 
able to demonstrate a triphasic inotropic effect of ATP
and heart block. In higher concentrations, they reported
/that both ATP and adenosine 5-diphosphate (ADP) produced 
an immediate increase in contractile force, followed by a 
short lasting negative inotropic effect and complete heart 
block; after which the force of contraction gradually in­
creased and remained elevated for a further 100 min.
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These authors also made the significant observation that 
the effects of ATP are not blocked by atropine, a result
which has been confirmed by subsequent investigators 
(Schenberg, 1956; Versprille, 1966).
The actions of ADP are qualitatively similar to those of 
ATP, although there are quantitative differences: the 
inotropic effects are generally smaller (Pettko & Straub, 
1949; Marshall & Andrus, 1953) and even in high concentra­
tions, it fails to produce heart block (Schenberg;, 1956). 
There is some disagreement concerning the effects of AMP. 
Loewi (1949) reported a positive inotropic effect, but 
this was not confirmed in subsequent studies of Kanda et 
al (1954). Adenosine is reported to have no effect on 
the frog heart (Kanda et al, 1954; Boyd & Forrester?, 1968).
In a more recent series of papers Versprille (1963a,, b; 
1964) has documented the effects of other related nucleo­
sides and their phosphates on the intact frog heart and 
on the isolated frog ventricle. An inotropic effect is 
obtained with cytidine -5 - triphosphate (CTP), guanosine
-5 - triphosphate (GTP), inosine -5* - triphosphate (ITP)
and uridine -57 - triphosphate (UTP), although the magni­
tude of the response and its shape differ with different 
nucleotides. Boyd & Forrester (1968) reported that low
concentrations of ATP, ADP and UTP produced marked inotropic
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responses, whereas ITP, CTP and GTP only acted in much 
high concentrations and produced qualitatively different
responses. Finally, Versprille (1965) showed that
_3ATP (10 M) has a negative chronotropic effect on the 
intact heart but a positive chronotropic action on the 
isolated ventricle. The negative chronotropic effect is 
not blocked by atropine (Versprille, 1966). These 
observations together account for some of the confusion 
regarding the mode of action of ATP, a point which is 
emphasised by observations on mammalian hearts (see below).
ATP has a marked effect on the cardiac action potential.
It restores electrical excitability to frog ventricles 
previously paralysed with high potassium solution (Kotowski, 
Antoni & Fleckenstein, 1959) or in a calcium deficient 
medium (Antoni, Englstfeld & Fleckenstein, 1960). It 
has a dose-dependent positive inotropic effect on frog 
atria and this is accompanied by an increase in the over­
shoot and duration of the action potential (Goto, Yatani 
& Tsuda, 1976, 1977; Yatani, Goto & Tsuda, 1978). More­
over, at higher concentrations, the transient negative 
inotropic effect of ATP is associated with a decrease in 
the overshoot and a shortening of the duration of the action 
potential. Voltage-clamp experiments by these authors
have demonstrated an increase in the slow inward calcium
current in response of ATP.
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Effects of ATP and related compounds on mammalian 
myocardium; Drury, (1936) emphasised that the principal 
sites of action on the heart of the various adenyl com­
pounds may differ in different species. His conclusion 
has been reinforced by more recent work. In general, 
the chronotropic and inotropic effects on the atria are 
negative, but predominantly ' positive on the ventricle.
Mammalian atria: Drury and Szent-Gyorgyi (1929) showed
that adenosine and adenylic acid exert a negative inotropic 
effect on dog atria. This was confirmed later by Drury 
(1932) and later by Wedd and Fenn (1933) who used isolated 
atria from dogs, guinea-pigs and rabbits. Drury and 
Szent-Gyorgyi (1929) also demonstrated that these actions 
on the atria were not blocked by atropine. More recent
studies have confirmed that ATP, ADP, AMP and adenosine 
depress the contractility of dog (Emmelin & Feldberg, 1948), 
cat (Green & Stoner, 1950; Acierno, Burno, Burstein & 
DiPalma, 1952; Bertelli, Bianchi & Beani, 1972), rabbit 
(Bielschowsky, Green & Stoner, 1944; Emmelin & Feldberg, 
1948; Marchetti, Merlo, Noseda & Ferrini, 1968; Bertelli 
et al, 1972) and rat (Hollander & Webb, 1957; Bertelli et 
al, 1972; Meinertz, Nawrath & Scholz, 1973) atria..
Treatment of rabbit atria with atropine (Bielschowsky et 
al, 1944) does not prevent the action of ATP. A marked
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but transient negative chronotropic effect of adenosine
and adenine nucleotides on canine sinus node, which is
unaffected by atropine, was reported by James (1965).
The depressant effects of ATP, ADP, AMP and adenosine on 
isolated rat, rabbit and guinea-pig atria are accompanied 
by a marked shortening in the duration of the action 
potential, with little or no effect on the size of the 
overshoot (Hollander & Webb, 1957; Bertelli et al, 1972; 
Meinertz et al, 1973).
Mammalian Yeutricular preparations: Early investigators
using dog ventricles failed to obtain a response to either 
adenosine or adenylic acid (Drury & Szent - Gyorgyi, 1929; 
Wedd, 1931; Drury, 1932). However, Lindner and Rigler 
(1931) observed that adenosine increased coronary blood 
flow and contractile force and Drury (1932) reported a 
long-lasting, positive inotropic effect resulting from 
treatment with adnylie and guanylic acids. Gillespie 
(1934) found that ATP caused temporary heart block, follow 
ed by a positive inotropic effect. Green and Stoner's 
(1950) work revealed that ATP has a triphasic inotropic 
effect on isolated rabbit ventricle, but adenosine has no 
effect and AMP has only a small effect. Green and Stoner
drew attention to the fact that ATP has effects which are
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unlike those of the other members of the adenyl series.
Whole animals: Adenosine and adenine nucleotides depress
contractility and slow the rate of beating in cats
(Bielschowsky et al, 1944; Emmelin & Feldberg, 1948; Green 
& Stoner, 1950), dogs (Emmelin & Feldberg, 1948; Angelakos 
& Glassman, 1961; Marchetti et al, 1968), rabbits (Sydow 
& Ahlquist, 1954; Buckley, Tsuboi & Zeig, 1961), guinea- 
pigs (Rand, Stafford & Thorp, 1955) and rats (Versprille 
& Duyn, 1966; Versprille, 1966) hearts. Generally, 
atropine has no effect on these responses, but in the cat 
it has been found that atropinization and/or sectioning 
of the vagi prevents these actions (Bielschowsky et al, 
1944; Emmelin & Feldberg, 1948).
Effects of the adenyl compounds in man have been investi­
gated extensively. Honey, Ritchie and Thomson (1930) 
injected adenosine into normal human subjects and reported 
impaired A-V conduction, with bradycardia. Similar 
results were obtained by Jezer, Oppenheimer and Schwartz 
(1933). Rothmann (1930) using adenylic acid from crude 
muscle extracts, observed depression of sinus -rhythm, but 
no A-V impairment, and Van De Velden (1932) also reported 
only bradycardia.. Hartmann (1932) found an initial
increase in heart rate followed by slight bradycardia. 
Richards* (1934) study of adenosine and adenylic acid
1
9
-i
-J'V;
1
‘-I
97
confirmed that these agents produce an initial tachy­
cardia and that in 25% of the subjects tested, there
is a disturbance in A-V conduction. He concluded that
adenylic acid acte primarily on the conducting system 
of the heart. This conclusion is supported by later 
studies of Wayne, Goodwin and Stoner (1949) who found that 
ATP has a profound effect on conduction, causing changes 
in cardiac rhythm; small doses produce sinus slowing, 
prolongation of the P-R interval and heart block, whereas 
larger doses produce standstill of either the ventricles 
or of the whole heart. Intravenous injection of atropine 
does not influence sinus slowing induced by ATP, but it 
reduces the duration of any heart block:.
Effects of exogenous ATP on cardiac metabolism; Endo-
genous ATP holds a key position as an energy donor in many 
cellular processes, and a deficiency (due for example to
hypoxia) produces an irreversible weakening of the heart 
and a gradual cessation of activity. Marshall and Andrus 
(1953) reported that the administration of exogenous ATP 
could improve the performance of the hypoxic heart. 
Moreover, Harary and Slater (1965) found that exogenous 
ATP could overcome the inhibitory effects of oligomysin 
and iodoacetate (inhibitors of oxidative and anaerobic 
energy production, respectively) on the contractile per-
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formance of isolated cells derived from rat heart.
Loss of-phosphocreatine and glycogen from hypothermic 
dog hearts is also mitigated by the injection of ATP 
into the coronary system (Fedelesova, Ziegelhoffer, 
Valachovic & Hubka, 1966; Fedelesova, Ziegelhoffer,
Krause & Wollenberger, 1969). The latter authors showed 
that intracellular adenosine nucleotides and phospho­
creatine levels were greater in ventricles treated with 
exogenous ATP than in control hearts. These observations 
have been confirmed for the anoxic perfused dog heart 
(Fedelesova, Ziegelhoffer & Styk, 1968; Ziegelhoffer, 
Fedelesova & Siska, 1971/72). Fedelesova et al (1968) 
conclude that ATP exerts its action by direct entry 
through the cell membrane although several studies have 
produced contradictory evidence on this point (see below).
Does ATP cross the cell membrane? If is a commonly held 
belief that ATP is unable to pass through the cell membrane 
(Boyle & Conway, 1941; Glynn, 1968), although there is some 
evidence to the contrary. Forrester and Hamilton (1975)
claimed that ATP is released from cat soleus muscle and
evidence for its entry into this muscle is provided by the 
work of Chaudry and Gould (1970). Forrester (1972) 
demonstrated that ATP appears in the circulation of the
occluded, exercising human forearms and he proposed that
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it is derived from muscle cells. Paddle and Burnstock
(1974) demonstrated elevated ATP levels in the coronary 
circulation of perfused guinea-pig hearts under anoxic 
condition, although it is not clear whether this was
derived from nervous tissues, vascular smooth muscle or
from the heart cells. More recently, Forrester and 
William (1977) identified ATP in the fluid medium surround­
ing heart cells isolated from rat ventricles, especially 
under hypoxic conditions. They suggested that this is 
derived from the myocardial cells.
Thus there is considerable evidence that ATP can leak out
of the cell; evidence regarding its ability to enter 
cells is less convincing. On balance, it appears more 
likely that ATP is first dephosphorylated, with liberation 
of adenosine and inorganic phosphate, and that adenosine 
then crosses the cell membrane and is rephosphorylated on 
the inside. Hoffmann and Okita (1965) working with per­
fused guinea-pig hearts, and Hatori, Miyazaki and Nakamura 
(1969), working with rat hearts, used a radioisotopic
method to investigate this question. Mixtures of aden- 
14osine 8 - C labelled triphosphate and adenosine triphos- 
32phate y - P of known isotopic ratio were employee..
Their results were consistent with the idea of indirect
entry. Similar results have since been obtained by
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others (Krause & Wollenberger, 1968; Fedelesova et al,
1969; Ziegelhoffer et al, 1971/72).
The site of dephosphorylation of ATP is not known.
There is evidence that dog coronary artery homogenates
are capable of releasing inorganic phosphate from ATP 
(Carr, Bell Bradyhouse & Kantz, 1953) and that coronary 
tissues contain 5-nucleotidase (Reis, 1951). Antoni et 
al (1960) concluded that in the frog heart, dephosphoryla­
tion occured on the outer surface membrane.
It is important to note that some at least of the effects 
of ATP are not mediated by a dephosphorylation - penetra­
tion - rephosphorylation mechanism. Recent work by 
Yatani et al (1978) using AMP - PNP, a non hydrolyzable 
analogue of ATP (Yount, Babcock, Ballantyne & Ojala, 1971), 
has shown that the actions of this substance on frog atria 
are essentially the same as those of A_TP. The question 
of direct entry of ATP into myocardial cells or of in­
direct entry is as yet unresolved.
Present Study; The work reported in this section was
undertaken to investigate the effects of ATP and related 
compounds on ventricular contractility and on intracellular 
cyclic 3, 5- nucleotide metabolism. Chapter V is con­
cerned with the effects of exogenous ATP on the mechanical
101
and electrical properties of the ventricle. This work 
led to the formulation of a working hypothesis on which
the remainder of the work in this thesis is based. In
Chapter VI, indirect evidence for the involvement of
/ tcyclic 3, 5- nucleotides in mediating the ATP-induced 
response is presented. Chapter VII is concerned with 
changes in the levels of intracellular cyclic AMP and 
cyclic GMP elicited by ATP. Chapter VIII describes the 
effects of ATP and some related compounds on ventricular 
contractility.
Preliminary accounts of some aspects of this work were 
presented to the Physiological Society (Flitney, Lamb &
Singh, 1977, 1978).
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CHAPTER V
EFFECT OF ATP ON MECHANICAL AND
ELECTRICAL PROPERTIES OF THE
VENTRICLE
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1 N T R O D U C T I 0 N
In this chapter, the characteristic form of the response 
of the superfused ventricle to treatment with exogenous 
ATP is described in some detail. Evidence is presented 
to show, first, that it is not mediated by the release 
of neurotransmitters from nerve ending within the pre­
paration; and secondly,that changes in the duration of
the action potential]., consistent with an effect of ATP 
on the slow inward calcium current, occur throughout the 
response. A working hypothesis is also described (in 
the Discussion) which actually formed the basis for a 
more detailed investigation of the mechanism of action 
of ATP, presented in subsequent chapters.
Characteristic form of the
inotropic response to ATP.
Fig.5.1A shows the time course of the development of the
hypodynamic condition prior to exposure of ventricles to 
-1ATP. The perfusion rate was 100 ml.min , stimulation
-1frequency 30 min and the total volume of circulating
fluid was 1 litre. Contractile force fell to around 25
35% of the initial value over a period of 70 to 80 minutes
Figure 5.1.
(A) Time course of the development of the hypo-
dynamie condition prior to treatment with ATP. Each
point represents the mean - S.E. taken from
10 preparations. Contractile force declines to 
about 30% of the initial value after about 80 
minutes. Abscissa; Time (min). Ordinate; Relative 
tension (fraction of initial (control) value).
(B & C) Original chart recordings showing inotropic— 5responses to two concentrations of ATP: 10 M (B)_3and 10 M (C) on the hypodynamie ventricle. Note 
that ATP exerts a characteristic triphasic inotropic 
response comprising (1) an immediate positive 
inotropic effect which is maximal within 2-4 beats 
(2) a second inhibitory effect, reaching a maximum 
within 15-18 beats and (3) a long-lasting secondary 
potentiation (about 80-100 min) which is maximal 
after 1.5 - 2 min. The arrows indicate the times
of application of ATP.
Stimulation parameters: Pulse width, 5 msec;
-1frequency, 30 min ; amplitude, lOV. Flow rate:
100 ml.min Temp, 18.5°C.
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Original chart recordings of the response to two con­
-5 -3centrations of ATP, 10 and 10 M, are shown in Fig.5.1B. 
Although these differ in detail (see pages 104 - 106) they 
illustrate the general form of the ATP-induced response. 
Generally, it comprises an initial, rapidly-developing 
positive inotropic effect, which is maximal after 2-4 
beats (hereafter referred to as the 1st phase), followed 
by a period in which the twitch amplitude is somewhat 
reduced, sometimes far below the control level (2nd phase) 
and superseded by a slowly-developing, secondary increase 
in contractile force (3rd phase) which is maximal after
1.5 - 2 minutes and which may persist for up to 100 minutes.
Log-dose response curves -to varying concentrations of ATP;
- - -10 -3 ,The effect of varying /ATP^Z (range 10 - 10 M) on the
form of the response was studied. Fig.5.2A illustrates 
in diagramatic form the three parameters which have been 
measured. The results are presented as a family of curves 
in Fig. 5.2B. Contractile force in the presence of ATP 
is expressed as a multiple of the control (hypodynamic) 
level prior to treatment.
-,-e
is
-J
%
■■■>
'J
•J
■’ §
These curves show several features which are of interest:.
The effect of varying concentrations of ATP on the third '
component of the response (50th twitch; Fig.5.2A) ppoduces da
' *
3
Figure 5.2.
(A) Characteristic triphasic form of ATP-induced
inotropic response. The four parameters measured 
were: (1) control (c) hypodynamie level
(ii) 1st phase (3rd twitch) (iii) 2nd phase 
(18th ' twitch) and (iv) 3rd phase (50th twitch). 
Results are presented as family of curves in (B).
(B) Log-dose response curves for 1st, 2nd and
3rd components of the response (range from 10-3to 10 M). Maximum tension reached during 1st,
2nd and 3rd phases is expressed as a multiple of 
the control (hypodynamie) level. Each point 
represents mean - S.E. taken from 10 preparations. 
Abscissa; Concentration of ATP (M).
Ordinate; Tension Ratio (ATP/control).
Stimulation parameters: Pulse width, 5 msec; 
frequency, 30 min \ amplitude, lOV.
Flow rate: 100 ml.min . Temp, 18.5oC.
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a sigmoidal log-dose response curve, rising to a maximum
-3at 10 M of around 3.60x, the initial value. The
amplitude of the first component (3rd twitch; Fig.5.2A)
shows a similar increase with increasing /ATP^ , but
with a slight downward trend at higher concentrations 
-3(10 M). The amplitude of the 2nd component (18th
twitch; Fig.5.2A) varies in a different manner, it increases 
-7for concentrations ^.10 M but thereafter it becomes pro­
gressively reduced, falling below the control level at
-5 -3around 10 M ATP. In some preparations, 10 M ATP was 
seen to halt the ventricle temporarily.
The form of the curve for the 2nd component of the ATP 
induced-response is particularly significant. It shows
clearly that the reduction in twitch amplitude is not 
simply due to the absence of a positive inotropic effect, 
since contractile force falls substantially below the 
pretreated control value, and for this reason, it is con­
cluded that the 2nd phase is actually a manifestation of 
an underlying inhibitory effect of ATP. Indeed, it 
suggests that ATP exerts a dual effect on the ventricle: 
a rapidly-developing and long-lasting positive inotropic 
effect and, superimposed upon it, a somewhat delayed and 
transient negative inotropic effect; and that what is 
recorded represents the resultant of these two opposing 
influences (Fig.5.3A).
Figure 5.3.
(A) The upper trace (P) illustrates in a
quantitative way the time course of a relatively
long-lasting positive inotropic effect. The 
middle trace (l) depicts the time course of the 
postulated inhibitory effect. The lower trace 
shows the time course of the tension response 
resulting from these two opposing influences 
(P and 1). The inhibitory effect (l) is 
obtained by subtracting the observed tension 
during the 2nd phase from the mean value of the
1st and 3rd phases. The results of 10 experiments
C. “1 -10 — 3A'TPJ'o range from 10 to 10 M are shown 
in (B).
(B) Log-dose response curve for the inhibitory 
effect of the 2nd phase of the ATP-induced inotropic 
response. Each point is mean value 0 S.E. 
Abscissa; Concentration of ATP (M). Ordinate; 
Inhibitory effect, Tension ratio (expressed as 
multiples of control values).
Stimulation parameter’s: Pulse width, 5 msec ;-1frequency, 30 min ; amplitude, lOV. Flow
rate: 100 ml.min ; Temp, 18.5 -C.
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Effect of varying CATP1 on the size of the inhibitory 
component: If the above supposition is correct, then
the method of analysing the results for depicting the 
effects of ATP on the 2nd component of the response used 
earlier (Fig.5.3A & B) is inappropriate. The lower 
curve (Fig.5.3A) illustrates the correct procedure. This
is to subtract the observed contractile force from the
force which would have been recorded in the absence of
any inhibitory influence. In practice, of course, it is 
impossible to do this accurately, since there is no way of 
telling how much force the ventricle would have produced 
had ATP exerted a positive inotropic response only.
However, a reasonably objective assessment can be made by 
subtracting the amplitude of the 2nd phase (twitch 18th)
from the mean value obtained for the first and third com­
ponents (3rd and 50th twitch respectively) of the response.
The result of doing this is depicted in Fig.5.3B for vary­
ing M0 . The resulting curve shows a progressive 
increase in the estimated size of the inhibitory component 
with increasing QaTp|J^.
Does ATP exert its effect by releasing
endogenous neurotransmitters?
The possibility that ATP exerts its effect by stimulating
Figure 5.4.
(A) Time course of the response to 10 M
acetylcholine (solid triangles) and the same
concentration of acetylcholine in the presence
— 6of 10 M atropine. Note that atropine almost 
completely abolishes the action of acetylcholine.
(B) Effects of 10 ATP alone (solid circles) 
on . the hypodynamie ventricle following pre­
treatment with, and in the continuing presence of,
“610 M atropine (open circles). The point to note 
here is that atropine reduces the initial com­
ponent but has little effect on the 2nd and 3rd 
phases.
(C) Time course of the changes in contractile
force during exposure of hypodynamie ventricle to
Ringer solution containing a mixture of either 
— 5 — 810 M ATP and 10 M acetylcholine (solid circles)
— 6 ~8or atropine (10 M), acetylcholine (10 M) and 
10 5M ATP. Acetylcholine greatly reduces twitch 
tension for the 2nd and 3rd components of ATP- 
induced response whereas atropine abolishes these 
effects.
The control tension response is shown by the broken 
horizontal line. Abscissa; Time (min). Ordinate; 
Tension ratio (expressed as a multiple of the control 
level prior to the addition of ATP, Adh or both)
Stimulation parameters: Pulse width 5 msec;
-1frequency, 30 min ; amplitude, lOV. Flow rate, 100 
ml.min . Temp,18.5°C
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the release of endogenous neurotransmitters has been 
tested by examining the effects of atropine and propranol­
ol on the form of the response. Neither of these 
blocking agents has any marked effect on the ATP-induced
response and it is therefore concluded that ATP influences 
the contractility of the ventricle in a way which does not 
involve either cholinergic or - adrenergic receptors.
Effects of atropine on the ATP response: The response
of the hypodynamie ventricle to acetylcholine above
- 8(10 M) is seen in Fig.5.4A (lower curve)and acetylcholine 
in the presence of 10 M atropine (upper curve). As
expected, atropine almost completely blocks the acetyl­
choline- induced negative inotropic effect. In contrast 
to this, pretreatment of the hypodynamie ventricle with 
10 6M atropine has only_a small effect on the ATP response. 
It reduces the first component somewhat (by 21%) but 
increases slightly the 2nd and 3rd components (Fig.5.4B). 
The effect of acetylcholine on the ATP-induced response 
is shown in Fig.5.4C (solid circles). The first phase 
is largely unaffected, whereas during the 2nd and 3rd 
phases of the response, the force of contraction is 
greatly reduced. Once again, this action is almost
entirely prevented by pretreatment with atropine (open 
circles; Fig.5.4C) leaving a near-normal ATP response.
Figure 5.5.
(A) Effect of 10 adrenaline (solid triangles)
on the hypodynamie ventricle and following pre­
treatment (for 5 min) with, and in the continuing 
presence of, 10 propranolol (open triangles). 
Control tension is shown by the broken horizontal 
line. Note the powerful positive inotropic action 
of adrenaline which is almost entirely abolished by 
propranolol,. Abscissa; Time (min). Ordinate;
Tension ratio (expressed as a multiple of the control 
level prior to stimulation with adrenaline).
(B) Time course of changes in isometric force
-5during exposure of hypodynamie ventricle to 10 M
ATP alone (solid circles) and following pretreatment
(for 5 min) with, and in the continuing presence of, 
-710 M propranolol. Control level is illustrated 
by the horizontal broken line. Propranolol has 
little effect on the response induced by ATP. 
Abscissa; Time (min). Ordinate; Tension ratio 
(expressed as a multiple of the control value prior 
to treatment with ATP),
Stimulation parameters: Pulse width, 5 msec;
-1frequency, 30 min ; amplitude, lOV. Flow rate:
100 ml.min \ Temp, 18.5°C.
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Effect of propranolol on the ATP response: The effect
-6of adrenaline (10 M) on the hypodynamie ventricle is 
shown in Fig.5.5A (upper curve). Adrenaline produces a 
powerful positive inotropic response, reaching a maximum 
after approximately fifteen twitches. This effect is
almost entirely blocked by pretreating for 5 mins with
-710 M propranolol, a p - antagonist. In contrast to this,
propranolol has no marked effect on the ATP-induced
response (Fig.5.5B).
Effects of ATP on the action potential: Intracellular 
microelectrode recordings have shown that ATP has a pro­
found effect on the shape of the action potential. In 
this series of experiments, narrow strips of ventricle were 
used and the perfusion rate was reduced to only 20ml min 
to avoid dislodging the microelectrode.
Initially, action potentials were recorded during the re­
latively Tong-lasting third phase of the response resulting
. -3from treatment with 10 M ATP, and these are described 
first. In subsequent experiments, action potentials were 
recorded at a specified time (between the 45th and 55th 
twitch) during responses elicited by varying I ATP I and 
also continuously throughout the time course of a single 
ATP response. The effects of verapamil ( o( - Irosproyl -
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S (N-methyl-N-homoveratryl) - J - aminopropylj -3,
4 - di-methoxylacetonitrile hydrogen chloride), an agent 
which reduces transmembrane calcium movements (Kohlhardt, 
Bauer, Krause & Fleckenstein, 1972), on the ATP-induced 
action potential have also been investigated.
The results of these experiments suggest that the primary 
effect of ATP on the ventricle is to increase the magni­
tude of the slow inward calcium current:.
Table 5.1; Membrane potentials from frog ventricular strips
-3during the 3rd component of the response to 10 M ATP
Control lmM 10 ’ JM ATP ; lmM
1. Resting potential 78.36- 3.34 (14^) 79.18- 3. 86 (14)
2. Action potential
height
104.76- 4.10 (14) 116.78- 5 .57 (14)
3. Mean o vershoot(2-1) 26.40 37.60
4. Action potential
duration at 
-30mV level (mJec)
520- 12.9 (14) 705- 19.0
5. Percent duration
increase - 35.5.
6. Action potential 
duration at 
resting level
695 - 14.0 951 - 21. 0 (14)
The figures in brackets denote the number of cells impaled from
Figure 5.6.
_ -3Effect of ATP (10 M) on action potential
(a, above) and twitch amplitude (a, below) during
the 3rd component (50th twitch) of the response. 
The control (prior to ATP treatment) action 
potential (b, above) and twitch tension (b, below) 
are shown for comparison. It can be seen that 
ATP produces an increase in the overshoot and 
duration of action potential and a marked 
augmentation of twitch contraction.
Stimulation parameters; Pulse width,, 5 msec. 
frequency, 30 min 1; amplitude, 25V. Flow rate; 
20 ml.min °. Temp, 18-19°C.
Action potential
0
-30mv
50 mv
200 msec
b
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11 preparations.
_3Effect of ATP (10 "M) on electrical properties of the
ventricle, .receded. . during.the.thj.rd .c,o,mp°n.e.n.t. . .of..the.
response: Data presented in Table 5.1 summarises the
results of these experiments. Eleven preparations were
used. The principal finding was an increase in the over­
shoot and duration of the action potential].. ATP had no
effect on the membrane potential between contractions.
The overshoot increased by around llmV, from 26.4 to 37.6 
and the duration of the action potential, measured at
-30mV level, which corresponds with the potential at which 
the calcium current becomes activated (Reuter & Beeler, 
1969; Beeler & Reuter, 1970; Noble, 1975) increased 
from 520 I 12.9 msec to 705 I 19.0 msec.
These changes in the shape of the action potential were
accompanied by an increase in contractile force. Fig.5.6
shows oscilloscope recordings of action potentials and
twitch tension before (b) and after (a) treatment with
-310 M ATP. The action potential overshoot is increased
from 27.5 mV to 38.0 mV and its duration at -30 mV level
increased from 520 msec to 688 msec. Peak tension
generated increase by 3.25 X control value but the time 
to peak tension remained unchanged. Thus the rate, of rise
in tension was increased by 3.57 times in the presence of ATP
Figure 5.7.
(A) Time course tension response of hypo­
- 3 .dynamic ventricular strips to 10 M ATP.
Membrane potentials were measured simultaneously
at (i) control (c) (ii) peak of 1st phase (b)
(iii) fully developed 2nd phase (d) and (iv) 
immediately after the peak of the 3rd phase (a) 
(see B, below). Abscissa; Time (min).
Ordinate; Tension ratio (ATP/control).
_3(B) Effect of ATP (10 M) on action potential
(above a, b, & d) and contraction (below a, b & 
d) for the 1st (3rd twitch), 2nd (18th twitch) 
and 3rd (50th twitch) components. The control 
action potential (above c) and twitch amplitude 
(below c) are shown for comparison). Note that
during the 1st and 3rd phases ATP increases the 
overshoot and duration of the action potential, 
and enhances the twitch contraction as compared 
to the control, whereas during the 2nd phase the 
amplitude is reduced and action potential 
duration markedly abbreviated.
Stimulation parameters; Pulse width, 5 msec;
-1frequency, 30 min ; amplitude, 25V.
Flow rate: 20 ml.min \ Temp, 18-19°C.
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A comparison of the form of the action potential recorded
during the 1st, 2nd and 3rd phases of the response and
the shape of the corresponding twitches; A series of 
superimposed oscilloscope recordings of action potentials 
and twitches are shown in Fig.5.7B taken at the times in­
dicated in Fig.5.7A viz: prior to the addition of ATP (c) 
at the peak of the first phase (b), during the fully- 
developed second phase (d), and immediately after the peak 
of the 3rd phase (a). Changes in both amplitude and 
duration of the action potential correlate with the ob­
served change in contractile force. During the 1st and 
3rd phases the overshoot and duration were increased as 
compared to the controls, whereas during the 2nd component 
the action potential is reduced in amplitude and substan­
tially abbreviatecl. It is notable that membrane re­
polarization commences just prior to or at the peak of the 
contraction during the 1st and 3rd phases of the ATP 
response, but that repolarization is almost complete before 
relaxation commences for both the control responses and 
during the second component of the ATP response.
Effects of verapamil on the contractile response and on the
shape of the action potential: The marked effects of ATP 
on the form of the action potential, particularly on its 
duration, suggests that it acts by altering the magnitude
Figure 5.8.
Effect of 10 ATP alone on the action potential
(a, above) and contraction (a, below) during the 
3rd component (50th twitch) of the response, and 
in the continuing presence of 10 5M verapamil 
(recordings above and below labelled b). The 
control responses for action potential (c, above) 
and twitch (c, below?) are shown for comparison. 
The main point to note here, is that verapamil 
reduces both the overshoot and duration of the 
action potential, and the twitch tension 
normally elicited by ATP.
Stimulation parameters: Pulse width, 5 msec.
• -1frequency, 30 min , amplitude, 25V.
Flow rate: 20 ml.min 1. Temp, 18-19°C.
ATP I0-3m 
c. Control
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of the show inward calcium current, increasing it during 
. the 1st and 3o^<d phases but reducing it during the 2nd.
The effects of the calcium blocking agent verapamil on
the response to ATP are illustrated in Fig.5.8. The
control responses are shown in the two recordings labelled 
-3’c’ and the effects of ATP above (10 M) by records 
labelled 'a*. Verapamil (10 ^M) almost entirely abolished 
these effects of ATP (records b). ATP alone increases the 
duration of the action potential by around 29%, but in the 
presence of verapamil an increase of only 7% is seen. 
Verapamil also reduces the size of the overshoot.
Relation between action potential duration and contractile
force: Fig.5.9 shows the relationship between the action
potential duration and contractile force for ATP ranging
— 8 “3from 10 to 10 M. All values are expressed as multiples
of the control values. The two curves show the relation
for the 1st (open circles) and 3rd (solid circles) com­
ponents of the ATP response.
These data reveal a clear correlation between the change 
in the contractile force and the action potential duration. 
Even more significant, however, is the fact that the slopes 
of the two curves are strikingly different. This implies 
that the relationship is a complex one. If it is assumed
Figure 5.9.
The relationship between action potential
duration (measured at -30 mV level) and twitch
potentiation for the first (open circles) and
third (solid circles) components for ATP of 
—3 * 8 '10 to 10 M. Both parameters are expressed 
as multiples of the control values. The values 
were obtained for the 3rd twitch and 50th twitch, 
respectively. Each point represents mean 
values S.E*s during impalement of 10 cells 
taken from 6 preparations. The number beside 
each point denotes M o The correlation is 
highly significant for the first (correlation 
coefficient - S.E. of estimate; 0.99 - 0.03, 
n = 10, P <C 0.001) and third (correlation co­
efficient - S.E. of estimate: 0.99 — 0.05, 
n = 10, P <C0.001) components. Note that the 
two slopes are statistically different (P <^0.001), 
the first component being steeper than the third. 
Abscissa; Duration of action potential (ATP/ 
control). Ordinate; Twitch tension (ATP/ 
control).
Stimulation parameters: Pulse width, 5 msec;
-1frequency, 30 min ; amplitude, 25V.
Flow rate: 20 ml.min 1; Temp, 18-19oC.
Duration of action potential 
[ATP/controll
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that the duration of the plateau phase of the action 
potential by and large reflects the magnitude of the 
inwardly directed calcium current, then this result means 
that calcium entry must be having an indirect effect on
the contractile mechanism. This point will be considered
in more detail later.
Changes in the shape of the action potential and twitch
-3amplitude during the course of a single ATP (10 M) -
induced response: It proved impossible to maintain a
successful microelectrode impalement for the entire duration 
of the ATP response. However, the data in Fig.6.10 show 
results obtained from experiments lasting approximately 
20 minutes in which the microelectrodes remained securely 
inside a single fibre. The data were collected during the 
entire rising phase of the 3rd component of the ATP res­
ponse, up to and then beyond the peak:. Both parameters
increased in a parallel fashion during the rising phase, 
but thereafter, contractile force fell more rapidly than 
the decrease in the action potential duration.
This result again suggests that the relationship between 
the duration of the action potential and its effect on con­
tractile force is not a straightforward one.
Figure 5.10,
Time course of the changes in action potential
duration (solid circles) measured at -30 mV
level and contractile force (solid triangles,
-3broken line) during exposure to 10 M ATP
for the slowly-developing and long-lasting 
third component of the response. Both para­
meters are expressed as multiples of the control 
values. Each point represents the mean - S.E. 
taken from 7 preparations. Note . that both
action potential duration and tension increase 
in a parallel fashion during the rising phase, 
but thereafter isometric force declines more 
rapidly than action potential duration.
Abscissa; Time (min); Ordinate; Duration of 
action potential andrtwitch tension (ATP/control) .
Stimulation parameters: Pulse width, 5 msec; 
frequency, 30 min 1; amplitude, 25V.
Flow rate: 20 ml.min 1. Temp, 18-19oC.
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DISCUSSION AND WORKING HYPOTHESIS
The characteristic triphasic form of the ATP - induced response
is well documented - in the literature, for both mammalian 
(Green & Stoner, 1950) and amphibian preparations (Parnas &
Ostern, 1932; Lindner & Rigler, 1931; Lichtneckert & Straub,
1949; Marshall & Andrus, 1953; Szent - Gyorgyi, 1953; Kanda et al, 
1953; Versprille, 1963), but relatively little is known of 
the underlying mechanism. In this context, the manner in which - 
the ventricle responds to differing EAAii)0 has proved to be 
particularly informative. It is clear, for example, that the 
so-called second component of the response is not merely due 
to a temporary cessation of the positive inotropic effect of 
ATP, since during this phase contractile force was often
observed to fall well below the initial control level, and
in some instances contractility was temporarily abolished.
For this reason, it is concluded that ATP exerts a delayed 
inhibitory effect on the ventricle.
4
At this point in the discussion we may reasonably exclude the 
possibility that the effects of ATP are mediated through the 
release of endogenous cholinergic or adrenergic neurotransmitters, 
since neither atropine nor propranolol has any significant 
effect on the responses. This is consistent with conclusions
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arrived at by previous authors (Bielschowsky et al, 1944; Kanda 
et al, 1954; Schenberg, 1956; James, 1965; Versprille, 1966; 
Versprille & Duyn, 1966; Yatani et al, 1978). These same 
experiments also imply that ATP does not exert its effect by 
combining directly with either cholinergic or y-adrenergic 
receptors on the outer cell surface. Nevertheless, ATP arguably 
exerts effects on the ventricle which clearly resemble those 
that one might anticipate if it did interact with both kinds 
of receptors, and this raises the interesting possibility 
that the intracellular changes involved may have certain features 
which are also common to the mechanism of action of cholinergic 
and adrenergic transmitters.
This conclusion actually formed the basis of a hypothesis, 
summarised below, on which the remainder of the work described
in this thesis is based.'
WORKING HYPOTHESIS.
It is postulated that ATP exerts a dual effect on the ventricle, 
comprising a rapidly - developing, long-lasting positive 
inotropic effect, and superimposed upon it, a somewhat delayed 
and transient negative inotropic effect. It was pointed out 
earlier (Fig.5.3) that these assumptions could account for the 
overall shape of the response; in particular it provides an 
explanation for the downward trend of the log-dose response
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curve for the first phase of the response, the argument
being that the onset of a larger inhibitory component, 
induced at higher EATilo would tend' to ’clip’ the first 
phase earlier.
Since the involvement of endogenous neurotransmitters is 
excluded the question to be answered is; what is the 
nature of the positive and negative inotropic ' effects of 
ATP? It seemed possible that these two components of 
the ATP-induced response are mediated through changes in 
intracellular cyclic AMP and cyclic GMP, respectively. 
Evidence that the positive, inotropic effects of p 
- agonists are accompanied by elevated level of intracellu­
lar cyclic AMP, and conversely, that the negative inotropic 
effects of acetylcholine are associated with elevated levels 
of cyclic GMP, was reviewed earlier (see main Introduction, 
pages 21-24,and 38). Thus, as a basis for further work, 
the component of the response labelled ’P’ in Fig.5.3A was 
tentatively identified as representing the time course of 
the change in cyclic AMP level, and that labelled ’I’ was 
taken to represent the accompanying changes in cyclic GMP
levels.
It will be seen (Chapter VIl)that these conclusions are 
broadly correct, although the precise time courses of the’ 
changes in cyclic AMP and cyclic GMP are not exactly as
predicted by Fig.5.3A. Indirect evidence pointing to 
the involvement of cyclic 3,,5'-nucleotides in the ATP 
response is presented in Chapter VI, and the results of 
experiments involving direct measurements of intra­
cellular cyclic AMP and cyclic GMP in Chapter VII.
Further discussions on the mechanism of action of ATP,
in particular, its marked effect on the action potential,
is deferred until later.
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C H A P T E R . VI
INDIRECT EVIDENCE FOR THE INVOLVEMENT
OF CYCLIC 3, 5-NUCLEOTIDES IN MEDIATING
THE ATP-INDUCED RESPONSE
119
I N T R O D U C T I 0 N
This series of experiments was designed to establish
whether or not it was worth pursuing the idea that 
intracellular cyclic 3*, 5* - nucleotide matabolism is 
influenced by ATP. They were actually made before those 
described in Chapter IV, concerned with the changes in 
intracellular cyclic 3*, 5* - nucleotide levels during 
the development of the hypodynamie condition.
The experiments fall into two broad groups.
Type, 1 experiments: These experiments are concerned with
the effects of ATP administered at various times during 
the development of the hypodynamie condition.
Type 2 experiments: These are concerned with the effects
of ATP on preparations in which the levels of cyclic 3’,5* 
nucleotides were artificially elevated by;
(i) Pretreatment with either DB cyclic aMP 
or 8-Br cyclic GMP alone.
(ii) Pretreated with a combination of 
theophylline (to inhibit cyclic 3*, 5’ - 
nucleotide breakdown by phosphodiesterases) 
and either DB cyclic AMP or 8-Br cyclic GMP.
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(iii) Pretreatment with adrenaline
to boost intracellular cyclic AMP levels.
These experiments will be considered in turn.
Type 1 experiments; effect of
administering ATP at various times .
during the development of the
hypodynamie state.
The gradual decline in contractility seen during the 
development of the hypodynamie condition was shown 
previously to be accompanied by a gradual reduction in 
intracellular cyclic AMP and an elevation of intracellular 
cyclic GMP levels. The relevant experiments, described 
earlier (Chapter IV), were in fact made prior to those
described in this section. It was reasoned that if the
hypodynamie depression is associated with, and the ATP- 
induced response mediated by, changes in intracellular 
cyclic 3*, 5* - nucleotides, then the precise form of the 
response to ATP should vary throughout the early stages 
of perfusion, while the preparation is settling down to 
its final steady-state level.
The results of an experiment in which the ventricle was
Figure 6.1.
Original chart recordings (A-J) of isometric 
twitch tension following administration of
10 5M ATP at various times during the develop­
ment of the hypodynamie state. The arrows 
indicate the different times of application of 
ATP. Note that the character (size and form) 
of the response is altered as the hypodynamie 
depression is developed. The size of the 
2nd phase increases as compared to the third 
component which decreases with increasing 
perfusion time. There is relatively little 
change in the response of the first component.
Stimulation parameters: Pulse width, 5 msec;
-1frequency, 30 min , amplitude, lOV.
Flow rate; 100 ml.min 1. Temp,19oG.
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_5subjected to a standard dose of ATP (10 M) during the 
decline in contractility is shown in Fig.6.1. It can 
be seen that the character of the response is indeed 
affected by the extent to which the hypodynamie de­
pression has developed. The most striking changes 
observed concern the size of the inhibitory (second com­
ponent) and the size and form of the long-lasting third 
phase. The size of the inhibitory component clearly 
increases with tacreasiiag perfusi°n times; ini-tially, up 
to 40 minutes of perfusion, the twitch tension remains 
above the control level during this phase, and only falls 
below it for periods in excess of around 50 minutes.
The potentiation seen during the third phase decays more 
slowly in ventricles perfused for short periods as com­
pared to those which have been superfused 'for a longer 
time. In contrast;, the absolute size of the potentiation 
seen during the first component of the response is relative­
ly constant.
It is not considered worthwhile attempting to explain the
precise form of each response at this time. It is
sufficient to note that the form of the ATP-induced response 
is affected by the degree to which the hypodynamie depression 
has been allowed to develop).
122
Type 2 experiment; effects of agents
which are known- to influence . cyclic
3', 5' - nucleotide metabolism on the
form of the ATP - induced response.
The three kinds of experiments described in this section 
were designed to artificially elevate the intracellular 
level of either cyclic AMP or cyclic GMP, by using their 
lipid soluble derivatives, or alternatively, by applica­
tion of agents known to alter_cyclic 3*, 5' - nucleotide 
levels indirectly by a pharmacological action on the cells.
The rationale is as follows; consider first the effect
on the ATP response of artificially elevating intracellular 
cyclic AMP levels. If these can be raised sufficiently 
so that the capacity of the fibres to produce still more 
cyclic AMP is severely limited, then the result of sub­
sequent treatment with ATP might be ' to elicit a negative 
inotropic response only, since presumably their capacity 
to produce additional cyclic GMP is unaffected by this 
procedure. The converse argument is applied in the case 
of artificially elevated cyclic GMP levels, where one 
might expect to obtain a monotonie, positive inotropic 
response only.
Effects of exogenous DB cyclic AMP and 8-Br cyclic GMP
Figure 6.2.
(a) Time course of the positive inotropic
-3effect to 10 M dibutyryl cyclic AMP on the
hypodynamie ventricle and the influence of
— 310 M ATP in the continuing presence of
dibutyryl cyclic AMP. The point to note is 
that ATP exerts a marked inhibitory effect only. 
Abscissa; Time (min). Ordinate; Relative 
tension (fraction of initial (control) level.
(B) Time course of the inotropic response to
—410 M 8-Bromo cyclic GMP on the partially
hypodynamie ventricle and the effect of sub­
-3sequently administering 10 M ATP in its 
presence produces a monotonic positive inotropic 
effect. Abscissa; Time (min). Ordinate; 
Relative tension (fraction of initial control 
level).
(C) Influence of 10 ^M ATP (alone) on the 
hypodynamie ventricle. Note the normal tri­
phasic nature of the inotropic response. 
Abscissa; Time (min). Ordinate; Relative tension 
(fraction of initial (control) value. The solid 
horizontal lines (in A & B) illustrate the 
duration of exposing the preparations to 
dibutyryl cyclic AMP and ATP.
Stimulation parameters: Pulse width, 5 msec;
-1frequency, 30 min ; amplitude, lOV. Flow rate: 
100 ml.min \ Temp, 19 °C.
Time-min
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on the ATP response: Fig.6.2 summarises the results
of two experiments, one concerned with the effect of 
pretreatment with DB cyclic AMP (Fig.6.2A) and the other 
with the effects of pretreatment with 8-Br cyclic GMP 
(Fig.6.2B). Consider first the effect of pretreatment
with DB cyclic AMP. The ventricle was superfused until 
it had become fully hypodynamie and DB cyclic AMP (10 M) 
was then administered for a period of 40 minutes. This 
produces a substantial positive inotropic effect, reach­
ing a maximum after approximately 30 - 35 minutes. The
-3effect of subsequently administering ATP (10 M) is to 
produce a large negative inotropic response. This is in 
fact followed by a return to the pre-ATP level and then 
a gradual deterioration approaching the original control 
twitch amplitude after approximately 10 minutes. Thus, 
the predominant effect of ATP under these conditions is
to produce a lowering of isometric twitch tension.
In contrast to this, Fig.6.2B shows the effect of pre­
treating the preparation with 8-Br cyclic GMP (10 Sm).
The heart was allowed to become partially hypodynamie and 
then 8-Br cyclic GMP was administered for a period of about 
20 minutes. This procedure depressed the contractile
response down to about 10% of its initial value. ATP
_3(10 M) was then administered. The resulting positive
Figure 6.3.
(A) Dose-response curve for the positive
inotropic effect of theophylline ranging from
“6 -210 to 10 M on the hypodynamie ventricle.
Each point represents the mean - S.E. for 10 
“ Apreparations. Note that 10 M theophylline 
exerts only minimal direct effect on isometric 
force. Abscissa; Concentration (M) of 
theophylline. Ordinate; Tension response 
(theop./contro1).
(B) Time course of change in contractile
force during exposure of 10 ventricles to 10 5M
ATP (solid circles) alone, and to the same con­
— Acentration of ATP but in the presence of 10 M 
theophylline (solid triangles). Each point 
represents the mean - S.E. Tension is expressed 
as a multiple of the control value prior to ATP 
stimulation. The control level is indicated
by the horizontal broken line. Note that 
theophylline reduces the first phase but 
potentiates enormously the third component of 
the ATP-induced response.
Stimulation parameters: Pulse width,, 5 msec ; 
frequency, 30 min ; amplitude, lOV.
Flow rate: 100 ml.min . Temp, 19°C.
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inotropic response shows only a small indication of a
negative inotropic action of ATP; the large negative
inotropic component seen on exposure of untreated
-3hypodynamie ventricles to 10 M (Fig.6.2C) is almost
absent.
Effect of pretreatment with theophylline alone or with
the theophylline and either DB cyclic AMP or 8-Br cyclic
GMP on the ATP-induced response; Consider first the
experiments concerned with the effects of pretreating the
ventricle with theophylline on the form of the ATP response
Fig.6.3A shows a log-dose response curve for the effect of
pretreating the hypodynamie ventricle with theophylline 
6 2(10 - 10 M) alone. In the subsequent experiments con­
cerned with the effect of theophylline on the ATP response,
-4a concentration of 10 M was selected!. It can be seen
from Fig.6.3A that this concentration produces a relative­
ly small potentiation of the hypodynamie twitch and would 
not therefore be expected to obscure to any great extent
the effect of subsequent administration of ATP. Fig.6.3B
-5shows the form of the response to ATP (10 M) alone -and
the response obtained after pretreating 10 ventricles with
-410 M theophylline for a period of 10 minutes. There are 
two features of interest. First, the initial first com­
ponent of the ATP response is reduced (from 2.90 to 2.20 
x the control level), whereas the third phase of the
Figure 6.4.
Log-dose response curves to varying concentra­
tions (10 - 10 ^m) ATP for the 1st (A),
2nd (B) and 3rd components of the inotropic
response in the absence (solid circles) and 
-4 /in the presence of 10 M theophylline (solid
triangles). Each point represents the mean 
+- S.E. from 10 preparations. Tension
response is expressed as a multiple of the 
control value prior to ATP stimulation.
The important point to note is that theophylline 
potentiates the second (B) and third (C) phases 
but depresses the first (A) (as shown by arrows); 
The results suggest that under normal condition 
the 1st response is in reality clipped by the 
onset of the inhibitory effect.
Stimulation parameters: Pulse width, 5 msec; 
frequency, 30 min 1; amplitude, lOV.
Flow rate: 100 ml.min 1„ Temp, 19oC.
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response is substantially increased, from around 2.70 x
the control value to 3.70 x this level. This is con­
sidered to be a significant result within the context of 
the hypothesis outlined in the preceding chapter, where 
it was argued that the full size of the first response 
is prevented from appearing because it is distorted by the 
rapid onset of the second (inhibitory) component. Thus, 
theophylline appears to be increasing the magnitude of the 
negative inotropic component:, and since the third phase is 
substantially increased, that of the secondary positive 
inotropic component is too. This is consistent with the 
non-specific nature of the inhibitory effect of theophylline 
on phosphodiesterase activity; it is known to inhibit both 
cyclic AMP and cyclic GMP phosphodiesterase activities.
This result is emphasised by the data in Fig.6.4, which 
shows log-dose response curves for the first (A), second 
(B) and third (C) components obtained with and without pre­
treatment with theophylline. The curves for the second 
component were obtained using the method of analysis out­
lined earlier (page 106) . It can be seen from these data 
that the second and third components are increased by 
theophylline pretreatment at all ATP concentrations, whereas
the first component is depressed.
Figure 6.5.
(A) Time course of the inotropic response
-3to 10 M dibutyryl cyclic AMP and theophylline
(10 Si) on hypodynamie ventricle and the effect
-3of 10 M ATP in the continuing presence of
dibutyryl cyclic AMP and theophylline. It can 
be seen that ATP exerts only a large negative 
inotropic response. Abscissa; Time (min).
Ordinate; Relative tension (fraction of 
initial (control) level).
(B) Inotropic influence of 8-Bromo cyclic GMP
on the partially hypodynamie ventricle and the
effects of subsequently administering theophylline / o(10 M) and ATP (10 M) in the presence of
8-Bromo cyclic GMP, It should be noted that ATP 
elicits a large mohophasic positive inotropic 
effect; the negative inotropic component usually 
seen is almost completely suppressed. Abscissa;
Time (min). Ordinate; Relative tension (fraction 
of initial (control) value.
_ o(C) Effect of 10 M ATP alone on the hypo- 
dynamic ventricle. Note the presence of the
three characteristic components of triphasic response
The solid horizontal lines (in A & B) depict the 
times of exposing the preparation to the inotropic
agents.
Stimulation parameters: Pulse width, 5 msec - 
frequency, 30 min ; amplitude, lOV. Flow rate:
100 ml.min S Temp, 19°C.
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Fig.6.5A & B depict the results obtained in two experiments
in which ventricles were pretreated with a combination of 
DB cyclic AMP'(A) or 8-Br cyclic GMP (B) and theophylline. 
Qualitatively, these data give essentially the same results 
as were obtained with either DB cyclic AMP or 8-Br Cyclic 
GMP alone (Fig.6,2). The effect of ATP (10 ^M) alone is 
shown in Fig.6.5C for comparison.
Effects of pretreatment with adrenaline.on the ATP response;
The action of ATP following pretreatment with adrenaline is 
shown in Fig.6.6. The hypodynamie ventricle was stimulated
with 10 6M adrenaline and 3 minutes from the onset of the
_3response it was treated with ATP (10 " M). This produced a
powerful inhibitory response which persisted in the con­
tinuing presence of adrenaline. The inhibitory effect was
abolished by removing ATP from the superfusate.
Figure 6,6,
Positive inotropic influence of adrenaline
—6(10 M) on the hypodynamie ventricle and the
-3effect of subsequently administering l0 M 
ATP in the continuing presence of adrenaline 
The solid horizontal lines indicate the 
duration of exposing the preparation to 
adrenaline and ATP. Note the powerful 
inhibitory effect only elicited by ATP and 
the augmentation of twitch tension following 
its removal from the circulating perfusate. 
Abscissa; Time (min). Ordinate; Relative 
tension (fraction of initial (control) 
value).
Stimulation parameters; Pulse width, 5 msec
-1frequency, 30 min ; amplitude, lOV.-JFlow rate: 100 ml.min . Temp, 19°C.
______________ATP I0"3M
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At the time, the results of these experiments provided
sufficient encouragement to warrant embarking on a more
detailed investigation of the possible effects of exogenous 
ATP on cyclic AMP and cyclic GMP levels within the ventricle 
These experiments are presented in the next chapter. It
will be seen that the results obtained are consistent with
the working hypothesis, and for this reason, it is felt that 
a more detailed discussion of the present experiments would 
be superfluous. It is sufficient to note here that the
hypothesis was able to predict:, with some accuracy, the 
qualitative nature of the responses obtained as a result of 
manipulating the intracellular levels of each cyclic 3’,5’- 
nucleotide separately, either directly, with suitable 
exogenous derivatives, or indirectly by using the appro­
priate pharmacological agents.
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CHAPTER VII
DIRECT EVIDENCE FOR AN . EFFECT OF
EXOGENOUS ATP ON INTRACELLULAR
CYCLIC 3 *, 51 - NUCLEOTIDE LEVEL
AND ITS RELATION TO THE CONTRACTILE
RESPONSE.
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INTRODUCTION
In these series of experiments ventricles were first
rendered hypodynamie (using ’standard* conditions) and
-3then subjected to treatment with 10 M ATP. At a pre­
determined time during the response the ventricle was 
* crush-frozen*, extracted and then assayed for cyclic AMP, 
cyclic GMP and total protein using methods outlined in 
appendix II A-C. Untreated, hypodynamie half ventricles 
served as controls, and care was taken to ensure that the 
*test* preparations were permitted to become hypodynamie 
to exactly the same degree as the control ones prior to
the addition of ATP.
Time course of changes in cyclic AMP and cyclic GMP
levels during the ATp-induced resp°nse: Fig.7-1A shows
a representative sample of original chart recordings for
an experiment of this type. The times at which different
preparations were frozen and assayed are indicated in
Fig.7.IB. Cyclic nucleotide levels in test and control 
-1ventricles were expressed originally in pmoles mg of 
ventricle protein (see Table 7.1, appendix VII) and the 
ATP-induced levels expressed graphically as multiples of 
the control levels. (This was necessary because each data
Figure 7.1.
(A) A representative sample of original
chart recordings (A - L) showing inotropic
-3responses during exposure to 10 M ATP 
and the times of ’crush freezing*. The 
arrows indicate the times of application 
of ATP.
(B) A typical response to 10 M ATP.
The letters A - L indicate the times at 
which the different preparations were frozen 
and assayed for cyclic AMP, cyclic GMP and
total proteins.
Mean values (- S.E’s) for levels of cyclic 
AMP and cyclic GMP on the control (hypo-
dynamic) ventricles (12 preparations) were 
8.05 - 0.43 pmol mg protein and 0.91
+ 0.13 pmol mg 1 protein.
Stimulation parameters: Pulse width; 5 msec 
frequency, 30 min 1; amplitude, lOV.
Flow rate; 100 ml.min 1 . Temp, 18.5°C.
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point came from a. different heart; the quantity of
tissue available was too small to enable time course
experiments to be made on a single heart).
Fig.7.2 shows the time course of the changes in cyclic
AMP (solid circles) and cyclic GMP (open circles) during
-3the response to 10 M ATP. ATP induces a large and rapid 
increase in cyclic AMP, up to 4.5 x control level attained 
within approximately 5-8 seconds, followed by an equally 
abrupt fall, to around 0.6 x control level, reached some 
30 - 40 seconds after the application of ATP. Cyclic AMP 
levels then rise again, more slowly, reaching a secondary 
peak of around 3.4 x the control value after 140 - 160 
seconds. Thereafter, the level declines slowly.
The initial rapid rise and fall of cyclic AMP is accompanied 
by a slower rise and fall in cyclic GMP levels. Cyclic 
GMP reaches a peak of 2.8 x the control level within 20 - 
25 seconds. It then returns slowly towards the control 
level, reaching it at around 80-100 seconds and remaining 
there throughout the rest of the response.
There are two important points to notice about these results
First, it is clear that ATP alters the levels of both cyclic 
AMP and cyclic GMP, and the relationship between their
altered levels and isometric force is considered in the
Figure 7.2.
Time course of changes in levels of cyclic AMP
(solid circles) and cyclic GMP (open circles),
expressed as multiples of control hypodynamie
values, measured at different times during the _3ATP (10 M) - induced inotropic responses 
(see Fig.7.1). The control level is indicated 
by the horizontal broken line. Note (a) the 
initial rapid rise and fall in cyclic AMP levels 
followed by a slow secondary rise, (b) t elevated 
levels of cyclic GMP correspond closely with the 
maximum inhibitory response and (c) cyclic GMP 
levels peak when cyclic AMP levels fall. 
Abscissa; Time (min). Ordinate; cyclic AMP 
and cyclic GMP levels (fraction of the control 
value).
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next section. Secondly, it is worth drawing attention
to the fact that cyclic GMP levels peak at a time which 
coincides with the maximum rate, of fall in cyclic AMP 
levels, and that cyclic AMP levels begin to rise again 
when cyclic GMP starts to fall. Taken at face value, 
this observation would suggest that cyclic GMP inhibits 
the formation of cyclic AMP and/or stimulates its conversion 
to 51 - AMP by phosphodiesterase activity.
Relationship between cyclic 3*, 5* - nucleotide levels
and contractile force; The interesting relationship found 
earlier between contractility and cyclic 3*, 5* - nucleotide 
levels (specifically the ratio cyclic AMP/cyclic GMP) 
during the development of the hypodynamie condition is also 
seen to hold in the case of the ATP - induced response.
Fig.7.3A shows (A) the time course of the change in con­
tractile force, indicated by the closed circles and by the 
solid line drawn in by eye to show the general shape of 
the responses; and (B) the corresponding changes in the 
ratio of cyclic AMP/cyclic GMP (open circles) in the presence 
of ATP, expressed as a multiple of the corresponding ratio 
for the control (hypodynamie) ventricle; viz;
Figure 7.3.
Data taken from Fig.7 1. and 7.2.
(A) Time course of changes in ratio of
cyclic AMP/cyclic GMP (open circles) together 
with the accompanying contractile response 
(solid circles). Cyclic nucleotide ratio and 
isometric force are expressed as multiples of 
the control (hypodynamie) values. The solid 
line is drawn by eye to indicate the general 
shape of the response. The control level is 
indicated by the horizontal broken line. 
Abscissa; Time (min). Ordinate, Tension 
ratio jp(ATP)/P(hypo))J and. cyclic nucleotide 
ratio
cyclic AMP/cyclic GMP (ATP)
cyclic AMP/cyclic GMP (hypo)
(B) A graphical illustration of the relation 
between twitch tension and cyclic nucleotide 
ratio. The solid line is drawn with a slope
of 1 to emphasise the fact that there is a 
direct 1:1 proportionality between these two 
parameters. Correlation"cof'ff icient + S.E.
of estimate: 0.98 t 0.35, n = 12, P <^0.001.
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cyclic AMP/cyclic GMP (ATP)
cyclic AMP/cyclic GMP (Control)
Once again, there is a striking correlation; the change 
in cyclic nucleotide ratio almost exactly parallels the
change in contractile force. This relationship is em­
phasised further by plotting the cyclic nucleotide ratio 
against contractile force, as in Fig.7.3B. The data 
fall almost exactly on the solid straight line which was 
drawn in by eye to indicate the results to be expected on 
the basis of a linear 1:1 correlation. Statistically, 
the correlation is highly significant: correlation co­
efficient + S.E. of estimate; 0.98 - 0.35, n = 12, 
p a 0.001).
Compared to this, the correlation between the change in 
contractility and the change in either cyclic AMP or 
cyclic GMP levels is less convincing, although significant. 
These data are plotted separately in Fig.7.4A & B. The 
data for cyclic AMP yield correlation coefficient (- S.E.) 
of 0.73 — 0.46 (n = 12; P<^0.01) and those for cyclic
GMP, -0.69 i 0.36 (n = 12; P <2 0.01). The raw data for
Figure 7.4.
Data taken from Fig.7,1 and 7.2.
(A) Relationship between changes in con­
tractile force and cyclic AMP levels (multiples
of control (hypodynamic) values) during
-3exposure to 10 M ATP. Correlation coefficient 
P S.E. of estimate: 0.73 P 0.46, n = 12,
P 0.001. Abscissa; Tension (ATP/control) 
Ordinate; cyclic AMP levels (ATP/control).
(B) Relation between changes in cyclic GMP 
levels and isometric force (multiples of control
(hypodynamie) values) following stimulation with
-3 + '10 M ATP. Correlation coefficient - S.E, of 
estimate: -0.69 - 0.36, n = 12, P <p0.001.
Note that the correlation between contractility 
and cyclic 3*, 5*- nucleotide levels is positive 
in the case of cyclic AMP and negative in the 
case of cyclic GMP.
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this experiment are collected in table 7.1,
appendix VII.
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The experiments described in this chapter support the
view that the triphasic response is in reality a mani­
festation of two opposing influences of ATP. They
clearly indicate that ATP has a marked effect on intra­
cellular levels of both cyclic AMP and cyclic GMP, in
addition to its effect on ionic conductance at the surface
membrane.
The close correlation between contractile force and cyclic 
nucleotide ratio? similar to that seen during the develop
ment of hypodynamic depression, is especially significant:. 
The form of the ATP - induced response is unquestionably 
bizarre, yet the results yield a correlation between con­
tractile force and cyclic nucleotide ratio which is just 
as convincing as that found during the development of the 
hypodynamie condition. Accordingly, it is felt that this
result substantially reinforces the suggestion that both 
cyclic 3*, 5* - nucleotides play an important role ■ in 
regulating the contractile capacity of the ventricle, and 
that this is not exclusively a property of cyclic AMP
alone.
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CHAPTER VIII
AN INVESTIGATION INTO . THE MECHANISM
OF ACTION OF ATP AND SOME RELATED
PURINE AND PYRIMIDINE NUCLEOTIDES
ON VENTRICULAR CONTRACTILITY.
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INTRODUC T 1 o 0 N
It is known from previous work that other nucleosides and 
their nucleotide derivatives have inotropic effects on 
the frog ventricle (see main Introduction, Part II) 
although the form of the response may differ from that 
seen with ATP. The experiments described in this Chapter 
are concerned with the effects of several ATP analogues on 
the form and size of the contractile,response. This com­
parative approach is used in an attempt to relate molecular 
structure to differing pharmacological effects of the various 
agents used on the ventricle. The real point of issue is: 
what is the nature of the receptors (Burnstock, 1972)?
It was concluded from experiments presented earlier, con­
cerning the classical receptor blocking agents atropine and 
propranolol, that ATP at least appears not to exert its 
actions either by releasing endogenous neurotransmitters, 
on the one hand, or by combining directly with cholinergic 
or p-adrenergic receptors on the other; neither atropine 
nor propranolol had any marked effects on the ATP-induced 
response. This result holds too for the other agents
tested.
The various analogues of ATP which have been studied
137
produce differing responses. They can be broadly clas­
sified, into groups on the basis of either (i) the
form of the inotropic response; or (ii) whether they 
produce predominantly positive or predominantly negative 
inotropic effects; or (iii) on the basis of their re­
lative potencies. For ease of description the various 
agents are here classified according to the form of the 
inotropic response, although emphasis is given, where 
appropriate, to their relative potencies.
Broadly speaking, the responses can be classified into 
one of three groups:
Type A response; This is the typical ATP-induced response,
comprising three more or less distinct phases, already
described in some detail and depicted diagrammatical^ in
Fig.8.lA. This class includes ADP, AMP and CTP (concen- 
-7 -3tration range from 10 to 10 Ml a: well a: ATP.
Type B response: This is a relatively-slowly developing
positive inotropic response (Fig.8.lB). It reaches its
maximum at c time corresponding to the peak of the third
component of the type A response (approximately twitch
No.50). 1TP, GTP and UTP in concentrations ranging from
“9 -410 to 10 M produce type B responses. The inotropic
effects of these agents develop more slowly than the
Figure 8,1.
(A) A graphical illustration of the
characteristic triphasic inotropic response
(Type A) induced by compounds such as ATP, ADP,
-7 -3AMP and GTP (range from 10 to 10 M). For 
analysing the magnitude of the 1st, 2nd and 
3rd phases, the 3rd, 18th and 50th twitches 
were used respectively.
(B) The form of type B response (slowly- 
developing with peak tension (approximately 
50th twitch) coinciding approximately with that 
for 3rd component of type A response induced by 
UTP, ITP and GTP (range from 10~9 to 10”3M) .
The dashed curve illustrates the nature of the 
response elicited by adrenaline.
(C) A diagrammatic representation of type G
(rapidly-developing, positive inotropic) response
induced by ATP, ADP, AMP and GTP (concentrations -710 M). Note that this is a variant of 
type A response.
(53 th twitch)
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response to adrenaline (dashed curve in Fig.8.IB). i
Type C response: This is characterised by a rapidly - 1
developing, positive inotropic response which reaches a 
maximum at a time coinciding with the first component of 
the type A response. Strictly speaking, it should perhaps
ibe considered as a variant of the type A response, since <
it is shown by type A agents when they are used in very |
low concentrations ( 10 ?M). It is illustrated dia­
grammatical ly in Fig. 8.1C. ??
Qualitative nature of type A
and B responses and molecular
structure.
Fig.8.2 and 8.3 show the characteristic forms of the type
A and type B responses respectively. Their molecular
structures are also shown. The data presented are from
10 experiments at a concentration of 10 and each point 
+represents the mean value - S.E.
The type A agents studied included ATP, ADP and AMP 
(purine based nucleotides) and CTP (a pyrimidine based 
nucleotide). The type B agents studied included UTP
(a pyrimidine based nucleotide) and ITP and GTP (both .1
Figure 8.2.
Time course of the changes in contractile 
force during exposure of the hypodynamie— (/j.ventricle to 10 M type A agents (ATP, ADP,
CTP and AMP). The molecular structure for
each compound is shown for comparison.
Tension is expressed as a multiple of the
control value. Each point represents the
+mean - S.E. taken from 10 preparations. 
Control tension level is indicated by the 
horizontal broken line. Note the triphasic 
form of the inotropic response induced by 
these compounds and their common structural 
features; namely, the presence of a phosphate 
group together with an -NH~ moeity which is 
located at 6C (purine ring) or 4C (pyrimidine 
ring) position. Abscissa; Number of beats; 
Time (sec). Ordinate; Tension ratio 
(test/control).
Stimulation parameters; Pulse width, 5 msec; 
amplitude, lOV; frequency, 30 min \ Flow 
rate: 100 ml.min 1: Temp, 19oC.
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purine based nucleotides).
The principal conclusions to be drawn are as follows:
(i) The classification into type A and type B responses 
does not correspond with the classification of the agents 
into either purine or pyrimidine based nucleotides.
(ii) There is a common structural feature to those agents 
which produce a triphasic (type A) response; namely, the 
presence of a phosphate group together with an “NH? group 
which is located on the 6C (purine ring) or on the 4C 
(pyrimidine ring) position.
(iii) It appears from the results obtained with the adenine
nucleotides that the amplitude of the third phase depends 
upon the number of terminal phosphate groups. Thus, the 
amplitude of the third phase is in the order: ATP ADP
> AMP. There is also an effect on the first phase,
but this is less pronounced.
(iv) The molecular feature common to type B agents is
the presence of a ketone group located at the same position 
as that occupied by the -NHg group in the case of the type 
A agents i.e. on the 6C (purine based nucleotides; ITP,
GTP) or on the 4C (UTP; a pyrimidine based nucleotide) 
position.
Thus, the presence of the initial rapidly-developing inotropic
Figure 8.3.
Effect of 10 4M type B agents (UTP, ITP and 
GTP) on the force of contraction of the 
hypodynamie ventricle. The molecular 
structure of each compound is shown for 
comparison. Tension is expressed as a
multiple of the control value. Each point 
is the mean — S.E. taken from 10 preparations 
Control level is depicted by the horizontal 
broken line. Note that these compounds 
produce a relatively slowly-developing 
positive inotropic response and structurally, 
each possesses a terminal phosphate together 
with a ketone group at 6C (purine ring) or 
40 (pyrimidine ring) position. It is 
interesting to note also that GTP has in 
addition, an -NHg group at 20 position of the 
purine ring and that the magnitude of the 
contractile response is far less than that 
observed with either UTP or ITP. Abscissa; 
Time (sec); Number of beats. Ordinate; 
Tension ratio (test/control).
Stimulation parameters: Pulse width, 5 msec;
frequency, 30 min ; amplitude, lOV.
Flow rate: 100 ml.min 1. Temp, 19o0.
TENSION RATIO [test/controi] RAT1Q [test/controj] TENSION RATIO [test/controi]
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response, seen in the case of type A agents, appears to
require an -NHo group on the nucleotide base and a ribose
phosphate.
(v) Of the type B agents studied, GTP gives a substan­
tially smaller response than either ITP or UTP. The 
principal structural difference between ITP and UTP on 
the one hand, and GTP on the other, is the presence of an 
-NHg group in 2G position in the purine ring. The signi­
ficance of this is emphasised by comparing GTP with ITP, 
both of which are purine based nucleotides.
It is worth mentioning briefly here that these formulae 
are planer projection of three dimensional structure.
The apparent positional correspondence of the -N^ and
= 0 groups may not therefore reflect a true spacial
correspondence.
Quantitative observations on
type A and type B responses
and molecular structure ,
In these experiments, the effects of differing concentrations 
-9 -3of agents were studied, ranging from 10 to 10 M. The
amplitude of the responses during the first, second and
Figure 8.4.
Concentration dependence of type A agents (ATP,
-9 -3ADP, AMP and CTP, range from 10 to 10 M) on
contractile force during the first phase (3rd
twitch) of the response. Tension is expressed
as a multiple of the control value. Each
*4“point represents mean value - S.E. taken from 
10 preparations. The control tension response 
is depicted by the horizontal broken line.
Note the order of relative potencies of type A 
agents: ADP > ATP > AMP > CTP.
Abscissa; concentration (M). Ordinate; Tension 
ratio (test/control).
Stimulation parameters: Pulse width,, 5 msec; 
amplitude, lOV; frequency, 30 min \
Flow rate: 100 ml.min 1. Temp, 19oC.
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third phases were measured at twitch numbers 3, 18 
and 50 respectively (Fig.5.8; vertical dashed lines).
Log-dose response curves for the first component (type A
agents only); Log-dose response curves for the initial,
fast-developing positive inotropic effects (1st phase) 
for the type A agents Is shown in Fig.8.4. The relative 
potencies are in the order: ADP > ATP > CTP > AMP. 
These results can be expressed more quantitatively in 
terms of the dose required to produce a half maximal 
response (ED^q). These were as follows: ADP, 4 x 10 M;
ATP, 1.5 x 10‘6M; CTP, 4 x lO"5M; AMP, 4.5 x lO_5M. 
Assigning the efficacy of AMP as unity, then CTP is 1.13x; 
ATP, 30x and ADP, l,130x as effective. The maximum 
potentiations observed at 10 M (expressed as a multiple 
of the control value) were: ADP, 4.55 - 0.30 x; ATP,
3.95 - 0.30x; CTP, 2.98 - 0.22x and AMP, 2.50 ± 0.17x.
This particular concentration is the same as the one used 
for the experiments shown in Fig.8.2.
Log-dose response curves for the second component
(type A) agents only: The method used to analyse the size
of the second component was described previously (see 
Chapter V) and is shown diagrammatically in Fig.8.5A. 
Fig.8.5B shows log-dose response curves for the observed
Figure 8.5.
(A) A diagrammatic illustration of the 
inhibitory effect of the 2nd phase. The 
inhibitory effect (l) is obtained by sub­
tracting the observed tension during the 2nd 
component from the mean value of the 1st and
3rd phases. The results of 10 experiments 
— -3for type A agents (range from 10 to 10 M) 
are shown in (C).
(B) Log-dose response curves for the 
observed tension responses'elicited by type A
agents (ATP, ADP, CTP and AMP) at concentrations
-9 -3ranging from 10 to 10 M. Note the decline 
in tension to below the control (hypodynamie) 
level (horizontal broken line) in the presence 
of high concentrations of ATP, ADP and AMP. 
Abscissa; Concentration (M). Ordinate; Tension 
ratio (expressed as multiples of control values)
(C) Log-dose response curves for the in­
hibitory effect of the 2nd phase of type A 
(ATP, ADP, CTP and AMP) agents-induced inotropic 
responses. Abscissa; Concentration (M). 
Ordinate; Inhibitory effect, tension ratio 
(expressed as multiples of control values).
Stimulation parameters; Pulse width, 5 msec;
-1frequency, -0 min ; amplitude, lOV.
Flow rate: 100 ml.min \ Temp, 19°C.
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■ J:••tension response, and Fig.8.5C after analysis. i
J
The relative potencies of the type A agents during the
Jsecond phase are in the order: ADP ATP > CTP .1
>AMP. Corresponding ED^’s are as follows:- ADP,
7.5 x IO" M; ATP, 7.5 x 10’ M; CTP, 1 x 10 M; AMP, I
-5 ?2 x 10 M. Again taking the efficacy of AMP as unity, $
J
CTP is 2x; ATP, 2.66x and ADP, approximately 26x as
effective.
■ 3
The maximpm twitch potentiations observed (as multiples 
-4 . +of control values; 10 M) were ADP, 3.10 - 0.26; ATP,
3.05 - 0.17; CTP, 1.92 - 0.12; AMP, 1.1 - 0.08.
Log-dose response curves for ^rd* component (Types A
and B responses): Both types A and B agents are con­
sidered here on the assumption (though not yet proven) that 
the type B response is essentially the same as the type A 
response without the first and/or second components.
Log-dose response curves for the third components are shown 
in Fig.8.6. The over all order of potency is: UTP 
ITP >> ATP > ADP > CTP > GTP > AMP. Considering 
the type A agents alone, the order is ATP ADP 7> CTP
AMP. The ED^q’s for the type A agents were: ATP,
5.5 x 10 6M; ADP, 6.5 x 10_6M; CTP, 7.5 x 10_6M; AMP,
... via.®
Figure 8.6.
Log-dose response curves of types A (ATP, ADP,
CTP and AMP) and B(UTP, ITP and CTP) agents
-9 -3(range from 10 to 10 M) for the ’3rd* com­
ponent of the contractile response. Tension
is expressed as a multiple of the control value 
+Each point is the mean - S.E. taken from 10 
preparations. Control level is denoted by the 
horizontal broken line. The letters A and B 
beside the compounds denote the type. Note 
the order of relative potencies: UTP
ITP > ATP > ADP >■ CTP > CTP AMP.
Note also the variation in the sizes of the 
responses induced by these compounds.
Abscissa; Concentration (M). Ordinate; Tension 
ration (ATP/Control).
Stimulation parameters: Pulse width, 5 msec; 
frequency lOmV; amplitude, lOV. Flow rate:
100 ml.min -. Temp. 19°C.
o
!<
o.
3RD PHASE
Zo
to
zLU
I0-9 10-8 IO'7 IO'6 IO'5 IO'4 IO'3
[m]Concentration
143
-51 x 10 M. Taking the efficacy of AMP as unity, CTP 
is 1.3x, ADP, 1.5x and ATP, 1.8x as effective. Thus, 
there is relatively little difference in the potency of 
the various type A agents investigated.
Maximum twitch potentiations (expressed as multiples of 
control values) at 10 Sd were: ATP, 3.50 - 0.16; ADP,
3.35 - 0.25; CTP, 3.15 - 0.20; AMP, 1.35 - 0.02.
The relative potencies of the type B agents are: UTP
ITP > GTP. The ED ' s were: UTP, 8.5 x 10_8M; ITP,
-7 -58 x 10 M; GTP, 1 x 10 M. Expressing relative potency 
in terms of the effectiveness of GTP as unity gives: UTP, 
118x and ITP, 12.5x as effective as GTP.
Maximum twitch amplitudes (expressed as multiples of the
. -4 +control values) at 10 M were as follows: UTP, 6.20 - 
0.23; ITP, 5.95 - 0.28 and GTP, 3.00 - 0.27.
Effect of a nucleoside (adenosine)
on ventricular contractility.
Adenosine differs from the type A and type B agents in that 
it exerts an exclusively negative inotropic effect. Fig.8.7A
Figure 8.7.
(a) Time course of changes in contractile force
following exposure of hypodynamie ventricle to
-410 M adenosine. The molecular structure of the
compound is shown for comparison. Tension is 
expressed as a multiple of the control value.
Each point represents the mean - S.E. taken from 
10 preparations. The! control level is shown by
the horizontal broken line. Note the negative 
inotropic effect elicited by adenosine and the 
absence of a terminal phosphate in the molecule. 
Abscissa; Number of beats, Time (sec). Ordinate; 
Tension ratio (adenosine/control).
(B) Dose-response curve for negative inotropic
'8 '3action of adenosine (range from 10 to 10 M).
Tension is expressed as a multiple of the control 
value. Each point represents the mean - S.E.
taken from 10 preparations. Abscissa; Concen­
tration of adenosine (M). Ordinate; Inhibitory 
effect (% age of control).
Stimulation parameters: Pulse width, 5 msec; 
frequency, 30 min; amplitude, lOV.
Flow rate: 100 ml.min \ Temp, 19°C.
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shows the time course of the response to 10 M adenosine, 
together with the structure of the molecule. Immediately
after the addition of adenosine the contractile force
decreases, falling to a minimum by the 18th twitch (approx­
imately 36 seconds). Fig.8.7B illustrates the dose-
dependent negative inotropic response induced by varying
-8 —3concentrations from 10 to 10 M. Adenosine produced a
—j—maximum negative inotropic effect of 52 - 4% of the control
Q £
level at 10 M, with an ED^q of 8.5 ■£ 10 M.
The effect of adenosine is of interest, since it differs 
from ATP, ADP and AMP by virtue of having no phosphate group 
attached to the ribose moeity. This difference in chemical 
structure must therefore be responsible for the difference 
between type A responses and the exclusively negative in­
otropic effect shown by adenosine.
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DISCUSS 1 0 N •K
These experiments (and those described previously, pages 106;-108) 
would appear to rule out either yS-adrenergic or choliner­
gic receptors in mediating the response to ATP and other 
high energy nucleotides. It has also been shown that the 
broad classification of the responses into types A and B 
does not correspond with the classification of the various 
nucleotides tested into either purine or pyrimidine based 
nucleotides. However:, a number of salient points emerged
which may later prove to be a clue as to the nature of the 
receptor or receptors involved.
First, the type A responses are given by agents which con­
tain one or more ribose-bound phosphate groups, together 
with a free -NH2 group located on the 6C(purine) or 40 
(pyrimidine) positions. When these are replaced by a
ketone group (as in ITP, UTP and GTP), the initial rapidly- 
developing positive inotropic effect (1st phase) and the 
2nd (inhibitory) phase produced by type A agents are both 
lacking and the response becomes a single, monotonic in­
crease in contractility with a time course which resembles 
closely that for the 3rd phase of the type A response.
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The data presented earlier (Chapter V) suggest ■ tHat 
the initial effect of ATP may be on the slow inward
calcium current, which in tunn inttiaes) chnngs) in
cyclic 3*,5*-nucleotide levels. Since with the type A 
agents contractile force was seen to be closely cor­
related with changes in cyclic AMP and cyclic GMP, it 
is reasonable to suppose that the type B agents, which 
give a different kind of response, probably affect the 
metabolism of cyclic 3',5'- nucleotides in a different 
fashion. This remains to be established. It is possible, 
for example, that the initial increase in cyclic AMP levels 
seen with the type A agents is either absent altogether, 
or is effectively * swamped* by a relatively large (.but 
transient) increase in the levels of cyclic GMP. A more 
detailed comparative study of the effects of types A and 
B agents on cyclic 3*,5*- nucleotide metabolism may yield 
useful information concerning the nature of the receptor 
involved in mediating these responses.
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PART II!
FURTHER EVIDENCE FOR A CORRELATION
BETWEEN VENTRICULAR CONTRACTILITY
AND INTRACELLULAR CYCLIC 3', 5'-
NUCLEOTIDE LEVELS
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CHAPTER IX
EFFECTS OF ISOPRENALINE ON CONTRACTILE
FORCE AND INTRACELLULAR CYCLIC 3*, 5'-
NUCLEOTIDE LEVELS
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INTRODUCTION
It was felt that the potential importance of the conclusion 
arrived at in the proceeding chapter - namely, that con­
tractile force is regulated by an intracellular mechanism 
involving both cyclic 3*, 5* -nucleotides - could be sub­
stantiated if the generality of the relationship between 
the cyclic nucleotide ratio and contractile force could be 
established in other physiologically - relevant situations.
For instance, does it hold too during the response of the 
ventricle to the catecholamines, to acetylcholine, to 
ouabain or to the E series of prostaglandins, all of which 
are known to have marked inotropic effects on ventricular 
contractility. This chapter presents the results of 
experiments concerning the effects of a/9-agonist, isopre- 
naline, on ventricular contractility and cyclic 3*, 51 - 
nucleotide levels. Isoprenaline was selected because 
(a) it has a powerful positive inotropic effect on the 
heart and (b) it ha^ been reported (England, 1976) to 
induce marked changes in intracellular cyclic AMP levels 
but to have little or no effect on the level of cyclic GMP.
Two kinds of experiments have been made. First, the time 
course of the changes in cyclic AMP and cyclic GMP were
Figure 9.1.
A representative sample of original chart
recordings (A - J) showing the time course of
the contractile responses following stimulation 
“ 6with 10 M isoprenaline, and also indicating 
the time of * crush freezing* the preparation 
prior to analyses for cyclic AMP, cyclic GMP 
and total protein. The arrows indicate the 
times of application of isoprenaline. Note 
the change in the tension scale labelled E.
Stimulation parameters: Pulse width, 5 msec;
-1amplitude, lOV; frequency, 30 min .
Perfusion rate: 100 ml.min . Temp, 19°C.
Note that in these time course experiments 
(10) ventricles from specimens of 
R. temporaria were used.
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followed in the presence of isoprenaline; and secondly, 
the effects of varying the concentrations of isoprenaline 
on the relationship between cyclic 3*, 5’- nucleotide
levels and contractility were studied.
The results of these experiments have been published 
(Singh, Flitney & Lamb, 1978).
Time course of changes in cyclic AMP and cyclic GMP levels
resulting from treatment with isoprenaline: The design of 
these- experiments was identical to that used for investi­
gating changes in cyclic nucleotide levels during the ATP-
-6induced response. Isoprenaline (10 • M) was applied to 
the hypodynamie ventricle and the resulting response 
terminated at varying times by * crush - freezing* the pre­
paration.
Fig.9.1 is a representative sample of chart recordings, 
showing contractile response and indicating the time of 
application of isoprenaline and the time of * crush - 
freezing*. The time course of the change in force
(dashed line), cyclic AMP levels (solid circles) and cyclic 
GMP levels (open circles) are plotted in Fig.9,2 (see table 
9.1, appendix IX for raw data). At this concentration,
Figure 9.2.
Time course of changes in contractile force 
(dashed line) and intracellular cyclic AMP 
(solid circles) and cyclic GMP (open circles)
during exposure of hypodynamie ventricles 
to 10 M isoprenaline. Both cyclic nucleotide 
levels and tension are expressed as multiples 
of the control (hypodynamie) values. Note
the early increase in ■iso.metrie tension 
response which corresponds more closely with 
the initial decrease in cyclic GMP level, to 
below the control (hypodynamie) value
(horizontal broken line). The rise in cyclic 
AMP level is delayed and lags behind. Control 
(hypodynamie) values (mean — S.E.) for cyclic 
AMP and cyclic GMP levels (pmol mg - total 
protein) were 9.39 - 0.66 and 1.44 - 0.15, 
respectively (n = 17). Abscissa; time (min). 
Ordinate; cyclic AMP and cyclic GMP levels 
(fraction of control (hypodynamic) value.
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isoprenaline induces a rapid and large positive inotropic 
response, the twitch amplitude rising to about 4.9 x the 
control level after approximately 60 seconds. Attention 
should be drawn to two points concerning the accompanying 
changes in intracellular cyclic 3’, 5’- nucleotide levels.
First, the initial increase in contractile force corres­
ponds most closely to a rapid fall (to around 40% of its 
initial value) in the levels of cyclic GMP, than to any 
change in cyclic AMP levels. Indeed, the data clearly 
show that the production of cyclic AMP lags behind the 
increase in contractility. This is a particularly signi­
ficant observation, since if cyclic AMP alone was acting 
as a second messenger for isoprenaline, then any increase 
in its levels would necessarily preceed the change in
contractile force.
Secondly, the onset of the return of cyclic GMP towards 
its control level is marked initially by a slowing down in 
the rate of rise in cyclic AMP levels, and then shortly 
after cyclic GMP levels increase beyond the control level, 
cyclic AMP begins to fall. This observation is consistent 
with that made earlier concerning the ATP - induced 
response, where there was also an apparent inhibitory 
influence of cyclic GMP on cyclic AMP levels.
Figure 9.3,
Data taken from Fig.9.2.
(A) Time course of changes in isometric twitch
tension (open circles) and cyclic nucleotide ratio
(solid triangles) measured at various times during
— 6the response to 10 M isoprenaline. Both
parameters are expressed as multiples of the 
control (hypodynamie) values (broken horizontal 
line). The solid line is drawn by eye to show 
the general shape of the responses, ' Abscissa; 
Time (min); Ordinate tension ratio . and cyclic 
nucleotide ratio (fraction of the control.(hypo- 
dynamic) level).
(B) Relationship between cyclic nucleotide
ratio and contractile force (multiples of control 
values). The solid line is drawn with a slope
of 1 to indicate a direct proportionality between 
the two parameters. Correlation coefficient
- S.E. of estimate: 0.99 - 0.14, n = 10, P d 
0.001. Abscissa; Tension ratio. Ordinate;
Nucleotide ratio.
TENSION RATIO 
isoR/ hypo.
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Unfortunately, it is again impossible to say whether
this is due to an inhibition in cyclic AMP . production or
to its enhanced destruction.
The relationship between the cyclic nucleotide ratio . and 
contractile force for the same data is presented in 
Fig.9.3A & B. Fig.9.3A shows the time course of the 
change in cyclic nucleotide ratio (solid triangles), 
together with the form of the contractile response (open 
circles), and Fig.9.3B depicts more clearly the relation­
ship between these two parameters. As before, the solid 
line in Fig.9.3B is drawn in by eye to indicate a 1:1 
relationship between a change in contractility and a change 
in the cyclic nucleotide ratio. Statistically, the 
correlation is highly significant: correlation coefficient
- S.E. of estimate: 0.99 - 0.14, n = 10, P -^0.001.
Log-dose response curve to isoprenaline: In these experi­
ments hypodynamie ventricles were exposed to varying 
concentrations of isoprenaline (range from 10 to 10 jM) 
Contractile force, cyclic AMP and cyclic GMP were this 
time measured close to the peaks of the resulting responses.
Fig.9.4 shows a representative sample of records. It
should be noted that these experiments were made using
Figure 9.4.
A representative sample of original chart
recordings of tension responses during exposure 
of hypodynamie ventricles to varying concen­
trations of isoprenaline (range from 10 to
-4 s10 M). The arrows indicate the times of 
application of isoprenaline. The preparations 
were superfused for approximately 100 seconds 
(peak of responses) prior to * crush-freezing1 
and cyclic nucleotides measurements. Note 
that in these log-dose experiments (7) hearts 
from another species of frogs, R escuelenta 
were used.
Stimulation parameters: Pulse width, 5 msec;
-1amplitude, lOV; frequency 30 min. ; Perfusion
“ 1rate: 100 ml.min . Temp, 19oC.
2 min
K
r J •. ■•i-.rli'i*t i-i i-i : •
ISOPRENALINE
153
ventricles from speciments of R escuelenta and not
R temporaria as were used in the time course experiments.
The raw data of these experiments are presented in table 9.2 
appendix IX.
Fig.9.5 shows log-dose response curves for cyclic AMP
levels (solM circles) and cyclic GMP levels (open circles) 
in the range of 10 10 to 10 4M isoprenaline. Both show
similar sigmoidal curves with which AMP levels increasing 
approximately 3.5 x and cyclic GMP levels approximately 
1.63 x over the range investigated. The relationship
between the varying concentrations of isoprenaline and 
intracellular cyclic nucleotide ratio, is depicted in 
Fig.9.6A (solid triangles) together with contractile force 
(open circles). Once again it is evident that the change 
in force is accompanied by a corresponding change in cyclic 
nucleotide ratio. The two parameters are plotted together 
in Fig.9.6B using the same method of representation as 
used before. The data again reveal a highly significant 
correlation (correlation coefficient - S.E. of estimate:
0.99 - 0.06, n = 7, P < 0.001).
Figure 9.5.
Log-dose response curves for intracellular cyclic 
AMP levels (solid circles) and cyclic GMP levels
(open circles) following stimulation with
varying concentrations of isoprenaline ranging 
-10 -4from 10 to 10 M. Both parameters expressed 
as multiples of the control values. The two 
cyclic nucleotides show similar sigmoidal curves. 
Cyclic AMP and cyclic GMP increased approximately 
3.5x and 1.63x respectively, over the range of 
j isoprenalstudied.. Abscissa; concen­
tration of isoprenaline (M). Ordinate; cyclic 
AMP and cyclic GMP levels (fraction of control 
value).
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DISCUSSION
The experiments with isoprenaline provide further
evidence for a close relationship between ventricular
contractility and intracellular cyclic 3,5*- nucleotide 
levels. These results extend the generality of the re­
lationship and add further weight to the idea that cyclic 
AMP and cyclic GMP together participate in an intracellular 
control system which regulates the force of contraction.
One particularly significant finding which deserves 
special comment concerns the changes which occur early on 
in the response to isoprenaline. In previous work,
England (1976) reported an increase in cyclic AMP levels 
in rat hearts, but failed to observe any change in the 
levels of cyclic GMP. Inspection of his results (his 
Fig.5) shows clearly that cyclic GMP levels were not 
monitored early enough to detect the initial fall in cyclic 
GMP which, in the context of the present study, is the 
most significant effect of isoprenaline, since it is this 
which is chiefly responsible for altering the cyclic 
nucleotide ratio in the upward direction. To emphasise 
this point still further, it is quite clear from these 
experiments that cyclic AMP does not function as the sole 
second messenger for isoprenaline, for its production lags
behind the increase in contractility.
Figure 9.6.
Data taken from Fig.9.4. and 9.5.
(A) Effects of isoprenaline ranging from
10 ^"0 to 10 on contractile force (open circles) 
and intracellular cyclic nucleotide ratio (solid 
triangles). Abscissa; concentration of iso­
prenaline (M). Ordinate. Tension ratio
isop.)/P(hypo)| • Cyclic nucleotide ratio.
cyclic AMP/cyclic GMP (isop.)
cyclic AMP/cyclic GMP (hypo.)
(B) Relation between isometric force and
cyclic nucleotide ratio. Both parameters are 
expressed as multiples of the control values.
The number beside each point indicates the con­
centration (M) of isoprenaline. The solid line 
is drawn by eye to show the theoretical relation­
ship between the two parameters, assuming a 1:1 
proportionality. Correlation coefficient 
- S.E. of estimate: 0.99 - 0.57, n = 7,
P < 0.001.
1TENSION RATIO
(c AMf/c GMP)-isop
(c AMP/c GMP)- hyp
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Special consideration too should be given to the results
obtained by varying the concentrations of isoprenaline. 
These indicate first, that isoprenaline exerts dose - 
dependent effects on the levels of cyclic AMP and cyclic 
GMP, and secondly, that the relationship between ventri­
cular contractility and altered 3*, 5' - nucleotide ratio 
is maintained over the entire range of concentrations
studied.
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CHAPTER X
GENERAL DISCUSSION
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The work summarised in this thesis points clearly to the 
involvement of both cyclic AMP and cyclic GMP in an in­
tracellular control system which in some as yet unknown 
fashion regulates the capacity of the ventricle to contract. 
This conclusion is based upon experiments concerned with 
three physiologically - distinct and apparently unrelated 
responses which (it transpires) all share a common feature; 
namely that changes in the ratio of cyclic AMP/cyclic 
GMP almost exactly parallel corresponding changes in con­
tractile force.
This discussion is concerned primarily with the formulation 
of a hypothesis concerning the possible nature of the 
cyclic 3', 5‘ - nucleotide dependent control system. Its 
essential features are summarised in Pig 10.1. It focusses 
attention on two main questions of current interest:
First, what is the nature of the event/s that initiate 
changes in cyclic 3’, 5* - nucleotide levels within the
fibres?
Secondly, how do cyclic AMP and cyclic GMP act in a co­
ordinate e^d manner to regualte the amplitude of the contractile
response?
Figure . 10.1
Possible mechanism for the involvement of intracellular
cyclic 3*, 5*- nucleotides in modulating cardiac
contractility.
(A) The sites of actions of neurohumoral agents to 
activate adenylate cyclase and guanylate cyclase which 
catalyse cyclic AMP and cyclic GMP production, respectively.
The influence of the protein modulator on cyclic 3*,
5*- nucleotide production is also depicted.
(B) An illustration of the sites of actions of cyclic 
AMP-dependent protein kinase and cyclic GMP-dependent
protein kinase.
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The principal aim of the discussion is to consider these 
two questions, and to attempt to relate the results of 
the present experiments to the well - established key 
position of calcium in regulating contraction.
What initiates changes in intracellular
cyclic 31, 5' - nucleotide level?
(a) Direct stimulation of cyclases; Consider, first, 
the possibility of direct activation of enzymes which 
synthesise cyclic 3’, 5’ - nucleotides. There is abundant 
evidence that several important agents stimulate adenylate 
cyclase activity directly (Drummond & Severson, 1974; 
see main Introduction) . Adenylate cyclase resides in 
the plasma membrane of the fibres (0ye & Sutherland, 1966; 
Drummond & Duncan, 1970; Wollenberger & Schulze, 1976) 
and is known to comprise separate receptor (or regulator) 
and catalytic subunits (Robison et al, 1971). A third 
component may also exist which couples events at the receptor 
with those taking place at the catalytic site (Lehotay,
Lo & Levey, 1977). The receptor is thought to be located 
on the outside of the membrane and to be responsible for 
determining hormonal specificity, whereas the catalytic 
subunit is situated on the inner . membrane surface and 
discharges its product intracellularly. The ft - agonists 
are one group of agents which are thought to stimulate
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cyclic AMP production directly by activating adenylate 
cyclase (Tsien, 1977) .
Guanylate cyclase differs from adenylate cyclase in that 
it exists in both particulate and soluble forms (Kimura
& Murad, 1974). Evidence for a direct effect of neurohumoral 
agents, such as acetylcholine, on guanylate cyclase ac­
tivity is contradictory, although it is clear that several 
stimulate cyclic GMP production (George et al, 1970, 1973, 
1975; Watanabe & Besch, 1975; England, 1976). Whhte et 
al (1973) and Sulakhe et al (1975) obtained direct evidence 
for stimulation of guanylate cyclase by acetylcholine 
in broken cell preparations, but Kimura and Murad (1974) 
and Limbird & Lefkowitz (1975) were unable to confirm 
these results. These conflicting data suggest that acetyl­
choline may influence guanylate cyclase activity indirectly, 
through an intermediate step.
(b) Indirect stimuuation of phorphoriesSerases and adeny­
late cyclase; This thesis focusses attention on the
significance of the ratio of cyclic AMM/cycdc GMP rather 
than on the role of cyclic AMP alone, and we must there­
fore look to a mechanism that could conceivably act in 
a co-ordinated way to alter the levels of both cyclic 
nucleotides. In this context, the properties of the newly 
discovered calcium - sensitive protein monuuator (Teo
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& Wang, 1973) are of paramount importance. These have 
been reviewed recently by Wang (1977). The protein modu­
lator combines with calcium to produce an activated pro­
tein moouUator—calcium complex (Teo & Wang, 1973; Brostrom 
& Wdff, 1974) which stimulates cyclic GMP and cyclic 
AMP phosphoHesterase activity, the former more so than 
the latter (Brostrom, Huang, Breckenridge & Wotff, 1975) , 
and also adenylate cyclase activity (Cheung, Lin, Liu 
& Smoake, 1975; Gnegy, Costa & Uzunov, 1976). Thus, a
change in the availability of cal-cuum to the protein modula- 
• 2+tor, resulting either from altered Ca entry during the
action potential or from the effect this might have on 
the release of intracellular stores of calcium, would 
cause the protein moUdlator to act in a concerted fashion 
to raise or lower the cyclic 3’, 5* - nucleotide ratio 
(Wang, 1977).
This, then, provides a mechanism whereby the nucleotide 
ratio might be varied in response to agents which affect 
the distribution of calcium. These include isoprenaline 
(Natham & Beeler, 1975), adrenaline (Reuter, 1975; Nobler 
1975; Reuter & Scholz, 1977), dibutyryl cyclic AMp (Tsien 
et al, 1972; Tsien, 1973), PGE. (Mironneau & Grosset,
1976) and ATP (Goto et al, 1976, 1977 and present results). 
all of which enhance the slow inward current, and acetyl­
choline (Ikemoto & Goto, 1977; Giles & Tsien, 1975; Giles 
& Noble, 1976; Ten Eick, Nawrath, McDonald & Trautwein,
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1976), 8-Bromo cyclic GMP (Nawrath, 1977) which reduce
calcium entry. Isoprenaline, adrenaline, PGEj and dibutyryl 
cyclic AMP all exert positive inotropic effects, and we 
should therefore expect the cyclic 3’, 5' - nucleotide 
ratio to increase; this has been shown to be the case 
for isopireniali^ne (Chapter IX) . Conversely, acetylcholine 
and 8-Bromo cyclic GMP produce negative inotropic effects,
and by the same line of reasoning, the protein moUdlator
24 ■ .would respond to reduced Ca entry by lowering the cyclic 
nucleotide ratio. This has yet to be confirmed. The 
actions of ATP are particularly informative in this context, 
for it produces both positive and negative inotropic responses. 
It has been seen that during the initial (1st phase) and 
during the third phase of the ATP - induced response, 
when contractile force is enhanced, the action potential 
duration is increased and the cyclic nucleotide ratio 
is elevated, w^^ireas during the second (inhibitory) phase, 
contractile force is reduced, the action potential is 
abbreviated and the cyclic nucleotide ratio lowered.
The mechanism responsible for altering 3’, 5' cyclic nucleotide 
levels during the development of the hypodynamic state 
is less clear, although there are two pertinent findings 
which would seem to have a bearing on this problem. Pros­
taglandins Ej and Eg are known to stimulate adenylate
cyclase activity (Sobel & Robison, 1969; Klein & Levey,
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1971b) and it was shown earlier (Chapter III) that both 
of these substances are lost from the ventricle during 
superfusion, together with a hitherto unidentified pros­
taglandin - like substance. It is conceivable, therefore, 
that this by itself would result in lowered cyclic AMP 
levels. Furthermore, hypodynamic depression is also known 
to be accompanied by diminished intracellular calcium 
levels (Boehm, 1914; Lieb & Loewi, 1918) and by reduced 
calcuum influx (Chapman & Niedergerke, 1970a) and this 
w^i^lLd also lower the cyclic 3’, 5' - nucleotide ratio 
via its effect on the protein moduuator.
Finally, consideration must be given to the possibility 
that cyclic GMP levels per se act to regulate those of 
cyclic AMP, and vice versa. In all three responses studied 
in this thesis, it has been observed that whenever there 
is a significant change in the level of one cyclic nucleo­
tide there is usually an opposing change in the other. 
Similar changes have been reported during the course 
of a single cardiac contraction. Wooienberger et al (1973) 
showed that both cyclic AMP and cyclic GMP undergo oscilla­
tory changes which are synchronised with the cardiac cycle, 
in such a way that when cyclic AMP increases, during the 
rising phase of the twitch, cyclic GMP falls. It is im­
possible to say at this time whether this reflects a change 
in the activity of the calcium sensitive protein moduuator,
or whether it is due to a direct effect of one cyclic
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nucleotide upon the synthesis am^y/or regulation of the
other,
Whatever the mechanism, it is clear that the synthesis 
am^//or degradation of both cyclic 3', 5' nucleotides is 
closely co-ordinated by a system which is capable of altering 
the nucleotide ratio very rapidly.
How do cyclic AMP and cyclic GMP together
act to regulate force production?
Cyclic AMP is known to exf^irt its regulatory effects by 
stimulating a class of protein - ph<^^s^f^oryl^^i^ng enzymes 
called cyclic AMP- dependent protein kinases (Greengard 
& Kuo, 1970). In recent years, several physiologically 
important phosphoprotein substrates for cyclic AMP-depen­
dent protein kinases have been implicated in regulating 
myoccrdial connractility. Their functional state is known 
to be altered by an ATP - dependent phosphorylatirn of 
certain amino acid residues, catalysed by the activity 
of cyclic AMP - dependent protein kinases. These phos­
phoproteins include Troponin I (TN - I), a subunit of 
the regulatory protein complex (Reddy et al, 1973; Cole 
& Perry, 1975; Rubio et al, 1975; England, 1975, 1976;
Solaro et al, 1976); pOrspholamban, a 22,000 dalton con­
stituent of the sarcoplasmic ret:Lculum (K^^berger et 
al, 1975; Tada et al, 1975; Katz et al, 1975); and a sur-
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face membrane-bound protein which is thought to be a struc­
tural component of the slow inward (calcium) channel (Krause 
et al, 1975; Wollenberger et al, 1975).
Phosphol^^mban and the calcium channel protein are thought 
to affect the distribution of calcium, and hence its availa­
bility to the contractile proteins, by regulating trans­
membrane movements between the sarcoplasmic ret-i^uumm 
and myoplasm on the one hand (phosphoiamban) and between 
the extracellular fluid and fibre interior (channel 
portein) on the other. The role of TN - I is less clear.
It is of course well established that it prevents interac­
tion of actin and myosin in a resting muscle, and that 
this inhibitory effect is suppressed when TN - C interacts 
with calcium, but recent work, involving several different 
lines of research, indicates that its action may be more 
subtle and that it may also regulate the sensitivity of 
the contractile proteins to calcium. Thus, all three 
phosphoproteins are intimately associated with the physio­
logical functions of ca-lcuum and their principal properties 
are therefore discussed in more detail below.
Phosprolylation of TN - I and calc^m sensstivity of myo­
fibrillar ATP ase: Bailey and Villar - Palasi (1971)
first demonssrated that a purified protein kinase can 
catalyse phospho^^tim of skeletal muscle TN - I in 
the presence of cyclic AM!?. These workers postulated
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that changes in the state of pho^s^hooyli^^tion of TN ~ I 
might be involved in mediating the positive inotropic 
response to adrenaline. Work on cardiac myofibrillar 
phospholyOation followed the initial studies on skeletal 
muscle protein (Reddy et al, 1973; Reddy & Schwartz; 1974). 
Cole and Perry (1975) drew attention to three major dif­
ferences between skeletal and cardiac TN - I which they 
considered to have functional significance.
(a) TN - I from cardiac muscle has more bound phosphate
• —1(approximately 2 moles phosphate mole TN - I) than that
isolated from skeletal muscle.
(b) PhospholyOation of cardiac TN - I by cyclic AMP - 
dependent protein kinase is not blocked by TN - C, as 
is the case for skeletal muscle TN - I •
(c) Cardiac troponin differs from its skeletal muscle 
counterpart in its association with high amounts of en­
dogenous cyclic AMP - dependent protein kinase (Reddy 
et al, 1973; Perry & Cole, 1974; Perry, 1975).
It is known that the increase in contraacility elicited
by^- adrenergic agents is accompanied by elevated levels
of phospholyOatilt of TN - I; there is a time - depen™
. . 3 2 . ,dent increase in Pi incorporation into TN - I foUowing
stimulation of rat (England, 1975, 1976) and rabbit (Solaro 
et al, 1976) hearts with varying concentrations of either 
isoprenaline or adrenaline. Significantly, the time course 
of the increase in phosphooylation closely parallels that 
of the increase in connraatility. This is a particularly 
interesting observation in the light of the experimental 
results presented here, which show a similar parallelism 
between the increase in contractile force and in the ratio 
of cyclic AMPPcyycic GMP. It raises the posssbility that 
the state of phosphooyyation of TN - I is actually regulated 
by cyclic AMP and cyclic GMP acting together. We shall 
return to this point later.
The physiological influence of phosphocylation of cardiac
TN - I is u^c^J-ear. Rubio et al (1975) found that pOosphocyla--
tion of TN - I in guinea - pig cardiac muscle increased
the sensitivity of actomyosin ATP-ase to calcium. However,
results obtained by Ray and England ■ (1976) and Cole, Frearson,
Moir, Perry and Solaro (1977) show that phosphocylation
of TN - I causes a decrease in the calcium iensitivity
of actomyosin ATPase from bovine and rat cardiac muscle.
The discrepancy is difficult to explain, alhhough it is
possible that a species difference might be involved.
Although the underlying mechanism must await further clari- 
a
fiction, the experimental observations are quite clear; 
increased myyocidial con^aactlity is accompanied by increased 
phosp^^or'yetion of TN - I and by a corresponding increase
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in the ratio of cyclic AMPPcydic GMP.
PhQspholylation of phosphoproteins involved in regulating
calcium distribution.
Phospholylatinn of phosphoiamban; Several authors (Kirch-
berger et al, 1972; Tada et al, 1974; Katz et al, 1975; 
Kirchberger et al, 1975) have observed that phosphooyla- 
tion of phosphoiamban from cardiac SR by cyclic AMP - 
dependent protein kinase increases the rate of uptake 
of caldum by isolated vesicles. In view of its known 
effects on cyclic AMP levels, Tada et al, (1974) have
suggested that this might afford a basis for the well 
know "relaxant" effect of adrenaline. Conversely, Kirch­
berger and Raffo (1977) observed that dephosp^or^^on 
of phosphoiamban by phosphoppotein phosphatases is associated 
with a decrease in the rate of caldum pumping by cardiac 
SR fragments.
Phosp^or^tim of the caldum channel protein; It
was mentioned earlier that several cardioactive substances
appear to exert their inotropic actions by moduuating
the slow inward caldum current. There is now evidence
that the degree of phospholylation of the channel protein,
catalysed by cyclic AMP - dependent protein kinase, is 
• 2+related to the magnitude of the inward Ca current (WoHen-
berger, 1975; Krause et al, 1975; Hui et al, 1976; Sulakhe
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et al, 1976; Will et al, 1976). On the basis of these 
observations it has been proposed that the surface membrane 
bound phosphoppotein is in reality an integral structural
of the calcium channel. It will be recalled 
that the positive inotropic effects of isoprenaline and 
ATP, both of which are accompanied by elevated cyclic 
nucleotide ratios, are also characterised by an increase 
in the slow inward current (Natham & Beeler, 1975; Goto 
et al, 1976; 1977) .
A possible site of action for 
cyclic GMP.
The preceeding section summarises the main properties 
of three important phosphocroCeins, two of which are in­
volved in regulating the distribution of cal-cuum and one 
of which may influence the sensitivity of myyoibrkllar 
ATPase to calcium. On evidence presently available there 
are grounds for arguing that the state of phosphooylation 
of one of these, namely TN - I, is determined by the rela­
tive amounts of cyclic AMP and cyclic GMP present in the 
fibres. This is based upon a comparison of the present 
results, showing a parallel increase in contract tile force 
and cyclic nucleotide ratio, and those obtained by England 
(1975, 1976) and by Solaro et al (1976) working iwth mam­
malian hearts, who found a similar paralleliam between
32 . . .contraatility and Pi incorporation into TN - I. If
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this conclusion is correct (and it should be emphasised
that the definitive experiments, measuring conntaaCility,
32 . . . .cyclic nucleotide ratios and Pi incorporation into TN - 
I in a single species (or heart) has yet to be made) then 
it provides a strong clue concerning the mechanism of 
action of cyclic GMP. At present relatively little is 
known of its site of action in the heart, but by analogy 
with what is known about cyclic AM]?, we should expect 
it to exert its effects by stimulating a specific class 
of protein kinases. A cyclic GMP - dependent protein 
kinase has in fact been found in the heart (Kuo, 1974) 
but direct evidence for the existence of a physiologically 
relevant phosphoprotein substrate is still lacking. The 
nature of the relationship between con^ac^t^y and cyclic 
AMPPcyclic GMP imp lies that the two cyclic nucleotides 
play opposing roles in regulating contiaaiility. Thus, 
it is reasonable to postulate that since cyclic AMP-depen­
dent protein kinases phosphooylate phosphoppotein substrates, 
cyclic GMP - dependent protein kinase may be involved 
in a dephosproiylating mechanism. This line of reasoning 
leads to an important conclusion: namely; that the phos­
phoprotein phosphatases may serve as substrates for cyclic 
GMP - dependent protein kinases. The potential signifi­
cance of this conclusion is that a similar mechanism 
may also determine the state of phosphoiylation of a wide 
range of phosphoppoteins in the heart, not only phosphoiamban 
and the channel protein, but perhaps also those phospha­
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proteins which are known to be involved in energy meta­
bolism.
Concluding remarks and . scope
for future study.
The present hypothesis forms a starting point for future 
work which will focus on the following lines of inquiry;
(1) The generality of the relationship between cyclic 
3*, 5* - nucleotide levels and contractile force; It 
is important to investigate in more detail the geneeality 
of this relltionship. For example, is contractile force 
closely correlated with the cyclic 3’, 5’ - nucleotide 
ratio during the course of other responses, such as those 
to acetylcholine, the prostaglandins, ouabain, glucagon
etc? .
(ii) The form of the isomeeric twitch: Future wook
will also be concerned with a detailed study of the form 
of the twitch under different conditions; first, when 
the ratio of cyclic AMP/cyclic GMP is high (for exam^Dle, 
in response to isoprmaline) ; and secondly, when ratio 
of cyclic AMP/cycHc GPP is low (for examppe, during ex­
posure to acetyllhoiine) . A detailed compulson of the 
shape of the twitch (eg. rate of rise of tension, relaxa­
tion rates) under these two extreme conditions might pro-
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vide important corroborative evidence relating to the 
sites of actions of the two cyclic nucleotides.
(iii) Relationship between cyclic 3', 51 ~ nucleotide
ratio- and the state of phosphhrylation.of troponin I; It
is necessary to measure the levels of cyclic AMP and cyclic 
32GMP together with the incorporation of Pi into TN - 
I following treatment of the heart with various agents 
such as, acetychojLa^ne and isoprenaline, and to correlate 
observed changes with the contractile state of the heart.
(iv) Identity oo ppQrpPoprQrein suUbtrates for cyylic
GMP - dependent protein kinases; It is important to 
obtain direct evidence for a stimulatory effect of cyclic 
GMP - dependent protein kinase on phosphatase activity.
(v) Relation between cyclic 3*, 5* - nucleotide levels,
contiaalillty and the regulatory effects of calcium; Allen
and Blinks (1978) recently reported experiments in which 
they looked at calcium transients (using the calcii^m - 
sensitive photoprotein aequorin) in frog hearts during 
single contractions. They examined the effects of acetyl- 
strophanthidin and isoprenaline, used in concentrations 
which were selected to give approximately the same degree 
of potentiation of the twitch, on the calcium transients. 
Isopre^^ne was found to produce a larger calyium flux
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than acetylstrophanthidin. Clearly, it would be of in­
terest to look at the relatoonship between cyclic 3’, 5' - 
nucleotide levels, phosphorylation of TN - I and contrac­
tility using these two agents.
APPENDICES.
s
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APPENDIX II
(A-C) Protein estimation and cyclic
3*, 5* - nucleotide assays ,
(A) Protein estimation: The e^tti^^t^iion of protein in
the unknown samples was made according to the Biuret Test 
(Cornwall, Bardawi 11 & David, 1949) . The Biuret reagent 
was prepared as foioows: 1.5g copper sulphate and 6.0g 
sodium potassium tartrate were dissolved in 500 ml distilled 
water. A volume of 300ml 10% sodium hydroxide was added 
to the content and the volume made up to 1 litre. The 
reagents were finally treated with 0.1% potassium iodide. 
Stock bovine albumen was made by dissolving lOOmg of the 
crystalline substance in distilled water to give a final 
concentration of lOmg/ml.
Varying dilutions, in duplicate, of bovine serum albumen 
were made ranging from O.5mg mlto mg ml—1. To 200jul 
of the final volume of protein solution from each dilution 
800jil of Biuret reagent was added. The contents were 
vortex mixed and aloowed to stand for 30 minutes at room 
temperature. The blanks (200 jul distilled water) and 
unknown samples (200 jul), in duplicate, were treated sir 
milarly. After incubation period, the optical density 
of the solution in each pair of tubes, startling with the 
blanks, was determined at 500 nm using a Beckman (Model
24) spectrophotometer. The average reading from the blanks
Figure 2.1. Appendix II
(A) A typical protein estimation standard 
curve. Abscissa; concentration of protein
(mg/ml). Ordinate; Optical density (A).
(B) A typical cyclic AMP standard curve.
+1Each point represents the mean - S.E. taken
from 10 experiments. Abscissa; concentration
of cyclic AMP (pmol/incubation tube).
Ordinate Co.
Cx
(C) At typical cyclic GMP standard curve. 
Each point represents the mean S.E. taken 
from 10 experiments. Abscissa; concentration 
of cyclic GMP (pmol/incubation tube) Ordinate
Co.
Cx
•600
Concentration of cyclic AMP (pmol/incubation tube)
12 r*
_J___ I
7 8
Concentration of cyclic GMP (pmol/mcubatiqn tube)
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was subtracted from that of each pair of known and unknown 
samples. A calibration curve (Fig.2,lA) was constructed 
using the data. The amount of protein in the unknown 
samples was determined from this curve.
(B) Cyccic AMP assay; The meesuremeets of cyccic AMP 
were made according to the method described by the Radio­
chemical Centre Assay Kit (TRK 420) .
Simml! test tubes suitable for centrifuging and in dupli­
cate were placed into a rack which was kept in an ice- 
water bath. The tubes were labelled and various reagents 
added according to the protocol shown in table 2.1B.
Each tube was capped and vortex mixed for 5 seconds.
The ice bath containing the assay tubes was placed in 
the refrigerator at 2- 4°C for 2 hours.
Tube
No.
Reagent
1 (Buf­
fer)
Stand­
ards
(cAMP)
Unknowns Reagent
3 (h3)
cAMP
Reagent
1 ^nn^ngg
Protenn
1,2 15C - — 5C — Charcoal blank
3,4 5C - - 5C 1CC Zero dose
5,6 - 5C - 5C 1CC lpmol standard
7,8 - 5C - 5C 1CC 2pmol standard
9,1C - 5C - 5C 1CC 4pmol standard
11,12 - 5C - 5C 1CC 8pmol standard
13,14 - 5C - 5C 1CC 16pmol standard
15,etc • - - 5C 5C 1CC Unknowns
All volumes are in microlitres.
4
Table 2.1 B: Cyclic AMP assay protocol.
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After inc£ubation, 100 jal of charcoal suspension (ice 
cold and continuously stirred) was added to each assay 
tube which was vortex mixed for 5, seconds. The tubes 
were centrifuged (lOmin, 3000 rpm, 0°C) ap^iroj^^m^lse^ly 
5 minutes from the addition of the charcoal suspension.
A volume of 200 ul of the clear supernatant was carefully 
removed and placed into scintillatoon vials, which con­
tained 100ml Toluene/Triton X-100, for counting. Each 
vial was counted for 5 minutes using the Packard Tri Card 
Liquid Scintillation Spectrometer.
The count per assay tube was determined as count per minute
(c.p.m.) after correction for instrument blank. The average
c.p.m. of tubes 1 and 2 gave the blank. From the average
c.p.m. of tubes 3 and 4 the blank was subtracted and
this resulted in c.p.m. bound in the absence of unlabelled
cyclic AMP (Co). The blank was also deducted from the
average c.p.m. bound in the presence of the standards
(tubes 5-14) and unknowns (tubes 15 etc) unlabelled cyclic 
C*o ■AMP (Cx). The ratio for each level of cyclic AMP was
plotted against standard inactive cyclic AMP (pmoi/incu~ 
bation tube) to obtain a linear standard curve (Fig 2. IB) 
with an intercept of one on the ordinate. The concentra­
tion of cyclic AMP in each unknown is calculated from
Cothe calibration curve using the ratio for each. The 
amount of cyclic AMP in the unknown is divided by the
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total weight of protein in the ventricle giving the re-
• -1 • suits in pmol mg protein.
(C) CycCic GMP assay; The annlysis of cycCic GMP was 
done according to the method described by the Radioche­
mical Centre Cyclic GMP Radioimmunoassay Kit (TRK 500).
Small test tubes suitable for centrifuging and in dupli­
cate were placed into racks which were kept throughout 
the assay in an ice-water bath. The tubes were labelled 
and the various reagents added according to the protocol 
in table 2.1C. The assay tubes were capped and vortex 
mixed for 5 seconds. The ice-bath containing the tubes 
was placed in the refrigerator at 2-4oC for one and a 
half hours.
After incubation, 1ml ice cold (NHo^ SOo solution (60% 
saturated) was added to each assay tube and vortex mixed 
for 5 seconds. The tubes were centrifuged (10 minutes;
3000 rpm; 0°C) approximately 5 minutes after the addition 
of the ammonium sulphate solution. The supernatant was 
decanted and ' the precipitate dissolved in 1.1ml ice-cold 
distilled water. A volume of 1ml sample was removed from 
each tube and added to vials containing 10ml Toluene-Triton 
X-100 scintillant for counting. Each vial was counted 
for 5 minutes using the Packard (TRI CARD) Liquid Scin- 
tiHation Spectrometer and the count per assay tube deter­
mined as count per minute (c.p.m.) after correction for
the instrument blank.
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The average c.p.m. of the blank (tubes 13 and 14) was
subtracted from the average c.p.m, of tubes 1 and 2 to
give Co (the c.p.m. bound in the presence of unlabelled
cyclic GMP). The blank was also deducted from the average
c.p.m. for each pair of assay tubes for the standards
(tubes 3-12) and unknowns (tubes 15 etc.) to give Cx (the
c.p.m.bound in the presence of the standard and unknown 
, Cocyclic GMP). The ratio was plotted against varying
dilutions (pmol) cyclic GPP to give a linear standard
curve (Fig 2.1C). The of cyclic GPP in the unknowns
Cowas calculated from the standard curve using for each.
The of cyclic GMP in each unknown is divided by
the total weight of the ventricle giving the results in 
pmol mg~^ protein.
(D) Extraction, boiassay and identification
of. prostaglandins .
Extraction of prostaglandin - like substance: Samples
of perfusates were acidified to pH3 with 1NHC1, and then 
extracted twice with equal volumes of ethyl acetate. The 
organic phase was washed neutral with distilled water 
and evaporated to dryness. Nitrogen was blown into the 
flask to remove traces of ethyl acetate and the residue 
was taken up in 30ml of 67% ethanol. The ethanolic solution 
was washed twice with 15ml of petroleum spirit (b.p. 40 - 
60°C), then evaporated to dryness. Prostaglandin - like 
substance in the final extract was either dissolved in 
1ml Krebs solution and subjected to biossay or (b) 0.5ml
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ethanol and subject to thin-layer chromatography.
Bioassay of prostaglandin - like substance; The final
extract dissolved in Krebs solution was assayed for pros­
taglandin - like activity using the rat fundus strip. The 
stomach strip was prepared according to Vane (1957), mounted 
in an organ bath and immediately superfused at a rate 
of 5-10 ml min-1 with Krebs solution (comepsition (mi):
NaCl, 118.4; KCl, 3.7; MgSO4 . 7H2O,1.2; KH2PO4, 2.2;
NaHCO.gr 24.9; CaClgr 2.6; glucose, 10; pH, 7.4) gassed
with 5% CO2 in O2. The technique of superfusion was basically
that of Gaddum (1953); the tissue was counterweighted
with 0.5 - 2g and its movement was recorded with an isotonic
lever writing frontally on a rotating drum.
s
To obtain specific responses of the assay organ to pro^ag-
landin the following were com^^^(^i;dd. A mixture of inhi- 
— 6bitors containing atropine (2 x 10 M), mepyramine (3
— fi — 7x 10” M), methysergide (6 x 10 M), phentolamine (1
-6 -5
x 10 M) and propranolol (1 x 10 M) was added to the 
superfusing solution in order to render the tissue in­
sensitive to acetylcholine, histamine, 5 — hydroxy tryptamine, 
noradrenaline and adrenaline while its sensstivity to pros­
taglandin was retained. In those experiments in which 
the heart was treated with indomethacin, the assay tissue 
was also superfused with the same drug at a concentration 
of 10 jM in order to inhibit the release of prostaglandin
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from the rat fundus strip,
Authentic prostaglandin was used as bioassay standard.
A sample measuring 0.5 mm. either of known prostaglandin
E° in Krebs or the unknown was assayed at 37°C. After 
superfusing the fundus strip for half an hour, varying 
concenlrations of prostaglandin E° were used. The concen­
tration of prostaglandin - like substance in the final 
extract was determined by bracket assay.
Thin-layer chromatography; The glass plates (0.4 x
20 x 20 cm) were coated by spreading a mixture of 50g
silica gel G (Merk) and 110 ml of water using the Camag 
coater 21251 (thickness of coating approximately 0.3 mm) .
In some cases silver nitrate (5.g) was dissolved in the 
water before addition to the silica gel. The plates wjre 
activated by heating for about 30 minutes at 110 - 115°0 
before being used. Authentic prostaglandins E°, E2, F1<x , 
°2o' °1 an^ A° and extracted prostaglandin - like material 
were applied on the plates as single spots using micropipettes
The chromatoplates were placed in glass jars containing 
the AI (benzene - dioxane - acetic acid, 20: 20: 1) and 
All (ethyl acetate - acetic acid - methanol, petroleum 
spirit - water, 110: 30: 35: 10: 100) solvent systems 
of Green and Samuulsson (1964) and covered with glass
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plates. The plates were developed using the ascending 
technique, which was interrupted when the solvent front 
reached a point 2-4 cm from the top (75 - 100 minutes). 
After development, the plates were dried at 100°C and 
sprayed with 10% phosphomolybdic acid in ethanol and heated 
for 15 minutes at 120OC, which resulted in the appearance 
of dark blue spots on a yellow back-ground. The R^ values 
of the spots from the authentic and unknown samples were 
compared.
(E) DRUGS,
Drugs wsre freshly prepared as stock concentrated solutions 
in distilled water or in frog Ringer solution immmdiately 
before useo Final dilutions were made from stock.
The foUowing drugs were used:-
0- acetylcholine chloride (BDH) , adenosine (Sigma) , adenosine
5'- triphosphate (Sigma), adenosine 5’- diphosphate (Sigma),
adenosine 5’- oonopholpiolic acid (Sigmaa , adenosine 3’, 5' -
cyclic monophosphate (Sigmaa, adrenaline tartrate (BDH),
arachadonac acid (Simgaa, atropine sulphate (BDH), 8-Bromo
guanosine 3’, 5' - cyclic monophosphate (ICN Pharmoacdticals), 
fi 9cytidine 5’- triphosphatd (Sigma), F, 0o- dibutyryl adenosine 
3', 5' - cyclic monopiolpiolic acid (Sigmaa, guanosine 
5’ - triphosphatd (Sigma), guanosine 3’, 5* - cyclic mono­
phosphoric acid (Sigma) , indomethacin lactose ((ierk, Sharpe 
and Dhome Ltd), inosine 5' - tri-phosphate (Sigma) , DL -
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isoprenaline hydrogen chloride (Sigma), mepyramine bimaleate 
(May and Baker Ltd), methysergide bimaleate (Sandos Ltd), 
phentolamine (Ciba) , propranolol hydrogen chloride (Sigma), 
prostaglandins E°, E°, ' F2 ' °1 an(^ °2 (Upjobn
Company Ltd), uridine 5' - triphosphate (Sigma) and vera­
pamil (Pfizer).
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Mean values (- S.E’s) for the levels of cyclic AMP
and cyclic GMP in freshly frozen ventricles (10
+ -1preparations were found to be 15.80 - 0.31 pmol mg 
+ -1protein and 0.55 - 0.04 pmol mg protein, respectively. 
Recovery of known amounts of cyclic AMP and cyclic GMP 
were 90.80% and 89.72%, respectively.
Table 4.2. Cyclic nucleotide levels in the superfusates 
during the development of the hypodynamic state
Time Cyclic AMP Cyclic GMP Tension
(min) (pmol mg” protein) (pmol mg"lprotein) (Fraction of 
initial value)
10 1.17 0.112 0.88
20 1.58 0.115 0.68
30 1.81 0.114 0.47
40 2.01 0.113 0.31
50 2.35 0.094 0.25
60 3.10 0.110 0.19
70 3.25 0.089 0.16
Intracellular cyclic AMP and cyclic GMP levels for the freshly
frozen ventricle (initial level) and the control (hypodynamic)
186
-1ventricle were 20.55 and 0.122 pmol mg protein and
7.99 and 0.245 pmol mg 1 protein, respectively.
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Mean values S.E’s) for levels of cyclic AMP and
cyclic GMP in the control (hypodynamic) ventricles
+ -1(12 preparations) were 8.05 - 0.43 pmol mg protein
+ -1and 0.91 - 0.13 pmol mg protein, respectively.
-3Interference from ATP (10 M). The cross reactivity of
-310 ATP with cyclic AMP binding protein and cyclic GMP 
antiserum was investigated to establish if ATP interferes 
with the assay. The results are shown in table 7.2.
and suggest that ATP does not cross-react in these
-3 ■assays at 10 M. These results are in agreement withI
the findings of the Radiochemical Centre Product Infor­
mation (1977) in which it is reported that ATP does not 
interfere with (a) the cyclic AMP assay, at concentrations 
up to 5 mM which represents approximately one million 
fold-excess over the tritium-labelled cyclic AMP or 
(b) the cyclic GMP assay, at concentrations up to ImM 
which represents a 5000,000-fold excess over tritiated 
cyclic GMP.
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Table 7.2.
Conditions Average c.p.m. % age cros: 
reactivity
Control c AMP, 8 pmol 625.4 -
Test c AMP, 8 pmol
4 10“%M ATP 623.0 0.38
Control c GMP, 4 pmol 440.5 -
Test c GMP, 4 pmol
+ 10"3M ATP 438.4 0.47
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Interference from isoprenaline. In the present study-
cross reactivity of isoprenaline (10 6M) with cyclic 
AMP binding protein and cyclic GMP antiserum was done 
to investigate whether the p-agonist interferes with
the assay procedures. The results are summarised in
table 9,2. and suggest that the extent of cross reaction
is negligible.
Table 9.2.
Conditions Average c.p.m. 7o age cross 
reactivity
Control c AMP, 8 pmol 625.4 —
Test c
+
AMP, 8 pmol
lO ^M isop. 622.5 0.46
Control c GMP, 4 pmol 440.5 -
Test c
+
GMP, 4 pmol
10 ^M isop. 438.8 0.38
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Effects of ATP on the hypodynamie frog ventricle
By F. W. Flftney, J. F. Lamb and J. Singh. Department of Physiology, 
University of St Andrews, St Andrews, Fife KY16 9TS
The effects of exogenous ATP on the electrical and mechanical proper­
ties of the hypodynamic frog ventricle have been investigated. Strips of 
ventricle were mounted horizontally and attached to a strain gauge. The 
inner surface was superfused with frog Ringer (100 ml. mm-1) containing 
ATP (10“® to 10“3 m) while the preparation was stimulated electrically 
(0 *2-1 Hz; 10 V square pulses; 5 msec duration). Fig. 1 shows the response
Duration of action 
potential (ATP/control)
Fig. 1, A, B, chart-recordings of two responses to ATP, 10-® M (A) and 
10~3 M (B). C, the relation between twitch tension and action potential 
duration for concentrations of ATP ranging from 10~® to 10~® m. The values 
were obtained for the 50th twitch, recorded during the third phase of the 
response. Mean values ± i s.D. are shown (n = 10 for each point). D, iso­
metric twitches (lower records) and action potentials (upper records) 
recorded in normal Ringer and in presence of 10-® m ATP (50th twitch).
[P.T.O.
2
to 10~5 M (J.) and IO-3 M (B) ATP. There is an immediate, positive ino­
tropic effect (1), followed by a period when the twitch is depressed, some­
times to below the control (hypodynamic) level (2), superseded by a 
longer-lasting (~ 80 min) potentiation (3), which is maximal after 1-2 min 
(cf. Versprille, 1963). Pretreatment with theophylline (10-4 M, 10 min) 
enhances the third component of the ATP response, but depresses the 
first. ADP produces a qualitatively similar response to ATP, as does AMP 
in high (IO-3 m) doses, but adenosine has a small inhibitory effect. ATP 
affects the time course of the action potential (Pig. ID). Pig. 1C shows 
the relationship between action potential duration (measured at — 30 mV) 
and twitch potentiation, recorded during the third phase, for [ATP] of 
10~8 to IO-3 m (slope of regression line = 4473 + 0-013; P < 0-001; n — 6).
The observations suggest that ATP facilitates entry of Ca2+ into the 
fibres and that its inotropic actions are mediated through changes in 
intracellular levels of cyclic-AMP and -GMP (Nawrath, 1976).
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Intracellular cyclic nucleotides and contractility of the hypodynamie frog 
ventricle
By P. W. Putney, J. P. LamB and J. Singh. Department of Physiolog'y and Pharma­
cology, University of St Andrews, St Andrews, Scotland
IhtraGellular cyclic AMP and cyclic GMP have been measured in isolated frog 
ventricles at various times during the development of the hypodynamie state. 
Ventricular strips were superfused with frog Ringer (100 ml. min-1; 1-8 hr) and 
stimulated at 0*5 Hz (square pulses, 10 V, 5 msec) through silver-wire electrodes. 
Preparations were frozen in liquid nitrogen and assayed for cyclic AMP, cyclic GMP 
and total protein.
The decline in twitch tension is depicted in Pig lA (triangles), together with 
observed changes in intracellular cyclic AMP and cyclo GMP. Tension and cyclic 
nucleotide levels are expressed as multiples of the initial (control) values. There is a 
progressive reduction in cyclic AMP, accompanied by a rise in cyclic GMP; the 
resulting decrease in the ratio [cyclic AMP]/[cyclic GMP] parallels closely the decrease 
in isometric force (Pig. IB).
Superfusion with Ringer solution containing exogenous cyclic nucleotides affects 
both the time course of the decline in twitch tension and the steady-state level 
attained in a dose-dependent fashion; 8-bromo-cyclic GMP accelerates the decay of 
tension and decreases the steady-state level, whereas dibutyryl cyclic AMP delays the 
development of the hypodynamie state and elevates the steady-state value. Dibutyryl- 
oyolic AMP ( > 10~® m) prevents the decline of twitch tension (up to 8 hr) and pro­
duces steady-state levels up to 1*3 x the initial (control) value.
These results suggest that the ratio [cyclic AMP]/[cyclic GMP] is an important 
determinant of contractile force in the isolated frog ventricle.
[P.T.O.
2Relative tension (fraction of initial tension)
Fig. 1. A, the decline in twitch tension and changes in cyclic nucleotide levels 
B, relation between relative tension and the ratio [cyclic AMP]/[cyelio GMP].
[From the Proceedings of the Physiological Society, 6-7 January 1978 
Journal of Physiology, 277, 69-70P]
Effects of exogenous ATP on contractile force and intracellular cyclic 
nucleotide levels in the hypodynamie frog ventricle
By F. W. Flitney, J. F. Lamb and J. Singh. From the Department of Physiology and 
Pharmacology, University of St Andrews, Scotland
We (Flitney, Lamb & Singh, 1977 a) postulated that the inotropic effects of ATP 
on the hypodynamie frog ventricle are mediated through changes in cyclic nucleo­
tide levels, and demonstrated (Flitney, Lamb & Singh, 1978) that the decline in 
isometric force during the development of the hypodynamie state is accompanied by 
a decrease in cyclic AMP and a rise in cyclic GMP. We now offer direct evidence for a 
close correlation between changes of twitch tension and [cyclic AMP]/[cyclic GMP] 
following treatment of hypodynamic ventricles with exogeneous ATP.
R i [cyclic AMP]/[cyclic GMP]~ATP 
atio [cyclic AMP]/[cyclic GMP] control
Fig. 1. Relation between relative force and cyclic nucleotide ratios (J.) measured at 
various times {B, arrows) during the inotropic response to lO~3 m-ATP.
Hypodynamie ventricular strips were superfused with frog Ringer containing 
10“® m-ATP. Preparations were frozen at different times during the ATP response 
(Fig. 1B) and assayed for cyclic AMP, cyclic GMP and total protein. Fig. l A shows 
the relation between twitch tension and [cyclic AMP]/[eyciic GMP]. Isometric force 
and cyclic nucleotide ratios are expressed as multiples of the control (hypodynamie) 
values. The observed linear relation (slope of regression line + s.E. : 1*01 ± 0*01 ; n = 
13; P < 0-001) suggests that ATP exerts its effect through changes in intracellular 
cyclic nucleotides and lends further sruppor^-t to the view (e.g. Nawrath, 1976) that 
these substances are important factors in determining myocardial coiri^rrint^t^il^ii’fcy.
[P.T.O.
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1. Introduction
The increase in contractiiity which occurs in 
response to /Sadrenergic stimulation of the heart is 
thought to be mediated through changes in the levels 
of intracellular adenosine 3',5'-cyclic monophosphate 
(cyclic AMP) [1—5]. The possibiiity that guanosine 
3',5'acyciic monophosphate (cyclic GMP) is also 
involved in regulating the contractile response of the 
heart has received comparatively little attention. This 
is somewhat surprising since it has been shown that 
the negative inotropic response to acetylcholine is 
associated with a rise in intracellular cyclic GMP 
[6—8], and that the levels of both cyclic AMP and 
cyclic GMP undergo osfccil^^ory changes which are 
synchronised with the cardiac cycle [9]. In addition, 
we demonstrated that the development of the hypoa 
dynamic condition [10] and the inotropic response 
of the isolated frog ventricle to stimulation with 
exogenous ATP [11,12] are characterized by changes 
in the levels of both cyclic 3',5'anucleotides. Moreover, 
in each instance a striking correlation exists between 
changes in isometric twitch tension and the ratio of 
(cyclic AMP)/(cyclic GMP).
This paper presents results which show changes in 
the levels of cyclic AMP and cyclic GMP following- 
stimulation of the hypodynamie frog ventricle with 
the /-agonist isoprenaline and here too there is a clear 
correlation between the magnitude of the contractile 
response and the change in the cyclic nucleotide ratio.
2. Methods
2.1. Heart perfusion
Hearts from frogs, Rana temporaria and Rana
esculenta, were isolated and superfused at room 
temperature (18—20“C) by the method in [13]. The 
perfusion rate was kept constant at 100 ml. min-1 
and the preparation was stimulated (Ag wire elec­
trodes) at 30 min_i (square, 5 ms pulses, 10 V). The 
ventricular strip was allowed to become hypodynamie 
and subsequently superfused with frog Ringer con­
taining isoprenaline. At a predetermined time during 
the isoprenaline response it was freeze-clamped in 
liquid nitrogen. Another strip taken from the same 
ventricle was allowed to become hypodynamic to 
the same extent as the first and then freeze-clamped 
in liquid nitrogen. The latter served as the control 
strip.
2.2. Extraction and assay for cyclic nucleotides
Frozen ventricular strips were pulverized into a 
powdered extract. Cyclic AMP and cyclic GMP from 
the latter were extracted and assayed by the techniques 
in [14] and [15], respectively. The amount of 
protein present in the extract was estimated by the 
method depicted by [16]. Cyclic nucleotide results 
were expressed as pmol cyclic AMP or cyclic GMP/mg 
protein.
3. Reeults ann discussioo
Figure 1 shows the time course of the changes in 
intracellular cyclic AMP and cyclic GMP following 
superfusion of isolated frog (JR. temporaria) ventric­
ular strips with 10“6 M isoprenaline. The accom­
panying contractile response is also shown (dashed 
line) for comparison. There are two points to empha­
sise. First, the early increase in contractile force
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Fig.l. Time courses of changes in contractile force (dashed 
line) and intracellular levels of cyclic AMP (solid circles) and 
cyclic GMP (open circles) during exposure of the frog ventricle 
to 10"* M isoprenaline. Control (hypodynamie) values 
(mean ± SE) for cyclic AMP and cyclic GMP levels (pmol 
mg"*, total protein) were 9.39 ± 0.66 and 1.44 ± 0.15, 
respectively (n = 17).
Fig.2. A. Time course of the change in isometric twitch tension 
(open circles) and cyclic nucleotide ratio (solid triangles) 
measured at various times during the response to 10"* M 
isoprenaline. Both parameters expressed as multiples of the 
control (hypodynamie) values. B. Data taken from fig.l.
Cyclic nucieotide ratio plotted against contractile force.
Solid line drawn with slope of 1. Correlation coefficient ± SE 
of estimate: 0.995 ± 0.143, h = 10,F < 0.001.
corresponds more closely with an initial decrease in 
the level of cyclic GMP; the rise in the level of cyclic 
AMP is delayed and lags somewhat behind the con­
tractile response. This result is of considerable interest 
since it was demonstrated in mammalian hearts 
[17—19] that a rise in cyclic AMP preceeds the 
onset of the inotropic response; indeed, this provides 
essential corroborative evidence in support of the 
‘second messenger’role for cyclic AMP [1]. Secondly, 
cyclic GMP levels reach to the control value (horizon­
tal broken line) at about the time when the contractile 
response is maximal and further increase is accom­
panied by a fall in isometric twitch tension and a 
decrease in the level of cyclic AMP.
It was found earlier that a striking parallelism 
exists between the time course of the change in 
ventricular contractility and the ratio of the two cyclic 
nucleotides during both the development of the 
hypodynamie condition [10] and during the inotropic 
response to exogenous ATP [12]. The results of fig.l. 
yield a similar correlation, as shown in fig.2A. This 
depicts the change in the ratio of cyclic AMP/cyclic 
GMP, that is:
[cyclic AMP/cyclic GMP (isop) 1 cyclic AMP/cyclic GMP (hypo) J
with time (solid triangles), together with the accom­
panying tension response (open circles). Statistically, 
the correlation is highly significant (correlation
coefficient ± SE of estimate: 0.995 ± 0.143, n = 10, 
P< 0.001) and reveals a clear correspondence 
between a change in the cyclic nucleotide ratio and 
the accompanying change in force (fig.2B, inset).
The effects of altering the concentration of iso- 
prenaline on cyclic nucleotide levels and on contractile 
force for seven preparations is shown in fig.3,4. In
Fig.3. Log dose-response curves for concentrations of iso­
prenaline ranging from 10‘10—10"* M. Solid circles, cyclic 
AMP; open circles, cyclic GMP. Preparations superfused for 
approximately 100 s prior to freeze-clamping. Both param­
eters expressed as multiples of control values.
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Fig.4. A. Effects of isoprenaline ranging from 10",o-10~4 M 
on contractile force (open circles) and cyclic nucleotide ratio 
(solid triangles; data from fig.3). B. Relation between iso­
metric force and cyclic nucleotide ratio (multiples of control 
values). Correlation coefficient ± SE of estimate: 0.996 ± 0.57, 
/i = 7,P< 0.001.
these experiments hearts from another species of frogs, 
R. esculenta, were used. Figure 3 shows log dose- 
response curves for the increase in cyclic AMP (solid 
circles) and cyclic GMP (open circles) measured 
~ 100 s after superfusing with the drug when the 
response was maximal. The change in the ratio of 
cyclic AMP/cyclic GMP with varying concentrations 
of isoprenaline and the corresponding change in 
isometric twitch tension, measured at the time of 
freeze-clamping each preparation, are shown in fig.4. 
The data again reveal a clear correlation (fig.4B. inset: 
correlation coefficient ± SE of estimate: 0.996 ± 0.057, 
n = l,P< 0.001) between the cyclic nucleotide ratio 
and contractile force.
I These results, and those referred to earlier [10,12],
lead us to postulate that cyclic AMP and cyclic GMP 
are important components of a control mechanism 
which regulates the capacity of the ventricle to 
produce force. The observed correlation between the 
ratio of the two cyclic nucleotides and isometric 
force suggests that they play opposing roles in the 
regulatory process, a feature which is seen in several 
other biological systems [20]. Both cyclic AMP and 
cyclic GMP are thought to exert their regulatory 
effects on cellular metabolism by activating a number
of protein kinases, and several substrates for cyclic 
AMP-dependent protein kinases have been implicated 
in regulating myocardial contractility, troponin I 
(TN-I), a subunit of the regulatory protein complex 
[21]; phospholamban, a 22 000 dalton protein con­
stituent of the sarcoplasmic reticulum [22]; and a 
surface membrane-bound protein, thought to be a 
component of the slow inward (calcium) current 
channel [23]. It has been previously demonstrated 
that perfusion of the rat hearts with isoprenaline 
produces a time-dependent increase in the state of 
phosphorylation of TN-I, which almost exactly paral­
lels the time course of the resulting contractile 
response [24]. The existence of a similar relationship 
between the contractile force and the ratio cyclic 
AMP/cyclic GMP raises the possibility that the state 
of phosphorylation of TN-I and perhaps of other 
phosphoproteins involved in regulating force produc­
tion may be determined by the relative amounts of 
intracellular cyclic AMP and cyclic GMP. A cyclic 
GMP-dependent protein kinase has been isolated 
from the heart [25], although to date there have 
been no reports of a naturally-occuring substrate for 
this enzyme in the heart. The phosphatase enzymes 
responsible for dephosphorylating protein substrates 
would appear to be plausible candidates in the light 
of the present results.
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Release of prostaglandins from the superfused frog ventricle during the
development of the hypodynamie state
By F. W. Flitney and J. Singh. Department of Physiology and Pharmacology, 
University of St Andrews, St. Andrews, Fife, Scotland
In a previous communication (Flitney, Lamb & Singh, 19J^^8) we reported changes 
in intracellular cyclic 3',5'-nucleotide levels during superfusion of isolated frog 
ventricular preparations. We now present evidence that the loss of two prosta­
glandins, PGE, and PGEg, and a prostaglandin-related substance (PRS) also accom­
pany the development of the hypodynamie condition.
First, agents which affect PG biosynthesis influence both the rate of development 
and the degree of hypodynamie depression. Indomethacin, a PG synthetase inhibitor 
(Vane, 1971), accelerates the rate at which the hypodynamie state develops and 
depresses the final steady-state twitch tension, whereas arachidonic acid, the 
principal precursor of PG biosynthesis (Samuelsson, 1972), delays the rate at which 
the twitch tension declines and elevates the final steady-state level. Secondly, bio­
assay of ethyl acetate extracts of superfusates from ventricles allowed to become 
either partially or wholly hypodynamie provides evidence for a time-dependent 
decrease in intracellular PG levels which correlates with the observed decrease in 
contractile force (correlation coefficient + s.E. 0-98 + 0-100, % = 8, P < 0-001), 
Thirdly, thin-layer chromatography of pooled extracts, using Green and Samuelsson’s 
(1964) A II solvent system, revealed the presence of PGEX and PGEg, together with 
a hitherto unidentified PRS "with an Rf value 0-28.
These results implicate the loss from the ventricle of PGEj. and PGEg, together 
with a PRS, as possible factors contributing to the observed deterioration in the 
contractile response. They broadly support Clark’s (1913) contention that leakage 
of a lipid from the fibres may be responsible for the development of the hypodynamie 
state. Establishing a casual relationship is of course difficult, but in t^h^iis context, it is 
worth noting that authentic PGEX and PGE2 both delay the onset of the hypodynamie 
condition and also potentiate the contractile response of the ‘fully’ hypodynamie 
ventricle. Moreover, the identification of prostaglandins in the circulating super- 
fusates adds significance to our earlier observations on changes in cyclic 3',5'- 
nucleotide levels, .since the E series of prostaglandins is known to stimulate adenylate 
cyclase activity (Klein & Levey, 1971). Thus, leakage of prostaglandins and/or the 
PRS may initiate changes in intracellular cyclic 3',5'-nucleotide levels, which in 
turn affect the capacity of the ventricle to contract.
This work was supported by a grant from the British Heart Foundation.
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